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Human brains selectively store knowledge about the world to optimise future behaviour. 
We automatically rehearse and contextualise, or discard information to create a robust 
collection of facts and events. The medial temporal lobe is central to a network of 
memory regions within the brain that select important memories for long term storage. 
Much of this memory selection is purported to occur automatically during sleep. Recent 
emerging data have suggested that dopamine might influence memory longevity. 
However, it has not been clear at which time point in the memory process dopamine is 
active, particularly whether dopamine biases memory at the time information is 
encountered or, later, during consolidation of memory during sleep.  
In two independent double-blind randomised placebo-controlled studies of healthy older 
adults, I administered dopamine to temporally target memory evolution at different time-
points in relation to learning using a verbal recognition task. Nocturnal dopamine 
enhanced efficiency of routine forgetting while sparing saliently tagged information. 
Importantly, dopamine administration did not affect encoding or retrieval, strongly 
suggesting that dopamine acts after encoding during memory storage processes. Analysis 
of polysomnography suggested that the behavioural tagging effect of dopamine was 
associated with increased spindle amplitude during slow wave sleep. Overnight dopamine 
also increased total slow wave sleep duration by 11%. No relationships were seen 
between memory and medial temporal lobe structures on structural MRI. However, 
volumes of hippocampal subfields CA2 and dentate gyrus and entorhinal cortex were all 
associated with slow wave sleep duration. Intriguingly, CA2 volume negatively correlated 
with slow wave sleep duration, but positively correlated with spindle density.  
In summary, nocturnal dopamine optimises the memory selection processes by 
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Chapter I: Background 
Your accent, your deepest fears, hopes and expectations, your worldviews and ethical values –
and the specific effortless sequence that makes your perfect cup of tea – all rely on combining 
complex pieces of information about the past to make a coherent representation of the present. 
Our ability to interpret current and future events, and to navigate our environment is filtered 
through and guided by our experiences. Memory is the process of maintaining and manipulating 
information over time. It is not a passive process but instead, we update our knowledge-base 
continuously as we learn new information.  
Within the brain, changes in neuronal activity underlie memory. An engram, or a neurobiological 
representation of a memory, is born at learning (Tonegawa, Liu, Ramirez, & Redondo, 2015). 
The exact myriad of events that leads to the birth, storage and up-keep of engrams is not known, 
but it has become increasingly clear that it involves plastic changes in the brain function (Hebb, 
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1949; Squire, 1992). Several physiological processes, neurotransmitters and anatomical structures 
seem to be involved in these changes.  
The involvement of the medial temporal lobe in memory has been postulated since the 1950s 
(Scoville & Milner, 1957), and these observations have been consistently confirmed since . In 
short, hippocampus, which lies deep within the medial temporal lobe, seems to be involved in 
the initial formation and storage of autobiographical memories, and, at least in some cases, in 
later retrieval (Rugg & Vilberg, 2013). Initially engrams are encoded in the hippocampus, but 
long term storage is more reliant on cortical regions (Rasch & Born, 2013). 
Different proteins and neurotransmitters are thought to support these hippocampal processes. 
Both sleep and dopamine are stipulated to play a role in memory by modulating hippocampal 
function (J. Lisman, Grace, & Duzel, 2011; Rasch & Born, 2013).   
In this chapter, I will first introduce the basic neuroanatomy and physiology of the hippocampal 
formation, dopamine and sleep (pg. 1), to provide necessary background to discuss these topics 
in the context of long-term procedural memory (pg. 33) and ageing (pg. 70). 
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Anatomy and neurophysiology 
Hippocampus 
The hippocampus is likely the most studied brain structure. It lies deep within the medial 
temporal lobe (Figure 1) and forms a part of the limbic system. Behaviourally, it has been 
associated with memory and sleep among other things (Buzsaki, 1986; Scoville & Milner, 1957).  
The hippocampus is not a uniform structure. Instead, it is composed of structurally and 
functionally separable but interconnected subfields: the dentate gyrus, cornu ammonis (CA)1, 
CA2, CA3, CA4 and the subiculum (Duvernoy, Cattin, & Risold, 2013). These subfields receive 
input from sensory processing areas through the entorhinal cortex (Figure 2A).  
One of the main processing pathways in the hippocampus is the trisynaptic loop (Figure 2B), 
which is thought to be involved in memory storage (Hyman, Van Hoesen, Kromer, & Damasio, 
1986; Lomo, 2003). Information processing within the hippocampus begins when input from the 
entorhinal cortex enters the dentate gyrus along the perforant path. The dentate gyrus is the 
prime site for hippocampal neurogenesis (Gould et al., 1999; Kuhn, Toda, & Gage, 2018). Mossy 
fibres from the dentate gyrus then project to the CA3, which in turn projects information to the 
CA1 along Schaffer collaterals. The CA1 then completes the loop by sending projections back to 
the entorhinal cortex. Another major output route from the CA1 projects to the subiculum, 
which also sends and receives projections to and from the entorhinal cortex, as well as from 
other limbic regions and the neocortex. 
Three main types of hippocampal neuronal activity, all of which occur along this route, have 
relevance to this thesis. These are the long-term potentiation and depression (Holscher, 1999) 
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and sharp wave ripple complexes, especially during sleep (van de Ven, Trouche, McNamara, 
Allen, & Dupret, 2016).  
Long-term potentiation and long-term depression 
Long term potentiation (LTP) is a process in which frequent co-activation of two neurons that 
share a synapse strengthens said synapse. LTP was initially discovered half a century ago in the 
rabbit dentate gyrus following targeted high frequency stimulation of the perforant pathway (T. 
V. Bliss & Lomo, 1973). Following its discovery, monumental effort has been made to study the 




Figure 1: The hippocampus is in the medial temporal lobe   
 
The hippocampus lies deep within the medial temporal lobe. The glass brain (top) shows the hippocampus 
in red. The bottom panel shows where the hippocampus lies in respect to the lateral surface. The bottom 
panel is not to scale. 
Top panel:  Life Science Databases (LSDB), Wikimedia Commons  
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Figure 2: Hippocampal subfields and connections 
 
Cross-section of the hippocampal body with a reference for the major pathways.  
EC = entorhinal cortex, EC2, EC2, EC deep = different entorhinal cortex layers, DG = dentate gyrus, Sub = 
subiculum.  
A simplified schematic of hippocampal subfield connectivity and major pathways. Solid lines together form the 
trisynaptic loop. 
 
Panel A:  Modified drawing by Santiago Ramón y Cajal (1911), Wikimedia Commons  
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Long term depression (LTD) on the other hand refers to the weakening of synaptic connections 
(Bear & Abraham, 1996). LTP and LTD are processes of Hebbian (Hebb, 1949) plasticity where 
the connectivity between two neurons is strengthened or weakened based on synaptic activity. 
This type of plasticity requires two events to occur: activation of synapse between cells and 
depolarisation that triggers action potentials in the postsynaptic neuron. 
LTP and LTD are often considered the main ways in which the brain adapts to experience (T. V. 
P. Bliss & Collingridge, 1993). Perhaps weakening and strengthening of connections is what 
allows us to build coherent models of the world.  
Morris et al (1986) were the first to demonstrate the behavioural relevance of LTP in a spatial 
learning task. Using a water maze, they found that a N-methyl-D-Aspartame (NMDA) receptor 
antagonist impaired learning as well as prevented hippocampal LTP (R. G. Morris, Anderson, 
Lynch, & Baudry, 1986). Later work by Manahan-Vaughan and others (1997) showed that the 
same concentration of NMDA antagonist that blocked learning and LTP was also blocking LTD 
in the hippocampus (Manahan-Vaughan, 1997). Together, these early findings suggest that both 
LTP and LTD are necessary for hippocampal spatial learning. Later evidence has strongly 
suggested that while LTP and LTD are both implicated in learning, they may support different 
processes (Kemp & Manahan-Vaughan, 2004, 2007). The basic mechanisms of hippocampal 
LTP and LTD are fairly well understood. 
There are several ways in which LTP and LTD can occur. The NMDA-receptor-dependent LTP 
and LTD in the CA1 region of the hippocampus are perhaps the most well understood (Dudek 
& Bear, 1992; Manahan-Vaughan, 1997; Manahan-Vaughan, Kulla, & Frey, 2001). This type of 
plasticity requires changes in AMPA receptor availability that are triggered by NMDA receptor 
events. The AMPA receptors are glutamatergic and the number of these receptors affects the 
strength of the synapse. 
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The NMDA receptors are normally blocked by a magnesium ion. The positively charged 
magnesium is latched onto the strongly negatively charged NMDA receptor causing a blockade. 
This voltage-dependent magnesium ion block prevents postsynaptic glutamate binding (Mayer, 
Westbrook, & Guthrie, 1984). The opening of the NMDA receptor requires both presynaptic 
glutamate release as well as depolarisation of the postsynaptic neuron. Depending on the level of 
stimulation of the AMPA receptor, and the type of AMPA receptors stimulated, the magnesium 
ion influx can either trigger LTP or LTD. The former requires short bursts of activation causing 
strong depolarisation of the postsynaptic neuron, while the latter requires longer term weaker 
depolarisation or inactivation of the synapse (Bear & Abraham, 1996). 
Long-term potentiation (LTP) 
First, during LTP, glutamate that is released by the presynaptic neuron binds to AMPA 
receptors, causing an action potential. When the AMPA receptor is frequently activated by 
glutamate, this causes depolarisation of the postsynaptic neuron. Depolarisation refers to a rapid 
shift in the electric charge of the cell – in this case resulting in reduced negative charge in the 
postsynaptic neuron. As the magnesium ion block is voltage-dependent, the ion is released from 
the NMDA receptor into the postsynaptic neuron, and therefore the neuron becomes less 
negatively charged. During LTP this release is widespread across NMDA receptors on the cell 
surface. 
The positive charge of the magnesium that influxes into the postsynaptic further increases 
depolarisation. As a result, more calcium influxes into the intracellular space. The calcium 
movement cascades events that lead to the release of the Ca2+/Calmodulin-Dependent Protein 
Kinase II (CaMKII) enzyme which triggers biochemical changes that lead to additional AMPA 
receptors being inserted onto the membrane. The additional AMPA receptors increase the 
likelihood of depolarising the postsynaptic neuron: the synapse has now become stronger.  
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Experimentally, these events have been associated with memory formation. Both genetic and 
pharmacological manipulations of both NMDA receptors and CamKII impact memory (J. 
Lisman, Schulman, & Cline, 2002). Furthermore, while LTP is most frequently studied within the 
CA3/CA1 synapse, it can also be observed along the CA1-subicular projections and elsewhere in 
the brain. Disrupting LTP in the CA1 (Tsien, Huerta, & Tonegawa, 1996) or along the CA1-
subiculum pathway has been shown to impair memory maintenance (Commins, Gigg, Anderson, 
& O'Mara, 1998).  
Therefore, in LTP, the repeated glutamate release from the pre-synaptic neuron makes the 
postsynaptic neuron more likely to respond to weaker signals from the presynaptic neuron by 
causing physiological changes in the synapse. The strengthening of this synapse supports 
memory formation. 
Long-term depression (LTD) 
LTD is less well understood than LTP but it is also posited to be important for memory. Again, 
there are several different types of LTD. The best understood process involves reductions in 
AMPA receptors due to insufficient magnesium release from AMPA receptors. While LTP 
typically occurs following a short high intensity stimulation of a postsynaptic neuron, LTD can 
also happen following a longer lasting low intensity stimulation or after an action potential.  
In a simple model, the type of low intensity stimulation that triggers LTD depolarises the 
postsynaptic neuron but less intensively than that required for LTP. Therefore, only some 
magnesium ions are removed from the NMDA receptor: the postsynaptic neuron is therefore 
not sufficiently depolarised to cause widespread magnesium ion release – as seen in LTP. The 
modest magnesium release does not trigger the insertion of further AMPA receptors onto the 
cell membrane, i.e. LTP does not occur. Instead, it cascades events that trigger the removal of 
AMPA receptors: the synapse has become weaker.  
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One interesting hypothesis of LTD is that it may allow “space” for new memories to form. By 
strategically “forgetting” or re-setting synapses, LTD allows for new memories to be born or 
important ones to be strengthened (Manahan-Vaughan & Braunewell, 1999; Stanton, 1996; 
Tsumoto, 1993). This hypothesis is often called the reversal hypothesis: LTD is considered the 
reverse, or the mirror image of LTP. This process may also, at least in part, support systems 
consolidation where newly acquired information is “removed” from the hippocampus during 
sleep to be stored preferentially in the neocortex. LTD may be necessary to allow space for new 
memories to be born, as will be discussed later in this chapter. 
However, this explanation of LTD and LTP is simplistic. These processes can take place in 
several different brain regions and they are not mere mirror images of one another (H. K. Lee, 
Barbarosie, Kameyama, Bear, & Huganir, 2000; Manahan-Vaughan, 1997). For example, LTP 
and LTD may be dependent on distinct NMDA receptor subunits (Liu et al., 2004). LTP and 
LTD are not merely involved in memory persistence either, but seem to support encoding as 
well (Kemp & Manahan-Vaughan, 2007). While the forgetting account is pervasive, it is worth 
noting that it is unlikely to be the only means by which LTD supports memory, and not 
everyone sits in its support. Indeed, some have coined the forgetting hypothesis of LTD as being 
“fatally flawed” (Kemp & Manahan-Vaughan, 2007). 
Alternatively, LTP and LTD have been suggested to work in parallel to modulate the signal-to-
noise ratio for forming associations that underlie memories (P. Dayan & Willshaw, 1991). 
Furthermore, while here I have presented a short account of how the NMDA receptor 
dependent processes work, there are other types of LTP and LTD. For example, LTD within the 
dentate gyrus is independent of NMDA receptors (Poschel & Manahan-Vaughan, 2007).  
While it is increasingly clear that both LTP and LTD are involved in memory persistence and 
modulation, their exact roles and functions are still much debated.  
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Oscillations in the hippocampus 
The brain has several mesoscopic activity patterns, known as oscillations, which are typically 
denoted by different letters of the Greek alphabet. While LTP and LTD refer to synaptic events, 
oscillation patterns are the outcome of several different action potentials firing synchronously. 
Cross-frequency coupling, or the temporal interaction of the different oscillation “bands”, are 
thought to be associated with sensory, motor and cognitive processes (Canolty & Knight, 2010).  
These oscillations can be observed recording electroencephalograms (EEGs) using sensors 
placed either directly on the brain’s surface or inside tissue, or on the scalp. Recordings from 
within the brain are known as local field potentials (LFP). These recordings are taken from the 
extracellular space and therefore they represent small populations of cells. EEG recordings of 
hippocampal activity require access to the intracranial space and cannot be recorded from the 
scalp. In humans these recordings can be obtained during brain surgery, typically from patients 
with severe epilepsy. For this reason, majority of the direct hippocampal recordings are made in 
animals.  
The hippocampus has three main types of oscillation patterns: theta, sharp waves and gamma. 
The former two are specific to the hippocampus while gamma can be recorded across several 
brain regions. All three are thought to support memory (Buzsaki, 1986; Nyhus & Curran, 2010).  
The different types of hippocampal oscillations are also associated with different behaviours. For 
example, during wakefulness, when a rat is exploring, rearing or sniffing, the LFPs recorded 
from the CA1 are dominated by theta activation (Vanderwolf, 1969). However, when a rat is 
eating or grooming, the theta activity is swiftly replaced by intermittently occurring sharp waves 
(Buzsaki, Leung, & Vanderwolf, 1983).  
Chapter I: Background 




Sharp waves are typically recorded from the CA1 stratum radiatum layer. They are short (40-
100ms) large amplitude negative deflections. What is interesting about them is that they are 
typically – though not always – cross-frequency coupled with short bursts of CA1 pyramidal 
activity known as sharp wave ripples (SwRs) (Buzsaki, 1986; Buzsaki, Horvath, Urioste, Hetke, & 
Wise, 1992; O'Keefe, 1976). 
SwRs can be seen in hippocampal EEGs during restfulness (when the animal is alert but still) 
and during sleep. They have been recorded across several species, including in humans (Buzsaki, 
1986, 2015; Buzsaki et al., 1992; Buzsaki et al., 1983; Buzsaki, Logothetis, & Singer, 2013). 
SwRs have several distinct features (Buzsaki, 2015) such as temporal coordination patterns 
between several neurons (Buzsaki et al., 1992). SwRs are also associated with transient changes in 
the excitability of hippocampus and adjacent structures (Buzsaki, 1986, 2015; Csicsvari, Hirase, 
Czurko, Mamiya, & Buzsaki, 1999). For the relevance of this thesis, the most important 
observation of SwRs are patterns of spike trains that occur during them.  
Although SwRs have a synchronous appearance, the cells activated during a SwR fire in a specific 
temporal order. More precisely, the sequential firing patterns observed during SwRs mimics that 
seen during wakefulness, except that the firing is faster paced (Skaggs & McNaughton, 1996; M. 
A. Wilson & McNaughton, 1994). In other words, during SwRs neuronal firing patterns 
associated with wakeful activity are rapidly replayed. It is thought that these patterns of neuronal 
replay support memory transfer from the hippocampus to neocortical regions during sleep.  
It is thought that, during encoding theta oscillations support learning (synaptic consolidation) 
while later, during sleep and rest, the SwRs support the transfer of information from the 
hippocampus to the neocortex. In subsequent sections of this thesis I will elaborate on this 
theory by presenting behavioural evidence in support.  
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Dopamine was first synthesised in 1910 but it was not recognised as a neurotransmitter until 
much later (Carlsson, 1993; Hornykiewicz, 1966; Marsden, 2006). Since then, it has been shown 
to play key roles in behaviours ranging from lactation and movement to reward and addiction. 
Dopamine is also implicated in multiple neurological and psychiatric diseases including 
depression, schizophrenia and Parkinson’s disease (Knickmeyer et al., 2014; Marsden, 2006). 
Parkinson’s disease is hallmarked by movement-related symptoms (tremor, rigidity and 
bradykinesia are core features plus gait imbalance and dystonia) that are driven by loss of 
dopamine cells in the midbrain (Jankovic, 2008). To pharmacologically treat dopamine depletion, 
typically either a dopamine agonist or L-DOPA (levodopa) is given orally. L-DOPA, unlike 
dopamine, can cross the blood brain barrier, and when it does it is centrally converted into 
dopamine (Figure 3). This is important because the finding that Parkinson’s disease is caused by 
loss of dopaminergic neurons in the brain and that it can be treated by L-DOPA opened up an 
avenue to study the effects of dopamine depletion and supplementation on several cognitive 
processes.  
Once dopamine has been produced and released into the synapse (Figure 4), it will either excite 
or inhibit the post-synaptic neuron, depending on the site of action and the receptor type. There 
are five heterogenous dopamine neuron receptor types, coined D1-5, that may affect cognition 
and behaviour in disparate ways (Granado et al., 2008; Lazenka, Legakis, & Negus, 2016). These 
are divided into two families by their properties; D1-like (D1 and D5) and D2-like receptors (D2, 
D3 and D4) (Civelli, Bunzow, & Grandy, 1993). D1 and D2 receptors are the most prominent 
and they were the first to have been identified (Carlsson, 1993). Hereafter, D1 and D2 will be 
used to refer to the families of receptors. These classes differ in genetic, signalling and 
anatomical properties, as reviewed elsewhere (Beaulieu & Gainetdinov, 2014). In short, they have 
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two main modes of action: the D1 receptors are stimulatory and get activated by dopamine, and 
the D2 family are inhibitory.  
L-DOPA affects activity of both receptor types indiscriminately, and in most human studies it is 
difficult to disentangle the effect of different receptors on cognition. Given its widespread 
pharmacological use, primarily in Parkinson’s disease, placebo-controlled trials using L-DOPA or 
dopamine agonists provide an accessible approach in studying dopamine’s effects on cognition.  
After reuptake from the synapse, dopamine can be re-used or metabolised into hemovanillic acid 
or noradrenaline. This is important because noradrenaline affects many cognitive processes, 
including memory (Kobayashi & Yasoshima, 2001; Swanson-Park et al., 1999). Both dopamine 
agonists and L-DOPA increase noradrenaline (L. Dayan & Finberg, 2003). As manipulating 
dopamine levels will inevitably also alter levels of noradrenaline, interpreting experiment 
outcomes from dopamine’s effects on behaviours is difficult. 
To further complicate things, dopamine at different quantities appears to affect behaviour in 
disparate ways. Evidence from Parkinson’s disease led to the observation that dopamine 
replacement therapies could both enhance and impair cognition (Gotham, Brown, & Marsden, 
1988). As L-DOPA acts indiscriminately across the brain, dopamine-laden regions relatively 
unaffected by Parkinson’s disease can become overdosed, impairing their function (Cools, 
Barker, Sahakian, & Robbins, 2001). It therefore seems that there is an optimal dose of 
dopamine (Chowdhury, Guitart-Masip, Bunzeck, Dolan, & Duzel, 2012; Cools & D'Esposito, 
2011; Gjedde, Kumakura, Cumming, Linnet, & Moller, 2010), and dopamine’s relationship with 
cognition can be described by an inverted U-shaped curve (Figure 5). 
Dopamine is also substantiated in several brain regions (Figure 6). It is most concentrated in the 
ventral tegmental area (VTA) and substantia nigra, where the loss of these dopaminergic neurons 
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underlies the hallmark motor symptoms of Parkinson’s disease. However, dopaminergic neurons 






Figure 3: Dopamine synthesis 
 
The production of dopamine begins with the aminoacid tyrosine, which can be exogenously sourced (e.g. 
through diet or supplements) or produced by endogenously. Tyrosine first resides in the extracellular space 
but in order to synthesise into dopamine the tyrosine transporter protein introduces it into the cytoplasm. 
Tyrosine transporters are specific to the dopaminergic synapse. In the cytoplasm, tyrosine is converted into 
L-DOPA. The DOPA decarboxylase enzyme then breaks L-DOPA down to dopamine. In the 
dopaminergic synapse, this is the final product. In other synapses, or following re-uptake, dopamine may be 
further broken down into hemovanillic acid or adrenaline 
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Figure 4: Dopamine and the synapse 
 
An action potential stimulates voltage-gated calcium channels on the presynaptic plasm membrane to activate. 
An influx of calcium into the presynaptic space is triggered, causing for vesicles to exocytose and release the 
dopamine into the synaptic cleft. Then, dopamine can either return to the presynaptic cell or bind to the 
postsynaptic cell. The dopamine binding in the postsynaptic cell can inhibit or exhibit the cell. Dopamine can be 
transported back into the presynaptic cell for recycling by the dopamine transporter protein (DAT), or it can be 
metabolised by several enzymes. Prominent examples are monamine oxidase (MAO) and Catechol-O-
Methyltransferase (COMT), which break it down into hemovanillic acid. 
 
Figure 5: Dopamine and cognition: An inverted U-shape 
 
Dopamine’s relationship with cognition can be describes by an inverted U-shaped function 
where too low or too high a dopamine load can cause impairment.  
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Dopamine and the hippocampus 
Dopamine is abundant in the hippocampus (Table 1) (Gasbarri, Packard, Campana, & Pacitti, 
1994; Gasbarri, Sulli, & Packard, 1997). Dopamine is required for memory related plasticity in 
the hippocampus (Frey, Schroeder, & Matthies, 1990; Y. Y. Huang & Kandel, 1995; Otmakhova 
& Lisman, 1996, 1998), and interfering with hippocampal dopamine has been shown to affect 
both LTP and memory (Axmacher et al., 2010; O'Carroll, Martin, Sandin, Frenguelli, & Morris, 
2006). Dopaminergic neurons from the ventral tegmental area (VTA) in the mid-brain project to 
the hippocampus and back through the VTA-hippocampal loop. From the other side of the 
loop, it has been shown that rats have enhanced learning in response to dopaminergic simulation 
of the VTA (Bao, Chan, & Merzenich, 2001). 
 
Figure 6: Dopamine distribution and pathways 
 
Dopamine projections connect the midbrain to other regions via several pathways. The largest 
pathways are the nigrostriatal pathway (substantia nigra to the striatum), the mesolimbic 
pathway (VTA to limbic structures) and the mesocortical pathway (VTA to cortex). The 
nigrostriatal pathway is the most prevalent pathway, containing around 80% of all  
dopaminergic neurons in the brain. It travels from the substantia nigra to caudate putamen 
and modulates communication between the motor cortex and the cortex via the thalamus. The 
loss of dopaminergic neurons in the substantia nigra is the landmark pathology of Parkinson’s 
disease. Both mesolimbic and mesocortical pathways originate from VTA. The former 
connects to the accumbens, ventral striatum and amygdala, and the latter to the prefrontal, the 
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The VTA-loop is activated by novel or salient information, or cues that predict saliency (J. E. 
Lisman & Grace, 2005; Wittmann, Bunzeck, Dolan, & Duzel, 2007). The dentate gyrus and the 
CA3 attempt to predict likely future events based on previously occurred events, and they feed 
this information into the CA1. Simultaneously, CA1 receives direct cortical inputs about sensory 
information. In other words, the dentate gyrus and the CA3 help CA1 combine stored 
information (memories from CA3 and dentate gyrus) with information from the environment. 
These inputs are compared within the CA1, which signals to the subiculum in response to salient 
events (Hasselmo & Wyble, 1997; J. E. Lisman, 1999; J. E. Lisman & Grace, 2005). The signal 
then travels through the subiculum, activating the VTA-hippocampal loop (see Figure 7).  
The activation of the VTA-hippocampal loop therefore increases dopamine activation, creating 
an optimal environment for LTP and therefore supporting the early stages of memory. Storing 
memories for the longer term, however, benefits from additional processes including sleep.  
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Table 1: Dopamine distribution in the hippocampus 
Relative density from minimal ( | ) to significant ( ) to more abundant ( ) labelling. Note that labelling 
technique differences may, at least partially, explain inter-species differences. 
DAT = Dopamine transporter.  
Based on (Shohamy & Adcock, 2010) 
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Figure 7: The dopaminergic VTA-hippocampal loop 
 
The VTA-hippocampal loop is activated when the subiculum receives signal from the entorhinal cortex and 
the CA1 in response to a novel environment. The ventral subiculum will then excite the nucleus accumbens 
which in turn inhibits the pallidum and the VTA. This inhibition causes an “inhibition of inhibition”, 
making dopaminergic neurons in the VTA more permeable, and more likely to fire in response to salient 
events (pink unicorn). The VTA then signals to the hippocampus, completing the loop. This theory is 
presented in full in Lisman & Grace (2005). 
VTA = ventral tegmentum. 
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Long-term potentiation and dopamine 
The aforementioned Hebbian (Hebb, 1949) type of plasticity underlying LTP and LTD may not 
be sufficient to explain the modulation of synaptic plasticity that underpins memory formation. 
In accordance to this simplistic account, events that co-occur several times should be always 
remembered. However, it is intuitive that several events or stimuli can co-occur but not be 
retained in memory unless if they are deemed important. As I will outline later in this chapter, 
behavioural relevance is pivotal for memory persistence. Therefore, several neurotransmitters 
and cortical higher-order processes are likely to modulate memory.  
One of these is the neurotransmitter dopamine. This model of memory-associated LTP that 
includes dopamine release was coined the neoHebbian framework by Lisman, Grace and Duzel 
(2011). Below, I will outline a short account of the mechanism by which dopamine may stimulate 
protein synthesis. 
In the hippocampus, stimulating dopaminergic neurons, and therefore increasing dopamine 
release in the synapse, increases synaptic transmission by triggering glutamate receptor 1 (GluR1) 
expression on the cell surface (W. B. Smith, Starck, Roberts, & Schuman, 2005). GluR1 is a type 
of AMPA receptor. Further evidence has also suggested the role of brain-derived neurotrophic 
factor (BDNF) in triggering AMPA receptor synthesis in the hippocampus (Lu, Christian, & Lu, 
2008). BDNF is a protein that regulates several neurodevelopmental events including dendritic 
connectivity, maturation and growth of neurons.  
BDNF is also involved in activity-dependent synaptic regulation by signalling movement of 
proteins to promote synaptic maturation and plasticity. Together, BDNF and D1 receptor 
mediated pathways activate mitogen-activated protein kinase, or MAPKs (Yoshii & Constantine-
Paton, 2010). MAPKs are signalling molecules that regulate several cell functions including gene 
expression. Activation of the MAPK can induce protein synthesis on the postsynaptic cell 
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membrane. Indeed, both memory and hippocampal late phase LTP can be blocked by 
interference of MAPK action in mice (Kelleher, Govindarajan, Jung, Kang, & Tonegawa, 2004). 
Dopamine can also regulate MAPK activity. Stimulating D1 cascades events that lead to 
increased MAPK activation (Valjent et al., 2005). Therefore, dopamine can influence late-phase 
LTP by increasing protein expression via activation of protein kinases.  
The release of dopamine into the synapse is dependent on higher-order processes including 
reward, motivation and novelty (J. E. Lisman & Grace, 2005). Therefore, dopamine is likely to 
be the missing link or one of the missing links that aid memory selection, possibly via activation of 
the VTA-hippocampal loop. Later in this chapter I will discuss how both dopamine and these 
behaviours are associated with memory persistence in humans and animals. 
 
Sleep 
During a full night of sleep, the brain fluctuates between different sleep stages (Figure 8): 
Wakefulness, Stage 1, Stage 2, slow wave sleep (Stage 3), and rapid eye movement (REM) sleep. 
Stages 1-3 are also referred to as non-REM (NREM). These stages are characterised by unique 
neural signatures (Table 2). Stage 2, slow wave sleep and REM are most frequently associated it 
memory. Slow wave sleep is characterised by high amplitude delta oscillations (slow waves) and 
high frequency spindles, which can be seen on scalp EEG traces. Slow waves originate from the 
cortex while spindles are produced by the thalamus. Slow wave spindles predominantly occur 
during delta depolarisations (‘upstates’). During the ‘downstates’ of the spindles, the 
hippocampus and surrounding regions produce sharp-wave ripples (SwR). SwRs are high 
frequency (100 –250 Hz) oscillations resulting from synchronous, rapid, neuronal firing. During 
some SwRs, patterns of neuronal firing seen during learning are re-activated (Figure 10). These 
‘replay’ events are closely linked with later memory for the associated learning (Molle, Yeshenko, 
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Marshall, Sara, & Born, 2006). Slow wave oscillations, spindles, SwRs and replay are therefore 
temporally linked, and they have all been associated with memory (Battaglia, Sutherland, & 
McNaughton, 2004; Clemens et al., 2007; Siapas & Wilson, 1998).  
Spindles and SwRs are also seen during REM and Stage 2, and SwRs are also seen during 
wakeful rest. In the following sections I will show that these sleep-events are relevant for 




Figure 8: Sleep cycles and stages 
 
Sleep stages vary in ultradian cycles lasting around 1-2 hours. These cycles are characterised by disparate 
neural oscillatory signatures. A hypothetical example of a sleep hypnogram demonstrating how 
proportionately more time is spent in slow wave sleep (green) during the first half of the night, while REM 
is more dominant later (blue). The transitions between cycles begins when a sustained period of REM ends.  
Note that this is an optimal schematic of sleep. It is possible for someone to go directly from 
Wakefulness to Stage 2 or even REM or slow wave sleep – especially if wakefulness is a short 
awakening at night.  
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Sleep stage Frequency 
(Hz) 
 




9-11 Low Alpha in occipital 
channels, blinks. 
Eyes closed, 





4-8 Low Theta. Slow eye 
movements on 
EOG and elevated 
EMG 
Very light sleep, 






























9-11 Low Mostly theta. As 
awake but with 
sawtooth waves 
(2-6Hz). Low 
EMG but rapid 
movements in 
EOG 
Atonia but eye 
movements are 
present.  
Table 2: Human sleep stages 
Different sleep stages are characterised by different patterns of neural events. The frequency and amplitude 
band characteristics for each sleep stage are subject to individual variation.  
 
PSG = Polysomnogram 
EMG = electromyogram  
EOG = electro-oculogram 




Note that previously there was also Stage 4. This is now no longer scored and instead Stage 3 
/ slow wave sleep includes both former stages 3 and 4.   
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Figure 9 The relationship between slow wave oscillations, spindles and ripples 
During slow wave sleep, the neocortex generates slow wave oscillations. Spindles take place 
during the up-states of these oscillations (arrow connecting spindle to slow wave), while 
ripples are associated with the down-states of spindles (arrow connecting ripple to spindle). 
Note that the size of the ripples is magnified here for illustration. During ripples, the 
memory engram is replayed. Slow wave oscillations and spindles can be seen on scalp EEG 
(green shade) but sharp wave ripples and replay events require intracranial access.  
The sleep events in this figure are not to scale. 
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Dopamine and circadian rhythms 
The relationship between sleep and dopamine offers a rich area of study, because dopamine is 
intimately involved in the regulation of sleep-wake cycles. Animal studies show that firing of 
dopaminergic cells is different during wakefulness compared to sleep, with more bursting activity 
and enhanced dopamine release in the nucleus accumbens and forebrain during wakefulness 
(Eban-Rothschild, Rothschild, Giardino, Jones, & de Lecea, 2016; Monti & Monti, 2007). 
Similarly, enhancing overall levels of dopamine causes changes in sleep and wakeful states. 
Central administration of a D1 or D2 agonist reduces REM and slow wave sleep and increases 
behaviours associated with wakefulness (Isaac & Berridge, 2003), while conversely, in a macaque 
model of Parkinson’s disease, central D1 agonist increases REM duration and daytime 
wakefulness (Hyacinthe, Barraud, Tison, Bezard, & Ghorayeb, 2014). 
The traditional view held that dopamine promotes wakefulness and does not play a role in sleep 
processes (Jones, Bobillier, Pin, & Jouvet, 1973; M. M. Lima, Reksidler, & Vital, 2008). Instead, 
dopamine is now widely accepted to play a role across circadian cycles –particularly in regulating 
REM sleep. The electrophysiological trademarks of REM closely resemble those of wakefulness: 
during REM, as during wakefulness, theta activity originating from the brain stem and projecting 
to cortical regions is abundant. Some of these projections are dopaminergic (M. M. Lima, 
Reksidler, et al., 2008; Saper, Scammell, & Lu, 2005) and dopamine levels in rats are elevated 
both during wakefulness and REM compared to slow wave sleep (Lena et al., 2005). 
Another line of evidence which shows that increased dopamine levels promote wakefulness 
comes from targeted REM deprivation. In these paradigms, volunteers (or animals) sleep 
otherwise normally but are woken up at each REM onset. A REM rebound effect – where the 
proportion of total sleep time spent in REM is increased – follows sleep deprivation, selective 
REM deprivation or stressful events (Suchecki, Tiba, & Machado, 2012; Vogel, 1975).  In rats, 
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REM deprivation causes an increase in striatal dopamine and impairs cognitive performance 
(Proenca et al., 2014). In drosophila, sleep deprivation causes short-term memory deficits but 
suppression of D1 activity can rescue the cognitive deficits (Seugnet, Galvin, Suzuki, Gottschalk, 
& Shaw, 2009). Blocking D2 receptor activity after REM deprivation can also reduce subsequent 
REM (M. M. Lima, Andersen, et al., 2008). These studies suggest that increased dopamine 
following REM deprivation may impair cognitive performance during subsequent wakefulness 
and induce REM during subsequent sleep.  
To further complicate matters, different dopamine receptors have disparate effects on 
wakefulness. Downregulating or impairing either of the two most expressed receptor types, D1 
or D2, causes somnolence in mice (Cromwell, Berridge, Drago, & Levine, 1998; Kelly et al., 
1998; Vallone et al., 2002; Zweifel et al., 2009), while D3 downregulation increases alertness 
(Accili et al., 1996; Xu et al., 1997). Findings relating to D4 or D5 receptors have been 
inconclusive or yielded no differences (Monti & Monti, 2007). 
Dosage may also introduce a biphasic effect of dopamine on sleep. For example, smaller doses 
of central D2 agonists apomorphine or bromocriptine were associated with increased REM and 
slow wave sleep in rats, while larger doses had the opposite effect. The D2 agonist pergolide also 
had a biphasic effect on slow wave sleep and wakefulness, but it inhibited REM at all given doses 
(Monti, Hawkins, Jantos, Dangelo, & Fernandez, 1988; Monti, Jantos, & Fernandez, 1989).  
However, a word of caution is required when interpreting rodent studies: rodent sleep is 
ultradian rather than circadian in nature, so differences between human and rodent sleep/awake 
cycle regulation are likely. 
It is difficult to piece together a unitary role of dopamine in sleep from the animal literature. 
Dopamine’s effects on sleep seem to depend on the receptor type, dose and organism. However, 
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it is possible that these findings are conflated by small sample sizes and biased reporting of 
scientific studies.  
Dopamine and sleep in humans 
Parkinson’s disease, which is characterised by accelerated dopamine neuron loss in the midbrain 
(Braak et al., 2003), is associated with multiple sleep-related dysfunctionalities (Swick, 2012; 
Videnovic & Golombek, 2013). Increased daytime somnolence and sleep attacks are side effects 
of dopamine replacement therapies (Homann et al., 2002). These attacks are characterised by 
sudden sleep onset, affecting around 6.6% of patients, with those on higher doses being at 
elevated risk (Montastruc et al., 2001; Tan et al., 2002). While the exact cause of sleep attacks is 
unknown, they are a side effect of all dopamine replacement drugs in Parkinson’s disease 
patients and therefore likely to reflect some dopamine dysfunction. This is somewhat paradoxical 
given dopamine promotes wakefulness.  
Sleep impairments in Parkinson’s disease also originate from the same mesocorticolimbic regions 
that promote wakefulness (Rye, 2004) and they are increased with chronic dopamine 
replacement therapy (Nausieda, Weiner, Kaplan, Weber, & Klawans, 1982). Up to 90% of 
Parkinson’s patients have co-morbid sleep disturbances, with the most common complaints 
being insomnia, REM behaviour disorder, sleep apnoea, restless leg syndrome and excessive day-
time somnolence (Gagnon et al., 2002; Kales, Ansel, Markham, Scharf, & Tan, 1971). Around 
15-47% of Parkinson’s patients have REM behavioural disorders (Gagnon et al., 2002). These 
are characterised by REM episodes during which atonia – or the lack of muscle tone 
characteristic of stage REM (Table 2) – is absent. Instead, patients can “act out” their dreams 
during sleep.  
An interesting observation in Parkinson’s disease patients with REM behavioural disorders is 
that the Parkinsonian motor control symptoms, such as impaired smoothness and speed of 
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movement or speech articulation, are absent during these episodes (De Cock et al., 2007). While 
to our awareness this has not been directly studied, a possible explanation is that during REM 
increased dopamine release in substantia nigra ameliorates motor control symptoms mimicking 
the effects of dopamine replacement therapy.  
There have been few efforts to study how L-DOPA and dopamine agonists acutely alter sleep. 
An early observation was that unmedicated Parkinson’s patients had later sleep onset and 
frequent arousals during nocturnal sleep (Kales et al., 1971). These problems were mainly 
associated with slow wave sleep (Stage 3) with REM being relatively unaffected. Onset of 
dopamine replacement therapy by L-DOPA was associated with changes in REM – with some 
patients having longer and some shorter REM durations. These effects returned to baseline with 
chronic treatment after 2 weeks. In 4 spouse-controls L-DOPA caused an acute, small, increase 
in REM but no other changes. Due to the discrepant findings and a small sample, it is difficult to 
draw conclusion from this study.  
In another study, nocturnal L-DOPA did not enhance sleep in patients with Parkinson’s disease 
following a period of time OFF dopamine replacement (Wailke, Herzog, Witt, Deuschl, & 
Volkmann, 2011). It is possible that there was no difference OFF L-DOPA due to insensitivity 
caused by chronic dopamine replacement treatment. In contrast, others have reported increased 
daytime somnolence with both L-DOPA and pramipexole (a D2-agonist)(Contin et al., 2003; 
Pal, Bhattacharya, Agapito, & Chaudhuri, 2001). While L-DOPAs effects in modulating sleep in 
healthy humans is less clear, in rats, L-DOPA treatment has a clear benefit in restoring circadian 
rhythm impairments (Boulamery, Simon, Vidal, & Bruguerolle, 2010). 
Not many studies have attempted to disentangle the effect of dopamine-medication on sleep in 
healthy individuals, but those that exist suggest that increased dopamine activity impairs sleep 
architecture. In young healthy men, a single dose of the D2 agonist pramipexole delivered 
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nocturnally reduced time in slow wave sleep and in REM and increased time in Stages 1-2, 
without affecting total sleep time (Feld, Besedovsky, Kaida, Munte, & Born, 2014). In other 
studies with healthy young adults ropinirole, also a D2 agonist, reduced sleep onset time (Ferreira 
et al., 2002) and pramipexole increased daytime somnolence at 3.5h and 5.5h delays from 
administration (Micallef et al., 2009). 
Similar findings have been found with acute pramipexole in restless legs patients, although in this 
cohort chronic use improved sleep (Saletu, Anderer, Saletu-Zyhlarz, Hauer, & Saletu, 2002). In 
this patient group, clonazepam, which alters dopamine activity, improves sleep efficiency and 
quality (Saletu et al., 2001), but it is more likely that clonazepam modulates sleep through GABA 
rather than by increasing dopamine activity.  
In humans, sleep deprivation is likely to reduce dopamine release. In line with this, sleep 
deprivation in Parkinson’s disease has been shown to ameliorate motor symptoms caused by 
reduced dopamine in the midbrain – possibly by making patients hyperresponsive to dopamine-
increasing medications (Bertolucci, Andrade, Lima, & Carlini, 1987; Reist, Sokolski, Chen, 
Coskinas, & Demet, 1995). In healthy adults, sleep deprivation decreased D2 binding in the 
ventral striatum as measured by [11C]-raclopride binding potential in a positron emission study 
(Volkow et al., 2012; Volkow et al., 2008). The magnitude of the dopamine suppression was also 
associated with increased sleepiness. Note that this is at odds with the findings that REM 
deprivation increase striatal dopamine in rodents (Proenca et al., 2014).   
While most of the available evidence suggests that dopamine only regulates wakefulness and 
REM, it may be implicated in slow wave sleep as well. First, slow wave sleep duration is reduced 
in Parkinson’s disease (Kales et al., 1971) (Wailke et al., 2011). Second, this decrease can be 
partially but not fully rescued with dopamine replacement therapy (Diederich, Paolini, & Vaillant, 
2009). Third, in healthy humans, glucose metabolism and therefore brain activity in midbrain and 
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forebrain regions expressing dopamine and in the hippocampus is increased during non-REM 
sleep (Nofzinger et al., 2002). Fourth, Feld et al (2014) found that a dopamine agonist reduced 
slow wave sleep. Finally, as I will outline in Chapter V (pg. 158), dopamine may play a role in 
memory-related plasticity during slow wave sleep.  
The effect of dopamine-enhancing agents can be paradoxical, with low doses possibly acting as 
sedatives and high doses having the opposing effect and promoting wakefulness (Monti, 
Hawkins, Jantos, D'Angelo, & Fernandez, 1988). The relationship between dopamine in and 
sleep is further complicated by the disparate effects of different receptor types. It is possible that 
different patients have different patterns of dopamine loss across the brain due to disease 
processes, age, and unknown factors. Acute and chronic effects of dopamine replacement 
therapies are likely to yield different effects as well. For this reason, studies in healthy 
populations are pivotal.  
Together these findings suggest that dopamine’s relationship with sleep is complex, and it is 
difficult to predict what, if any, acute effects dopamine-enhancing medications may have in 
healthy people. As outlined above, there is overwhelming evidence that dopamine is implicated 
in the maintenance of wakefulness. The available literature also suggests that dopamine, 
particularly at D2 receptors, is required for REM sleep. Yet, much of the evidence comes from 
animal and patient studies and relatively little is known about the effects of L-DOPA or D2 
agonists/antagonists in healthy individuals or in prodromal disease states. Also, there is little 
evidence of dopamine affecting slow wave sleep, a stage which is also impaired in Parkinson’s 
disease (Wailke et al., 2011).  
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Exploring dopamine, hippocampus and sleep in 
humans 
Due to the complex nature of the interactions between hippocampus, dopamine and sleep, to 
fully begin to understand dopamine’s role on human cognition requires integrating evidence 
from several methodological modalities.  
Neuroimaging, such as magnetic resonance, lesion studies and EEG can be used to study the 
function and structure of the hippocampus in humans. Direct recordings can also be obtained 
from patients undergoing intracranial surgery, and while sharp wave ripples and replay are not 
visible in scalp EEG, sleep spindles can be used as a proxy to study them.  
Dopamine in humans 
Common approaches to study dopamine are: 
1. Genetics: Differences in cognitive performance by gene-load of dopamine-activity-
altering genes, e.g. , e.g. (de Frias et al., 2004). 
2. Patient studies: Cognitive changes in patients that have either increased (e.g. 
Schizophrenia) or decreased (e.g. Parkinson’s disease) levels of dopamine, e.g. (Dubois & 
Pillon, 1997). 
3. Drug interventions: Assessing changes associated with dopamine-level altering 
medications in healthy controls and patient populations, e.g. (J. P. Grogan et al., 2018; 
Shohamy, Myers, Geghman, Sage, & Gluck, 2006) and this thesis. 
4. Neuroimaging: Positron emission tomography allows to detect individual variability in 
dopamine binding. Functional magnetic resonance and electroencephalograms can also 
be used to study cognition-related variability in neural responses in relation to genetics, 
pharmacological manipulations or disease states, e.g. (Salami et al., 2019). 
Chapter I: Background 




In the following section, I will discuss these topics in the context of procedural human long-term 
memory. 
  






Long-term memory refers to memory that persists from minutes to lifetimes. According to the 
multi-store model of memory (Atkinson & Shiffrin, 1968), before information enters long-term 
storage, it is first processed by the sensory system, which has little storage capacity and from 
where it passes through rapidly. If this information is attended to, it then progresses into short-
term memory. The duration of these memories is only a few seconds, and the short-term 
memory system can only hold 7 ±2 items at any given time. A proportion of these memories are 
retained for a longer duration as they enter long term memory.  
In contrast, the levels of processing model (Craik & Tulving, 1975) proposes that instead of 
having distinct storage systems, memories are processed on a continuous scale ranging from 
shallow to deep processing. A combination of the two models is likely to hold true. For 
information to flow into long-term memory, it needs to be held in short-term memory first, but 
it is unlikely that there is a hard boundary between the two processes (Figure 10). 
A healthy memory system cannot retain every piece of information encountered in the 
environment. Even if the storage capacity were limitless, the behavioural utility of non-selective 
memory is questionable. For example, it is not necessary to remember details about noises of 
traffic when you navigate to a new location, but the route itself is salient. The memory system 
instead prioritises salient memories over irrelevant information. In this chapter, I will discuss 
different memory stages and processes considering their involvement in selecting memories – 
not all information is equally encoded, consolidated, retrieved and forgotten 
 
 










Figure 10: Types of memory 
 
Before entering long term memory, information is first processed by sensory memory, which lasts only some 
fractions of a second. After that, information flows into short-term storage, also called working memory. The 
storage capacity here is only up to a minute after which information is being transferred into long term 
storage.  
Long term memories can roughly be divided into explicit (or declarative) and implicit (or procedural) 
memories. This division reflects the level of conscious awareness one can have of the information; explicit 
memories refer to information you can name and describe, while implicit memories consist of information 
that is more procedural. Explicit memories can further be divided into episodic and semantic, where the 
former refers to information that is personal and unique to the individual, and the latter to facts and concepts. 
(Atkinson & Shiffrin, 1968; Craik & Tulving, 1975)  
 






Encoding, which is heavily reliant on the hippocampus, is the initial step in explicit long term 
memory formation (Scoville & Milner, 1957). The idea that memory encoding involves 
transcribing the external experience into an internal representation of the world was first 
suggested over a century ago by Richard Semon. He coined this internal representation as the 
‘mnemic trace’ or the engram (Semon, 1909). He suggested that an engram is born at encoding 
and reactivated when memories are accessed later. While several aspects of his theory – such as 
engrams being inherited – did not survive the test of time (Peitikainen, 2007), successfully 
encoded memories do create biophysical or biochemical changes in response to the external 
environment.  
During encoding, explicit memories are transcribed into an engram within the hippocampus 
(Figure 11). This representation takes the form of synchronously activated cell assemblies, and as 
these cells fire together the connections between them become stronger during subsequent 
memory processes, see page 39 (Manahan-Vaughan & Braunewell, 1999; Tonegawa, Liu, et al., 
2015; Tonegawa, Pignatelli, Roy, & Ryan, 2015). The hippocampus is likely not required for 
procedural encoding nor is it the only site implicated in explicit memory encoding. Instead, 
widespread cortical networks are also involved at encoding (Kensinger, Clarke, & Corkin, 2003; 
Squire, Genzel, Wixted, & Morris, 2015).  
There is little uncertainty about the involvement of the hippocampal formation in explicit 
encoding. In short, in humans, the extent of recruitment of the hippocampus during encoding 
predicts later memory performance. This subsequent memory effect, or difference due to 
memory, can be studies using paradigms where participants’ brain activity is measured during 
learning. A common finding is that hippocampal activation predicts subsequent memory. This 
effect can be seen in intracranial (Elger et al., 1997; Long, Burke, & Kahana, 2014) and scalp 





EEG (Kamp, Bader, & Mecklinger, 2017), and in functional magnetic resonance imaging (Hayes, 
Hayes, Williams, Liu, & Verfaellie, 2017; Kim, 2019). Note that in scalp EEG signal source 
localisation is difficult and one cannot be certain where the effects in those studies originate 
from.  
The subsequent memory effect not only demonstrates the intimate link between neural activity at 
encoding and subsequent memory, but it also indicates that not all information is equally 
encoded. Instead, encoding is selective, and strength may vary with information characteristics 
such as saliency.  
Saliency-tagging 
Salient or rewarded information is typically prioritised for memory. I will refer to this saliency-
driven difference in memory strength as the tagging effect. At encoding, contextual information 
or previous experiences influence tagging of some information over others. During subsequent 
memory stages, this tag guides the selection of memories to be stored. A possible anatomical 
underpinning of the tag is likely within the hippocampus. Newly synthesised proteins induced by 
salience – or tags –  optimize the environment for synaptic changes that underlie memory 
persistence (Ballarini, Moncada, Martinez, Alen, & Viola, 2009; Frey & Morris, 1997a, 1997b; 
Redondo & Morris, 2011). Thus, the synaptic changes that underlie memory persistence (page 
39) effectively capture this saliency tag.  
 
  





The subsequent memory effect provides a platform for studying tagging. Human intracranial 
recordings have shown that theta activity in the hippocampus and cortex during encoding 
 
 
Figure 11: Engrams and encoding  
 
Information (cat) in the external environment (top left) influences the state of “naïve” hippocampal cells (bottom 
left). Encoding creates a unique neural representation corresponding to the newly acquired information (right). 
  





predicts subsequent memory performance (Long et al., 2014). Cortical theta refers to low 
frequency scalp EEG oscillations that are often associated with memory encoding. Theta 
rhythms can also be recorded from the hippocampus where they may be linked to learning and 
memory (Hasselmo, 2005). When theta activity is induced in the rat prefrontal cortex during 
encoding, the animal has enhanced memory for behaviourally salient information (fear 
conditioning), but not for non-salient information (Jarovi, Volle, Yu, Guan, & Takehara-
Nishiuchi, 2018).  
These tagging processes may involve dopamine and the dentate gyrus. Dopamine is one of the 
most abundant neurotransmitters in the human nervous system, and its role in reward and 
saliency has been well established in animal and human studies (Bromberg-Martin, Matsumoto, 
& Hikosaka, 2010; Schultz, 1998). Photostimulation of dopamine in the dentate gyrus induces a 
reduction in synaptic connectivity and reduces both theta oscillations and subsequent learning. A 
behavioural reward yielded similar effects for upcoming learning trials (Du et al., 2016). Learning 
was enhanced before a reward and impaired after. These findings suggest that dopamine in the 
dentate gyrus may improve encoding of salient information by shielding it from interference. 
Tagging therefore continues to bias memory selection during subsequent memory stages.  
Saliency can also tag engrams retroactively. When participants learn neutral information which is 
subsequently associated with rewards, the previously neutral memories benefit from saliency-tags 
(Braun, Wimmer, & Shohamy, 2018; Patil, Murty, Dunsmoor, Phelps, & Davachi, 2017). After 
learning salient information, functional connectivity during rest between the ventral tegmentum 
and the hippocampus is increased, and the magnitude of this increase predicts persistence of 
salient but not non-salient information (Gruber, Ritchey, Wang, Doss, & Ranganath, 2016).  
In this study (Gruber et al., 2016), functional connectivity was measured from the two regions 
using resting state fMRI. In this kind of a paradigm, two regions are considered to be 





functionally connected when the blood oxygen level dependent signal, an indirect measure of 
brain activation, from these regions follows a similar timeline. In other words, when brain 
activity in two regions is temporally correlated, they are considered to be functionally connected. 
The ventral tegmentum and the hippocampus are also structurally, or synaptically, connected. I.e. 
there are structural pathways supporting communication between the two regions (J. E. Lisman 
& Grace, 2005). 
Given functional connectivity between the dopaminergic ventral tegmentum and the 
hippocampus is associated with memory persistence for salient information, it is likely that this 
functional connection supports memory through dopamine. 
Therefore, the tagging effect is likely a result of neuronal dynamics during and after encoding 
biasing salient encoded items to be preferentially consolidated in the long term. Given that the 
neuroanatomical basis of this learning seems to rest on the ventral tegmentum and the 
hippocampus, it is likely modulated by dopamine. 
 
Maintaining memories 
Once explicit memories are encoded, consolidation is required to make them last. The dual 
processing theory of memory suggests that at least two complementary routes to memory 
persistency are at an interplay: systems and synaptic consolidations (Mcclelland, Mcnaughton, & 
Oreilly, 1995). Both processes are, at least partially, supported by the hippocampus and are 
primarily studied along the CA1/3 Schaffer collaterals. During initial stages of memory storage, 
the hippocampus supports rapid learning by encoding information into neural representations 
with immediate effect (Figure 12). Early synaptic consolidation processes begin rapidly, within 
seconds from learning (Bonstrup et al., 2019). Meanwhile, systems consolidation refers to a 
process whereby information is moved from within the hippocampus to the neocortex for long-





term storage. The hippocampus works as a switchboard during this process, signalling repeats of 
the activation present at encoding.  
Memory and long-term potentiation 
Over half a century ago, neurons and synapses were first suggested to be modifiable by 
experience. The Hebb rule (Hebb, 1949), or the “neurons that play together stay together” rule, 
states that the strength of a synapse is dependent on the interaction between the presynaptic and 
postsynaptic neurons. In short, if cell X excites cell Y, their connection will be strengthened and 
maintained.  
The study of long-term potentiation (LTP) sprung support to Hebb’s theory. In the CA1, LTP 
follows Hebbian principles (Wigstrom & Gustafsson, 1986): LTP requires both presynaptic 
input (cell X response) and postsynaptic depolarisation (activation of cell Y in response to cell X 
activity). There is little doubt about the importance of Hebbian LTP for memory persistence (T. 
V. P. Bliss & Collingridge, 1993; Lomo, 2003). However, from anecdotal experience information 
in the environment can co-occur repeatedly but it is not until this information bears some 
importance/salience that we learn associations. This observation can be explained by the 
‘neoHebbian’ framework first proposed by Lisman et al (2005, 2011).  
 






NeoHebbian framework  
What might signal salience at the synapse? According to the neoHebbian view, for LTP to persist, 
in addition to Hebbian conditions, a release of dopamine is required (J. Lisman et al., 2011; J. E. 
Lisman & Grace, 2005). Importantly, early LTP does not seem to be dependent on dopamine, 
while late LTP is – suggesting dopamine plays a role in memory persistence. Dopamine’s role in 
late LTP has been demonstrated several times (Edelmann & Lessmann, 2013; Granado et al., 
2008; Hamilton et al., 2010; Y. Y. Huang & Kandel, 1995; Lemon & Manahan-Vaughan, 2006; 
Matthies, Schroder, Hollt, & Krug, 1997; Otmakhova & Lisman, 1998; Papaleonidopoulos, 
Kouvaros, & Papatheodoropoulos, 2018) and these have been outlined earlier in this chapter.  
 
 
Figure 12: Early consolidation  
 
During early consolidation processes, the strength of memory-associated synapses becomes gradually 
strengthened over time. Later, during systems consolidation (not shown here), these connections within the 
hippocampus weaken as information is stored in a more widely distributed network.  
 





These cell-level dopamine-driven changes in synaptic strength are directly associated with 
behavioural changes in memory persistence. Therefore, dopamine is associated with salience and 
it can induce late LTP in the hippocampus, but it is not required for early LTP.  
Abundance of evidence to support the link between dopaminergic LTP and memory comes 
from animal studies. For example, an injection of a D1 agonist preceding encoding impairs 
memory when performance is tested 30 minutes later but memory is improved, compared to 
control rats, when tested after a 12-hour delay (Floresco & Phillips, 2001). As increased 
dopaminergic activity would have still been present at the 30-minute test, these data do not 
reveal whether dopamine impairs encoding or retrieval. However, they do suggest that D1 
activity is important for consolidating memories long term, over a period that coincides with 
sleep.  
These findings are in line with other research in animals (Rossato, Bevilaqua, Izquierdo, Medina, 
& Cammarota, 2009) that have found that dopamine controls persistence of long-term 
memories. An injection of a D1 antagonist into dorsal hippocampus impairs long-term memory 
when injected 12 but not 9 hours after learning. In another group of animals, a D1 agonist to the 
hippocampus enhanced memory 12 but not 9 hours after learning. These effects were associated 
with changes in protein synthesis in the ventral tegmental area, suggesting that the VTA-
hippocampal loop is associated with memory persistence. Together these findings suggest that 
the timing of dopamine in relation to memory is crucial: it may impair encoding and enhance 
consolidation. 
Support from humans 
At least one study has found supporting evidence of the neoHebbian model in humans. 
Recordings from Deep Brain electrodes inserted for deep brain stimulation from the substantia 
nigra in 23 Parkinson’s disease patients showed that 25% of neurons were novelty sensitive, 





indicating their role in memory (Kaminski et al., 2018). These, mostly dopaminergic, neurons 
activated ~500ms after stimulus onset during correct trials in a recognition memory test. The 
activity changed at each trial and it was predictive of recognition accuracy. Moreover, spiking 
patterns were temporally associated with prefrontal theta oscillations and the functional 
connectivity between substantia nigra and theta also predicted recognition memory accuracy. 
In a previous study neurons in the hippocampus have been shown to activate in response to 
novelty in this same task (Rutishauser, Mamelak, & Schuman, 2006). The results from these 
studies lend first-in-human direct support for the neoHebbian model and the VTA-hippocampal 
dopaminergic loop’s involvement in memory (J. Lisman et al., 2011). 
From synapse to system  
Memory traces do not rely on the hippocampus indefinitely. Instead, the recruitment of wide-
spread cortical networks is also required for memories to persist. This memory migration into 
the cortex is referred to as systems consolidation. During this process, information becomes 
reorganised and more widely distributed in the cortex while hippocampal involvement is 
weakened (Frankland & Bontempi, 2005). Initial accounts posited that memories are first stored 
in the fast-learning hippocampus from where they transfer to the neocortex, which is a slow 
learner. Memories then become wholly independent of the hippocampus. However, memories 
do not literally migrate outwith the hippocampus to the neocortex. Instead the relative weighting 
of contribution of different regions in the memory network are changed over time. Both the 
hippocampus and the neocortex are likely to be involved in episodic memory persistence from 
the onset of encoding to late consolidation and possibly retrieval (Genzel et al., 2017; Squire et 
al., 2015). 
Yet, the weightings between hippocampal and neocortical memory representations do change 
over time. When participants learn a memory task and they are tested later in an fMRI scanner, 





the duration between learning and test is predictive of recruited brain networks (Takashima et al., 
2009). If tested 15 minutes later, the hippocampus is more heavily recruited during test, and the 
connectivity between the hippocampus and cortical regions is increased compared to a 24-hour 
test. In comparison, at a 24-hour test, functional connectivity within cortical regions is increased. 
While these findings are congruent with the current understanding of memory maintenance, this 
study did not account for qualitative differences in encoding strength. The memory task at 15 
minutes would have been easier than it was at 24 hours, which could, in part, explain the results. 
Encoding strength is tightly interlinked with consolidation speed. 
Indeed, the position that neocortical learning is universally slow-paced has been challenged. 
Initially in simulations that showed that information congruent with previous experience can be 
‘fast mapped’ to the cortex rapidly (McClelland, 2013), and soon after experimentally in humans 
(Coutanche & Thompson-Schill, 2014). Further evidence comes from a virtual navigation task. 
During initial exploration of the virtual environment, efforts to navigate relied more heavily on 
hippocampal-cortical connectivity, consistent with early phases of consolidation. With prolonged 
exploration of the virtual environment, less hippocampal activity was required, and processing 
became reliant on the connectivity between cortical networks instead (Brodt et al., 2016). This is 
analogous to systems consolidation but could be seen in a single fMRI session in this study. In 
other words, these findings support the notion that rapid systems consolidation is possible 
during repeated exposure. 
Similar findings have been seen in a verbal memory task where participants studied a word list 
seven times with each repeat followed by an immediate recall (Himmer, Schönauer, Heib, 
Schabus, & Gais, 2019). Rapid change-over between memory systems was observed again. The 
effect persisted after a full night of sleep. Interestingly, if volunteers spent a similar amount of 
time awake instead, the hippocampus had “forgotten” about the supposed systems consolidation 
that took place during learning. There are two main implications from these studies. First, 





repeated testing seems to provide a fast route for systems consolidation, and second, systems 
consolidation may require sleep to stabilise.  
In sum, initial consolidation begins rapidly after learning and is supported by synaptic plasticity. 
Behavioural tagging during learning may bias the synaptic environment in way that enhances the 
likelihood of this plasticity. Systems consolidation is typically slower and takes place later, but it 
can be accelerated by previous information or repetition. Intentional awake repetitions of learnt 
information, such as repeat study or exploration, provide a fast route for consolidation, possibly 
by reactivating neuronal assemblies present at learning. This may also be supported by previous 
knowledge: presumably repeated information may be deemed as more salient and therefore 
become tagged for prioritised storage.  
 
Dopamine, encoding and consolidating 
Dopamine’s roles during different memory stages are unclear. While some have found dopamine 
to be selectively involved in consolidation (Bethus, Tse, & Morris, 2010), other evidence has 
linked it with active forgetting, working memory and encoding (Berry, Cervantes-Sandoval, 
Chakraborty, & Davis, 2015; Cools & D'Esposito, 2011; Du et al., 2016). As memory persistence 
is modulated by novel events both before and after learning, dopamine is likely involved not just 
in the consolidation but also in the encoding stage. 
Dopamine and memory in Parkinson ’s disease 
Dopamine’s effects on cognition are often studied in Parkinson’s disease patients using 
paradigms were patients abstain from dopamine replacement therapies (OFF treatment) for 
short periods of time. Coulthard et al (2012) investigated probabilistic learning in 22 Parkinson’s 
disease patients ON and OFF their usual treatment (Coulthard et al., 2012). During learning 





participants made left / right judgements in response to four cartoon characters – e.g. four 
different hamsters. Each hamster was associated either with disparate probabilities of positive 
and negative feedback depending on the left / right judgement: for two hamsters a left press 
resulted in an 80% probability of positive (“Well done you caught it!”) and a 20% probability of 
negative (“Bad luck” displayed on screen) feedback, and vice versa for the other two hamsters. 
Participants completed 30 study trials per hamster, with feedback at each trial.  
Medication status did not affect initial learning – i.e. whether participants were ON or OFF 
dopaminergic medication they performed equally well toward the final learning trials. After a 20-
minute delay, being ON medication increased performance by ~15%. Therefore, dopamine did 
not play a role in the initial learning process but following repeated repetitions of trials, 
subsequent performance was enhanced. This suggests that dopamine during learning may 
accelerate fast systems consolidation during learning over repeated blocks.  
A limitation of this study was that participants were either ON or OFF medication throughout 
the testing sessions, and therefore isolating between the effects of dopamine on encoding, 
consolidating and retrieving is not possible.  
In another study in Parkinson’s disease, dopamine had disparate effects on memory depending 
on the timing of administration in relation to the memory stage (J.P. Grogan, Bogacz, Tsivos, 
Whone, & Coulthard, 2015). When patients encode a list of 12 words OFF compared to ON 
medication, memory performance is enhanced 24 hours later. If patients are ON medication 
during the subsequent night and memory test, their performance is further enhanced. At an 
earlier 30-minute test with the same items, participants’ memory was impaired if they were ON 
medication. The most optimal performance in this task was reached when patients were OFF 
medication during learning but ON during the subsequent night. These findings suggest that in 





Parkinson’s disease, dopamine during encoding impairs memory, while nocturnal dopamine 
enhances it.  
Note that this finding is opposite to that seen in drosophila (and some rodents), where dopamine 
enhances encoding and accelerates forgetting (Berry, Cervantes-Sandoval, Nicholas, & Davis, 
2012; Berry, Phan, & Davis, 2018; Castillo Diaz, Hernandez, Capella, & Medina, 2019). Berry et 
al (2012, 2018) conducted a series of studies in which they modulated dopamine neuron activity 
acutely and reversibly, visualised dopamine cell activity and observed behavioural deficits in 
dopamine mutant drosophila. Blocking dopamine post-learning enhanced memory persistence 
and stimulating dopaminergic neurons boosted forgetting, while dopamine stimulation during 
encoding enhanced memory (Berry et al., 2012). The dopamine activation that enhances 
encoding simultaneously blocked consolidation of old memories (Berry et al., 2018).  
An alternative explanation that bridges the gap between humans (J.P. Grogan et al., 2015) and 
flies is that at dopamine has a dual effect on memory that is driven by salience: dopamine 
accelerates forgetting for non-salient items and spares salient information. According to this 
explanation, dopamine between learning and the subsequent 30-minute test enhanced routine 
forgetting, effectively “impairing” performance. The repeated test of the same items at 30-
minutes tagged them as salient, after which subsequent dopamine enhanced memory for this 
information. Rather than enhancing consolidation globally, dopamine selectively shielded salient 
information from memory decay and accelerated nocturnal forgetting.  
Dopamine and memory in randomised controlled trials 
To fully understand dopamine’s roles in memory and cognition, pharmacological trials in healthy 
humans are also needed. While dopamine’s effects can be studied in Parkinson’s disease, the 
hallmark pathology of substantia nigra dopamine loss may also affect cognition (Dubois & 
Pillon, 1997). An advantage in studying dopamine as an intervention in healthy individuals, rather 





than by withdrawing regular medication of people with Parkinson’s disease, is that it allows using 
double-blinded designs. Findings from placebo-controlled trials in healthy humans have shed 
further light to dopamine’s role in memory. 
Dopamine accelerates the rate of language learning over multiple days, possibly by enhancing 
repeated learning. Healthy young adults were given 100mg of L-DOPA 1.5h before learning a 
language task. This was repeated over five separate learning sessions (Knecht et al., 2004). At 
each visit, participants completed 400 learning trials, during which they learnt to associated 
pseudowords with images. Each word-image pair was presented four times over the session 
(Breitenstein & Knecht, 2002). The L-DOPA mediated enhancement on word-learning started 
to emerge on the second day. L-DOPA accelerated the initial learning over the first 2-3 days, and 
it slowed down forgetting over time compared to placebo. The L-DOPA mediated enhancement 
in memory persisted at delayed tests a week and a month later, after the treatment period and 
training had finished (Knecht et al., 2004). Very similar effects of L-DOPA on word-learning 
have been found by others, where beneficial effects only begun after repeated testing (Shellshear 
et al., 2015). Dopamine therefore enhances language learning over study periods spread over 
multiple days. 
It is difficult to differentiate when dopamine was influencing memory from these trials. 
Participants in both studies were dosed prior to learning and exogenous dopamine was active 
throughout testing (Knecht et al., 2004; Shellshear et al., 2015).  It is tempting to say that 
dopamine is only acting at encoding but encoding processes may be different when information 
is re-encoded, particularly if that re-encoding event is associated with a memory test as it was 
here. Information learnt over multiple days, as opposed to on the same day, is also more 
resistant to forgetting (Ezzyat, Inhoff, & Davachi, 2018). These findings further support 
dopamine’s involvement in prioritising memory persistence for salient information, possibly by 
enhancing the tagging effect.   





Other studies have targeted different memory processes more carefully. In one such study, while 
L-DOPA was active during both learning and encoding, fMRI was used to study the underlying 
neural signature of L-DOPA at encoding (Chowdhury et al., 2012). Old adults were dosed with 
150mg L-DOPA (or placebo) 90 minutes preceding a reward-scene learning task in the scanner. 
During encoding, participants learnt 120 still scenes that were either rewarded (£1.00) or not 
(£0.00). Recognition was probed 2h and 6h later outside the scanner using the Remember-Know 
paradigm (which is discussed later). Recollection for neutral scenes was enhanced for a group of 
participants receiving a “medium dose” (based on body weight), while no effect of was seen in 
low or high dose groups. This effect was seen both by splitting the participants into groups 
based on body weight and by fitting a quadratic curve.  
Furthermore, the L-DOPA-mediated enhancement in memory was independent of hippocampal 
activity during learning. While the subsequent memory effect – where hippocampal activity at 
encoding predicts later memory – is not always seen in elderly (e.g. (Morcom et al., 2010), in this 
study it was present during placebo but not during the L-DOPA visit (Chowdhury et al., 2012). 
The authors concluded that L-DOPA wiped out effects of preferential encoding of rewarded 
information by boosting consolidation globally. In conjunction with the behavioural findings, 
this study suggests that dopamine does not modulate encoding but rather enhances 
consolidation.  
Similar findings have been found in healthy young individuals. Nocturnal D2 agonist 
pramipexole given after learning, to target consolidation, wipes out the tagging effect between 
high and low reward items by enhancing memory for low reward (Feld et al., 2014). It is notable 
that pramipexole was given after learning, to target consolidation. Together with these two 
studies suggest that dopamine at encoding does not modulate memory in healthy individuals 
regardless of age. Interestingly, high reward information did not benefit from subsequent 
dopamine in either study. Dopamine may instead tag low reward items retrospectively to increase 





consolidation, while high reward items do not benefit as they are already at “ceiling” when it 
comes to the reward-mediated memory boost. I suggest that as participants knew they would be 
tested on all items, even non-rewarded information carried a saliency-tag.  
 
Sleep and memory 
Sleep has long been recognised as playing a role in consolidating memories (Stickgold, 2005; van 
de Ven, Trouche, McNamara, Allen, & Dupret, 2016). The initial observation on sleep’s role in 
memory was made by Ebbinghaus, who pioneered memory research over a century ago. He 
noted that forgetting curves were not linear but instead they were slowed down during sleep 
(Ebbinghaus, 1885; Jenkins & Dallenbach, 1924). Seemingly, sleep protects memories from 
decay. However, memories during sleep are not stable. Instead, while we sleep, they are 
selectively stored or forgotten, or adapted to integrate into our previous network of knowledge 
through the process of systems consolidation.  
Here, I will demonstrate that sleep supports memory consolidation and maintenance. Sleep also 
supports several other cognitive and physiological restorative functions – from stabilising mood 
and satiety to clearing brain amyloid and regulating insulin (Li, Kechter, Olmstead, Irwin, & 
Black, 2018; Reutrakul & Van Cauter, 2018; Shokri-Kojori et al., 2018). Given that during sleep 
memories – at least in past – migrate from the hippocampus to cortical regions, sleep and 
consolidation might also restore encoding capacity in the hippocampus. Indeed, hippocampal 
activation is reduced when retrieving memories that have been consolidated overnight (Wang & 
Morris, 2010).  
 
 






What then may support the gradual information transfer between the hippocampus and the 
cortex? The sharp wave ripples touched upon earlier, (see Figure 9 on page 20), seem to play a 
key role in bolstering systems consolidation, at least for some types of memories. In rodents, a 
well-replicated finding is that sequences of hippocampal place cell firing active at learning are 
spontaneously replicated at a higher frequency during sharp-wave ripples (Skaggs & 
McNaughton, 1996; M. A. Wilson & McNaughton, 1994). While they take place both during 
wakefulness and sleep, sleep seems to provide an optimal environment to support hippocampal 
replay (Carr, Jadhav, & Frank, 2011; Foster & Wilson, 2006; Molle, Yeshenko, Marshall, Sara, & 
Born, 2006; Ramadan, Eschenko, & Sara, 2009).  
Not only do the ripples reactivate patterns of neuronal activity, they also support consolidation. 
Abundant evidence for this comes from experiments on animals. For example, ripples induce 
LTP in the hippocampus (Sadowski, Jones, & Mellor, 2016), and artificially suppressing ripples 
impairs memory (Girardeau, Benchenane, Wiener, Buzsaki, & Zugaro, 2009). In primates, ripples 
during wakefulness and sleep are temporally associated with suppressed activity in thalamic and 
cortical regions (Logothetis et al., 2012; M. Y. Yang, Logothetis, & Eschenko, 2019). This 
cortico-thalamic silence may provide an optimal window for systems consolidation by reducing 
interference.   
Sleep spindles, which are time-locked to ripples, also support the kind of communication 
between medial temporal lobe and the cortex that is needed for systems consolidation. 
Connectivity between cortical regions and the hippocampus is enhanced during slow wave 
spindles (Siapas & Wilson, 1998; Sirota, Csicsvari, Buhl, & Buzsaki, 2003). In line with this 
observation, the density of spontaneous ripples during slow wave sleep is associated with 
enhanced memory for the repeated events (Ramadan et al., 2009). Intracranial recordings from 





patients with epilepsy also show that ripples are associated with neocortical slow oscillations 
(Axmacher, Elger, & Fell, 2008). Spindles and slow wave activity after learning has also been 
shown, in scalp EEG, to mediate the process of integrating newly learnt information into an 
existing knowledge framework (Tamminen, Lambon Ralph, & Lewis, 2013). Together these 
studies robustly show that hippocampal activity during sleep promotes memory consolidation.  
Note that this sleep-dependent replay parallels the “fast route” online systems consolidation 
driven by repeated learning trials (Brodt et al., 2016; Himmer et al., 2019). Replay involves 
spontaneous unintentional repeats of learning-related neuronal firing, possibly analogous to 
repeated exposure to stimuli.  
Finally, while there is less evidence of replay in humans, some affirmation comes from patients 
with parasomnias. A behavioural re-enactment of a learnt motor task has been video recorded in 
one sleep-walking patient during slow wave sleep (Oudiette et al., 2011). In the daytime the 
patient underwent vigorous training of a motor-reaction time task where obvious, large and 
uncommon hand and arm gestures were required. At night sequences of the learnt task were 
spontaneously repeated. However, the replay was not linked to spindles. 
Nevertheless, these evidence together build a robust case that replay during sleep and awake 
plays a role in memory persistence. While studies in humans are scarce, there have been several 
attempts to induce replay in humans.  
Targeted memory re-activation 
Efforts to study memory replay in healthy humans have also been made. An analogue to 
memory replay can be induced artificially using targeted reactivation paradigms. In these studies, 
participants typically learn paired associates in the day-time – such as a smell or a sound paired 
with other information, such as a word (e.g. “meow - Finland”, “squeak - Greece”). During sleep, 





the associated sound is played (e.g. “meow”), and participants are more likely to retain information 
related to the sound (“Finland”) than other information (“Greece”), even though participants are 
not consciously aware of the sound (Rudoy, Voss, Westerberg, & Paller, 2009; Shimizu et al., 
2018).  
Targeted memory reactivation may be particularly beneficial during slow wave sleep. When a 
distinct odour was present during both learning and slow wave sleep, performance in an 
association task was enhanced (Rasch, Buechel, Gais, & Born, 2007). The presentation of the 
odour during slow wave sleep was also associated with increased hippocampal activity during an 
fMRI scan. No beneficial memory effect was found if the odour was presented during REM 
sleep, after learning during wakefulness, or during slow wave sleep but not at learning. Others 
have also found that targeted memory activation during slow wave sleep increases spindles and 
subsequent memory (Cairney, Guttesen, El Marj, & Staresina, 2018). These findings give indirect 
support to memory replay affecting hippocampally-mediated memory. They also suggest that, as 
seen in rodents and primates, slow wave sleep provides an optimal timing for memory 
consolidation.    
Evidence that targeted memory reactivation is causally related to replay comes from rats. When 
memories are reactivated during slow wave sleep by presenting a sound, the overall incidence of 
replay events does not increase. Instead, the sound-associated sequences are preferentially 
replayed (Bendor & Wilson, 2012). This suggests that the replay does not enhance memory 
overall but rather biases it. This raises the question: what factors play a role in selecting which 
memories will be re-activated during sleep? 
Salient memories 
Sleep-dependent consolidation is not equal: some information is retained while others are lost 
(Figure 13). Encoding-related events may bias memory selection during subsequent sleep. Salient 





- rewarded, novel and unusual – information may particularly benefit from sleep. In line with 
this, hippocampal ripples, which are time-locked to spindles, have recently been shown to  
selectively contribute to the consolidation of rewarded items (Michon, Sun, Kim, Ciliberti, & 
Kloosterman, 2019). 
When learning salient information is followed by sleep, it is prioritised for storage even when 
tested 3 months after learning (Igloi, Gaggioni, Sterpenich, & Schwartz, 2015). Importantly in 
this study, this effect only applied to salient information. While the tagging effect was present 
months later when the volunteer had taken a nap after learning, in the absence of post-learning 
sleep, rewarded and non-rewarded memories decayed equally. It is not just rewarded information 
that is prioritised during sleep.  
 Personal values and can also guide consolidation. When participants were learning foreign-
language words, the degree to which sleep facilitated learning was associated with how much 
they valued the language they were learning (van Rijn, Lucignoli, Izura, & Blagrove, 2016) 
Sleep therefore preferentially consolidates behaviourally salient information. However, when 
participants do not know that their memory is going to be tested later, they perform equally well 
regardless of whether they have slept or not (Wilhelm et al., 2011). When participants know they 
will be tested, memory is enhanced. This enhancement is associated with an increased spindle 
count during slow wave sleep – but no such relationship was seen when information was not 
behaviourally salient. Similarly, sleep-mediated increases in memory persistence are biased 
toward prospective memories (Diekelmann, Wilhelm, Wagner, & Born, 2013) and other 
memories that are relevant for future behaviours (Fischer & Born, 2009; Rauchs et al., 2011). 
Other evidence that sleep benefits memory selectively for salient information comes from 
studies showing that sleep enhances memory for overall concepts, or the gist, of the memory but 
not for specific information. For example, when participants learn objects with shared category 





features and specific individual features, sleep improves memory for the former but not the latter 
(Schapiro et al., 2017). It may be much more beneficial for the memory system to extract the gist 





Figure 13: Long term consolidation and forgetting, and sleep 
 
Before memories have stabilised (left) they rely heavily on hippocampal nodes and connections, and they 
are weakly connected to cortical regions. During repeated reactivations, which often take place during sleep 
(middle), the cortex becomes more involved in memory storage and begins to form novel associations 
between nodes.  Memories that are salient are also prioritised for spontaneous reactivations, while irrelevant 
information is selectively lost. Weeks later (right) memories rely more heavily on cortical nodes and 
connectivity. Some hippocampal connections between nodes may even become lost as the “cortical gist” of 
the memories is prioritised over fine grain detail stored in the hippocampus.  
 
 






Throughout sleep, the brain fluctuates across different sleep stages. These stages are likely be 
disparately associated with cognition. Many animal studies report slow wave spindles to be 
temporally associated with memory replay. Studies in rats have mostly associated consolidation 
with sleep events, such as spindles, during slow wave sleep. Rat slow wave sleep is analogous to 
human non-REM sleep, and therefore it encompasses sleep events that takes place across human 
stages 1, 2, and slow wave sleep. In humans spindles are abundant in stage 2 and several studies 
show that spindles during both stage 2 and slow wave mediate memory performance (Andrade et 
al., 2011; S. M. Fogel & Smith, 2006; Genzel et al., 2017; Squire et al., 2015).  
While here I have mostly discussed slow wave sleep, the dual processing hypothesis stipulates 
that different sleep stages serve to consolidate different types of information. In short, REM has 
been suggested to serve implicit memories, while slow wave sleep has been suggested to serve 
consolidation of explicit memories (Gais & Born, 2004; Rasch & Born, 2013; Rauchs, 
Desgranges, Foret, & Eustache, 2005). Yet, the picture is unlikely to be this clear-cut as there are 
some exceptions with emotionally loaded information being preferentially consolidated during 
REM (Harrington, Johnson, Croom, Pennington, & Durrant, 2018; Wiesner et al., 2015).  
Forgetting 
A healthy memory system cannot consolidate all information that is encoded. Even if the storage 
capacity was limitless, the behavioural utility of non-selective memory is questionable. As we 
have seen, the memory system prioritises salient memories over irrelevant information, and 
strategic forgetting of what is not later required likely allows important items to be better 
retained. In other words, blocking consolidating or encoding of competing information may 





support consolidation of salient information. For memory to be successful, a degree of routine, 
strategic forgetting may be necessary.  
Initially, it was thought that forgetting was caused by interference from competing stimuli alone, 
and that sleep enhanced memory by blocking this interference (Jenkins & Dallenbach, 1924). 
Since this view has been extended by including passive, and later active, memory decays as 
alternative routes for forgetting (Hardt, Nader, & Nadel, 2013). Sleep not only plays a role in 
consolidating memories but it also facilitates forgetting (Berry et al., 2015; Davis & Zhong, 2017; 
Feld & Born, 2017). 
It is not entirely clear what facilitates routine forgetting in a healthy brain but increased cognitive 
load may increase the demands for strategic forgetting. In a word-learning task memory was 
enhanced by sleep when volunteers learnt 160 word-pairs but not when they learnt 320 (Feld, 
Weis, & Born, 2016). In the 320-word condition participants performed equally well whether 
they had slept or not. This suggests that during sleep instead of consolidating some of the word-
pairs, the memory system actively suppressed consolidating or triggered active forgetting of these 
items, mimicking processes like those caused by interference during wakefulness. Under pressure 
from a large amount of memories to consolidate, sleep may facilitate active forgetting in favour 
of other salient information.  
Several studies in drosophila have identified molecular and cellular structures that support 
routine forgetting, including pioneering studies linking it to forgetting (Berry et al., 2012). 
Drosophila are a commonly used model to study the effect of brain chemicals on sleep and 
disease. As in humans and other mammals, in drosophila dopamine regulates sleep-wake cycles 
and arousal (Andretic, van Swinderen, & Greenspan, 2005; Kume, Kume, Park, Hirsh, & 
Jackson, 2005) .  





Dopamine’s effects on learning fluctuate with circadian rhythms. In drosophila, increased 
dopamine during wakefulness increases routine forgetting and decreased dopamine during rest 
inhibits it (Berry et al., 2015). In drosophila, dopamine is required for both encoding and active 
forgetting (Berry et al., 2012; Berry et al., 2018), and while these are mediated by the same set of 
neurons, they are associated with separate receptors. Therefore, one dopamine neuron can have 
disparate effects on memory and cognition.  
Research in rodents has localised these effects into the VTA. Castillo Dias et al (2019) conducted 
a series of experiments with D1 antagonists and agonists injected into the VTA, hippocampus or 
nucleus accumbens at varying delays after learning. D1 projections from the VTA to the nucleus 
accumbens were found to enhance memory persistence, while projections from the VTA to the 
hippocampus accelerated active forgetting (Castillo Diaz et al., 2019). Therefore, D1 receptors in 
the VTA, projecting to the hippocampus might provide a neurophysiological basis for forgetting. 
Blocking dopamine activity in either inhibits active forgetting, while exciting D1 receptors 
accelerates it, at least for salient information. In light with the findings in drosophila, this 
suggests that the dopaminergic connections to and from the hippocampus can active forgetting. 
In sum, memory is not just an outcome of successful consolidation but instead forgetting is an 
active process that can be triggered by behavioural or pharmacological interventions. The effects 
of dopamine on forgetting are difficult to interpret in the context of the findings where these 
same regions enhance memory persistence. The above results may be specific to cocaine-related 
memory. Acute cocaine can increase memory persistence in mice (Introinicollison & Mcgaugh, 
1989; Janak, Keppel, & Martinez, 1992).   
It is also possible that disparate sub-populations of dopaminergic neurons have disparate effects 
on memories depending on the type of memory, time since learning and so on. Indeed, Berry et 
al (2018) demonstrated that the same neurons at different receptors both enhances encoding and 





forgetting. Some have suggested that dopamine influences memory persistence via two separate 
routes – one involving the locus coeruleus and the other the hippocampal-VTA-loop 
(Duszkiewicz, McNamara, Takeuchi, & Genzel, 2019). It is not presently clear why dopamine 
seems to induce forgetting in some studies and consolidation in others.  
A possible explanation is that of publication bias and the file drawer effect. In short, publication 
bias refers to the phenomenon where publishing positive studies is incentivised in a way that 
leads to studies with negative results being underreported or ending in the file drawer. Selective 
publishing of results can lead to several low-power studies with discrepant findings.  
The file-drawer effect can be estimated from published results. When studies are poorly 
powered, as they are in neurosciences (Button et al., 2013), published findings become less 
reliable. First, the likelihood of false positive findings increases as smaller samples increase the 
likelihood of chance findings. Second, true effects become less likely to be detected which means 
that when they are found, observed effect sizes are likely to be larger than the size of the true 
effect – as the true effect may be too small to be observed in a small sample. Furthermore, the 
distribution of p-values is heavy-tailed when the alternative hypothesis is true (i.e. when there is 
an effect very low p-values are more likely) but equally distributed when the null hypothesis is 
true (i.e. when there is no effect every p-value is equally likely). 
Using reported summary statistics from published research studies one can attempt to quantify 
the magnitude to which publication bias is affecting the reliability of findings from a given field. I 
am not aware of any meta-analyses that have systemically tried to quantify the magnitude to 
which publication bias is a problem in the dopamine/memory literature. However, using data 
from over 3800 published papers, Szucs and Ioannidis (2017) estimated that up to 50% of 
published findings in cognitive neurosciences may be false (Szucs & Ioannidis, 2017).  





Several of the aforementioned studies have low power and small effects. This increases the 
likelihood of false positives and therefore studies being selectively published. This is likely to at 
least partially explain the discrepancies in findings.  
 
Retrieval 
Recollection and familiarity 
The final memory stage in the traditional stage model is retrieval. During retrieval, memories are 
reconstructed in a process that mimics the neuronal firing patterns associated with learning. This 
process is also supported by hippocampal sharp wave ripples (Joo & Frank, 2018). Retrieval can 
either take the form of free recall or recognition. 
In experiments, recall is prompted either by cueing learnt items or by free recall. Both free recall 
and recognition can be used to test either episodic or semantic memory. In episodic recognition 
tasks participant are asked to judge if an item was presented previously (OLD) or not (NEW). 
This task is considered episodic because participants are asked about items presented in a specific 
situation and context (Migo, Mayes, & Montaldi, 2012). The reasoning is, that participants are 
recollecting the specific situation in which they learnt the tested item. Yet, it is intuitive that 
participants can make OLD – NEW judgements in the absence of recollection for the learning 
context. Participants can therefore make two types of correct OLD judgements – ones that are 
based on recollection of the learning context and ones based on familiarity with the presented 
item.  
Thus, recognition memory can be divided into recollection and familiarity. Recollection refers to 
episodic memories about events – where contextual information relating to the recollected 
information is recalled. Familiarity instead relates to knowing that information was encountered 





before, in the absence of recollection. These can be considered analogous to episodic 
(recollection) and semantic (knowing) memories (Brown & Aggleton, 2001; Tulving, 1985). A 
classic example to illustrate this distinction is recognising a person on the street as familiar with 
no recollection of who they are. 
 One approach for dissociating recollection and familiarity experimentally is to use the 
Remember-Know procedure (Tulving, 1985). In this task, participants are prompted follow-up 
questions after OLD – NEW judgements. Upon recognising information as OLD participants 
are asked to determine if they REMEMBER (recollect) or KNOW (familiar) the item, or – in 
case of a forced-choice task – if they made a GUESS (Figure 14).  
The end outcome of both recollection and familiarity is recognition. While behaviourally these 
are separable processes, there is great controversy associated with the neuroanatomical basis of 
recollection and familiarity. The dual processing view holds that recollection and familiarity are 
achieved by separable neurophysiological processes. In accordance to this view, the perirhinal 
and lateral entorhinal cortices support familiarity while the hippocampus supports recollection 
(Bowles, Duke, Rosenbaum, McRae, & Kohler, 2016; Diana, Yonelinas, & Ranganath, 2007; 
Rugg & Yonelinas, 2003; Yonelinas, Kroll, Dobbins, Lazzara, & Knight, 1998).  
 
 
Figure 14: Example of a Remember Know task 
 





In contrast, others regard the difference between familiarity and recollection a question of 
memory strength: both processes are mediated by the same medial temporal lobe regions that are 
involved in processing recognition memory strength (Brezis, Bronfman, Yovel, & Goshen-
Gottstein, 2017; Wixted & Squire, 2010). However, evidence from a recent fMRI study suggests 
that the hippocampus is not sensitive to recollection strength but to the quantity of recollection 
(Mayes et al., 2019).  
This study (Mayes et al., 2019) used a modified version of the Remember-Know task where, 
during recognition and cued recall, participants were asked to judge the memory strength for 
recognised words (on a scale from 1 to 3), whether they were recollected, or if they were 
distractor words. Participants completed both recognition and cued recall trials while in the 
fMRI scanner. During each recognition trial, participants saw a word (e.g. HAMSTER), and they 
had to make one of the following responses: 1, 2, 3, Recollected, New; where 1, 2, and 3 
corresponded to memory strength. During the cued recall trials, participants saw a cue for a 
word (e.g. HAM _ _ _ _) to which they responded to as in the recognition trials. After they had 
made a response, they were shown two words (e.g. HAMSTER, HAMBURG), and they were 
asked to determine which one they had thought of during cued recall. 
Crucially, this task allows isolating memory strength, accuracy and quantity. Quantity was 
measured as the number of recollected items in the cued recall condition. For accurate cued 
recall, spontaneous recollection of the word itself was required, so any recollections would have 
reflected a change in the amount of recollection, rather than a switch between familiarity and 
recollection. The hippocampus was sensitive to the amount of recollections, but not to 
recollection strength or accuracy (Mayes et al., 2019). This suggests that the difference between 
recollection and familiarity cannot be explained by strength alone. 





A disadvantage of the traditional Remember-Know procedure is the heterogeneity in its 
adaptation. The fine difference between recollection and familiarity is difficult to explain to 
participants in the context of experimental tasks – for a layperson the difference between 
remembering, knowing and recognising is often neither clear nor intuitive. This may lead to 
participants making Remember-Know judgements that are analogous to judging memory 
strength. Care needs to be taken when instructions are delivered to participants. One approach 
to limiting bias based on participants’ understanding of the task, is to ask them to justify their 
answers. Whenever a REMEMBER response is made, the investigator can ask participants to 
explain what they recollect.  
While this approach partially limits participants’ likelihood of erroneously identifying recollected 
items as familiar, it does not address the issue of memory strength: the average recollected 
memory is likely to be stronger than the average familiar item, and it does not solve the problem 
of erroneously identifying recollected items as familiar. Indeed, recent evidence suggests that 
hippocampal activation seen during familiar trials in fMRI studies may be explained by 
participants inaccurately judging familiarity (Mayes et al., 2019).  
Familiarity is further complicated by previous knowledge of the words presented. Typically, real 
words are used in these tasks. In a task designed this way, each item is familiar from some 
previous context or contexts. Others (C. N. Smith et al., 2014) have argued that familiarity 
judgements in verbal Remember-Know tasks measure associative memory between the word and 
the context of the learning situation, rather than true familiarity. This view suggests that 
familiarity judgements rely on the hippocampus. The hippocampus plays a key role in integrating 
pieces of information with one another, and thus supporting associative memory (Bird, 2017). 
These limitations and discrepancies in findings and implementations of these tasks make it 
difficult to interpret what the underlying physiology related to these tasks is. 





It is therefore not entirely clear whether familiarity and recollections are truly independent. 
However, the medial temporal lobe structures do seem to play some role in supporting both 
types of judgements. In rats, attempts to isolate familiarity and recollection have been made by 
applying response deadlines during recognition memory. In accordance to this reasoning, under 
time constraints recollection is eliminated and rats will rely on familiarity – while when no time 
constraints are applied, they will use recollection and familiarity equally. Results from this task 
behaviourally mimic response patterns seen in humans (Sauvage, Beer, & Eichenbaum, 2010). In 
rats there is a clear involvement of the lateral entorhinal and perirhinal cortices during familiarity 
judgements, while hippocampal subfields CA1 and CA3 are not recruited under time constraints 
(Atucha, Karew, Kitsukawa, & Sauvage, 2017). These findings suggest that the dentate gyrus and 
the perirhinal cortex support familiarity, while the CA1-CA3 support recollection.  
However, there are obvious caveats to this approach. Separating familiarity from recollection is a 
difficult task even in humans and participants typically need training and detailed explanations to 
understand the difference. While faster responses in rats may certainly resemble recollection in 
some ways, these results should be taken with a pinch of salt. Furthermore, there is on-going 
debate about the involvement of hippocampus in recognition memory (Bird, 2017). 
Retrieval modulates memory 
Retrieving information is not a passive process of accessing something that has been stored. 
Instead, memory traces are recreated rather than accessed, and the act of retrieval is 
accompanied by a myriad of events that can cause plasticity in both retrieved and contextually 
related information.  
Perhaps the most widely recognised effect of retrieval is that it improves memory for the 
retrieved information. Active retrieval enhances subsequent memory opposed to re-study (C. 
Yang, Potts, & Shanks, 2018). This has been coined the testing effect – testing one’s memory 





enhances persistence of the tested memory trace (Wing et al, 2013). The hippocampus, temporal 
cortical regions and the prefrontal cortex are recruited to a higher extent during re-testing, 
compared to passive re-study. This activation pattern is remarkably similar to that seen during 
initial encoding for items that are later correctly retrieved, i.e. the subsequent memory effect 
covered earlier in this thesis. However, in this study they did not control for task difficult.  
Intuitively, active memory testing is more difficult than passive restudy, which may bias their 
findings (Wing, Marsh, & Cabeza, 2013).  Yet, their results are consistent with the wider  
theoretical framework, and they suggest that retrieval can enhance encoding processes – possibly 
by retroactively tagging previously learnt information as salient. Alternatively, previous 
knowledge of the tested information may guide re-encoding during memory test. It is not clear 
whether these are separate processes.  
In line with encoding-related activity being triggered by testing, retrieval has been suggested to 
trigger awake replay in rats (Carr et al., 2011; Foster & Wilson, 2006). For example, in situations 
where a rat is faced with a cued-recall, and needs to make decisions between multiple different 
routes, fast-paced replay of the hippocampal place cell activity corresponding to each possible 
route takes place. This might reflect decision making processes about future paths (Johnson & 
Redish, 2007; van der Meer, Johnson, Schmitzer-Torbert, & Redish, 2010). Note that 
dopaminergic neurons are likely to play a key role in orchestrating this type of action selection 
(Schultz, 1998; Westbrook & Frank, 2018).The strength of this replay is associated with memory 
success (Dupret, O'Neill, Pleydell-Bouverie, & Csicsvari, 2010).  
Indeed, retrieval has been suggested to act as a fast route to offline consolidation (Antony, 
Ferreira, Norman, & Wimber, 2017). Repeated testing increases enhances memory by creating 
more “elaborate” memory traces (Rosburg, Johansson, Weigl, & Mecklinger, 2015). This 





suggests that wakeful re-activation of memories by re-test can trigger processes that resemble 
systems consolidation.  
Wakeful reactivation on its own is unlikely sufficient to support healthy memory function. 
Perhaps wakeful reactivation and rehearsal provide a quick and easy route for consolidation that 
still requires subsequent sleep for information to “solidify”. As we are unable to rehearse all new 
information it is unlikely that wakeful reactivation alone could replace sleep-dependent 
consolidation.  
To my awareness there is no literature to show whether wakeful reactivation can also trigger 
hippocampal clearance of “nuisance” information (Figure 13). After periods of sleep-deprivation, 
learning new information is impaired (M. P. Walker, 2008). It seems that during sleep processes 
that support selectively retaining some information over other allows for the memory systems to 
“reset” to optimise subsequent memory performance. However, it does seem to provide a 
parallel route to learning that might mimic processes that promote memory selectivity during 
sleep.  
Carefully selecting which memories to keep likely serves a behavioural benefit. When we are 
required to retrieve information, such as a new co-worker’s name, it is likely because this 
information has some value. It may be that during retrieval-test the practised items are tagged as 
salient. Simultaneously, as contextual information is not tested, it may be preferentially forgotten 
in order to allocate cognitive resources where they are needed. Wimber et al (2015) coin this type 
of forgetting the ‘dark side’ of remembering (Wimber, Alink, Charest, Kriegeskorte, & 
Anderson, 2015). However, strategic forgetting may carry a behavioural benefit that is likely to 
generalise outwith the laboratory environment.  
 
 





Retrieval induced forgetting 
Paradoxically, retrieving previously learnt information can induce forgetting of contextually 
related information. Retrieval-practice is a commonly used three-stage paradigm (Anderson, 
Bjork, & Bjork, 1994) used to study retrieval-induced forgetting. First phase (1) is the initial 
encoding stage where participants learn to associate pairs of items, often categories paired with 
some of its constituent items (e.g. ANIMAL – cat, ANIMAL – hamster, FOOD – chocolate, 
FOOD – peanut, COUNTRY – Finland, COUNTRY - Australia). Then (2), memory for a 
proportion of the items is practiced by retrieval, using cued recall (e.g. ANIMAL – ha_ _ _ _ _, 
FOOD – ch_ _ _ _ _ _ _). Following this retrieval-practice phase, test items fall into three 
subgroups:  
a. practised items    hamster  chocolate 
b. unpractised related items  cat  peanut 
c. unpractised unrelated items   Finland Australia 
The latter category acts as a baseline. A common and well-replicated finding is that compared to 
the baseline practised items (hamster, chocolate) are better retrieved at the final test stage (3) 
while unpractised items are more likely to be forgotten in comparison:  
a. practised items    → IMPROVED 
b. unpractised related items  → IMPAIRED 
c. unpractised unrelated items   → UNAFFECTED 
Interestingly, the practice-induced tagging effect is increased by both an active suppression of the 
unpractised related items (cat, peanut) and an enhancement of the practiced items (hamster, 
chocolate) – in relation to the unpractised and unrelated items (Figure 15). 





What then might mediate this active forgetting process? Using distinct categories of visual stimuli 
(faces and objects), Wimber et al (2015) isolated unique fMRI signals corresponding to different 
stimuli during a retrieval induced forgetting task. In this study, participants first viewed the visual 
stimuli whilst in an fMRI scanner in order to create a template of the brain activation that 
corresponds to each viewed image. Participants then learnt to associate two competing associates 
(images) with the same word. For example, they would be shown the word SAND with a picture 
of Marilyn Monroe (first associate) in one trial and a picture of a hat (second associate) on a 
second trial.  
Subsequently, while in the MRI scanner, the participants were encouraged to selectively retrieve 
the first associate on cue: they were shown the cue (SAND) and asked to retrieve the first 
 
Figure 15: Retrieval and memory 
 
During learning related information is learnt equally well. Later, when items are selectively retrieved 
practised items (hamster) are tagged. To solve the cognitive demands associated with the saliency-tag, 
“competing”, or contextually related information is actively suppressed.   
 





associate (Marilyn Monroe). The rationale is, that upon presenting the cue, memory traces for 
both associates would automatically become active. However, the active cuing of one over the 
other associate would encourage participants to actively suppress memory of the second 
associate.  
Over several cued reactivations of the first associate, the neural activation during cue (SAND) 
representation activated the same patterns of BOLD responses as were active during the initial 
viewing part of the study. In other words, the association between the cue and the first associate 
became stronger. Simultaneously, and in the absence of cueing retrieval for the second associate, 
the neural activity during retrieval started to become more dissimilar to patterns of activation 
associated with the second associate.  
At retrieval practice the activity associated with the practiced item was therefore upregulated 
while the neocortical activity associated with the unpractised related items was suppressed. This 
is remarkable given the unpractised items were not presented at these trials, and yet the neural  
representation corresponding to them was altered. No such alteration was seen in control items 
that were present during learning but not manipulated using cued retrieval.  
Furthermore, the level of suppression of these items was further associated with was also 
behaviourally relevant and predicted subsequent memory for the items. Together, this provides 
strong evidence that retrieval can induce active forgetting of contextually or semantically related 
information.  
Others have shown that the retrieval induced forgetting has neural processing benefits – i.e. it 
reduces the burden on cognitive control mechanisms at play during selective retrieval (Kuhl, 
Dudukovic, Kahn, & Wagner, 2007). These effects are likely driven by processes during retrieval 
that directly inhibit competing information (for review, see (Storm & Levy, 2012)).  
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Coming of age 
Old age is associated with several physiological and behavioural changes in the brain and in 
cognition. A short outline of the changes relevant to this thesis is given below.  
Hippocampus 
Hippocampal connectivity is affected by old age (I. A. Wilson, Gallagher, Eichenbaum, & Tanila, 
2006). Within the hippocampus, projections between the dentate gyrus and the CA1 deteriorate 
with old age. Similar changes in connectivity are seen along the perforant pathway that projects 
from the entorhinal cortex to the dentate gyrus, and between dentate gyrus and CA3, and along 
the Schaffer collaterals (CA3/1 synapse). Along the perforant pathway, the threshold for long 
term potentiation (LTP) is increased together with a decrease in LTP magnitude (Barnes, Rao, & 
Houston, 2000). The dopaminergic firing from the VTA to the hippocampus and entorhinal 
cortex is also decreased with old age (Penner & Mizumori, 2012).  
Hippocampal volume has also been shown to decrease with old age. A systemic review of 28 
studies and 3422 participants assessing the volume changes across different age groups showed 
that hippocampal atrophy accelerated with age (Fraser, Shaw, & Cherbuin, 2015). In adults under 
the age of 55, the annual rate of volume reduction was small, between 0.1% and 0.7%, while in 
those over 70 years of age, the average annual atrophy rate was between 0.9% and 1.4%. There 
was no effect of laterality or gender. Age-related atrophy in the hippocampus also has functional 
relevance and it is associated with memory decline (Salami, Eriksson, & Nyberg, 2012).  
Of the hippocampal subregions, the CA1 and the dentate gyrus are the most affected by old age. 
Several cell types within the CA1 are affected by age (Hayakawa, Kato, & Araki, 2007). While 
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neurogenesis in the dentate gyrus continues throughout the lifespan, it is considerably slowed 
down with age (Gould et al., 1999; Heine, Maslam, Joels, & Lucassen, 2004; Jinno, 2016; Kuhn 
et al., 2018). This decline in neurogenesis may be partially reversible: several studies have shown 
that environmental enrichment, exercise and diet can reduce the effect of ageing, while increased 
stress and increase it (for a review see Kuhn, Toda & Gage, 2018). The age mediated LTP 
reduction in the Schaffer collaterals can also be rescued pharmacologically (Billard & Freret, 
2018).  
Microscopic scale changes in hippocampal structure and function are difficult to study in living 
humans but magnetic resonance imaging can be used to assess larger morphological and 
functional changes in ageing. Functional connectivity measured between CA1/subiculum 
boundary and the entorhinal cortex is decreased in old compared to young adults (Dalton, 
McCormick, & Maguire, 2019), and decreases in hippocampal connectivity along the perforant 
path in old age are associated with cognitive impairment (Yassa et al., 2010). These findings 
convincingly support what has been seen in animals.  
In the human hippocampus, another method, that has not yet gained large-scale popularity, is to 
study hippocampal structure integrity using magnetic resonance imaging. T2 relaxometry can be 
used to assess microstructural integrity of brain parenchyma beyond macrostructural MR 
volumetry. The T2 relaxation time – or transverse relaxation time – is a quantitative MRI 
parameter that is a measure of loss of transverse magnetisation through relaxation.  
Image contrast in structural MRI is an outcome of voxel-wise differences in relaxation times and 
proton density, which have different characteristics in each tissue types. The T2 MRI signal is a 
measure of water movements and mobility. After a radio frequency pulse, protons align with one 
another in a transverse plane in the rotating frame reference. It is said that the protons are in 
phase, and the transverse magnetisation is high. Transverse magnetisation begins to decay due to 
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inherent T2 relaxation of protons resulting in loss of phase coherence. T2 relaxation time is the 
time take for 33% of transverse magnetisation been lost.  
Relaxation times refer to the duration protons take to dephase after the radio frequency pulse 
has been sent. This is influenced by the properties of the tissue they are measured from. 
Relaxation is typically slower in water (e.g. cerebrospinal fluid) than in dense tissues (e.g. bone), 
but other properties such as concentrations of myelin, macromolecules, proteins, and 
paramagnetic atoms (e.g. iron in blood) strongly enhance relaxation processes shortening thereby 
relaxation times (Meiboom & Gill, 1958; Papadaki et al., 2019)  
Microstructural alterations together with altered water dynamics result in abnormal MRI 
relaxation times. Consequently, T2 relaxation time can reveal abnormal tissue properties even 
within the same structure and tissue type even prior to visible macrostructural changes. These 
changes in brain are affected by widely processes, such as maturation  (Matsumae et al., 2001; 
Paus et al., 2001), pathology, cognition and healthy ageing (Callaghan et al., 2014; Knight, Wearn, 
Coulthard, & Kauppinen, 2019).  
In addition to the absolute T2 relaxation time, the width of the distribution of the T2 relaxation 
times within a structure can be useful in detecting age-related changes associated with tissue 
integrity. Importantly, and as reviewed elsewhere (Tang et al., 2018), the T2 relaxation times are 
sensitive to early stages of disease related early pathology in dementia. These changes also 
precede volumetric changes (Callaghan et al., 2014; Knight et al., 2019). Early neurobiological 
changes associated with age and pathology that are missed out by looking at the volumes alone 
can thus be detected with T2 relaxometry.  
Although the focus of this thesis is on human cognition, it is important to note that animal 
models of neurocognitive ageing and the hippocampus (reviewed in Leal and Yassa, 2015) are a 
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complementary research approach, albeit with major caveats to interpretation of animal 
cognition and sleep including lifespan and differences (Leal & Yassa, 2015). 
Dopamine 
While loss of dopaminergic neurons is typically associated with Parkinson’s disease, a less severe 
reduction in density of such cells is associated with normal ageing (Kish, Shannak, Rajput, Deck, 
& Hornykiewicz, 1992). Several studies have shown age-related losses of dopamine. One such 
study estimated that striatal dopamine binding reduces by 6.6% per decade of age in healthy 
individuals (Werner et al., 2018). 
Age-related dopaminergic alterations are also associated with changes in memory processing. For 
example, in a reward learning task, old compared to young participants were slower at making 
responses and this slowing was associated with reductions in theta band activity during encoding. 
The response time reduction was associated with a loss in structural integrity of the substantia 
nigra (Steiger & Bunzeck, 2017), suggesting that age-related dopamine dysfunction impairs 
reward learning.  
Reductions in dopamine in the ageing brain are also associated with deficits in other dopamine-
mediated behaviours such as decision making and learning from rewards. For example, older 
compared to younger elderly humans show reduced nucleus accumbens activity in response 
reward prediction errors, as measured by functional MRI. Performance differences in a reward 
learning were associated with age-related declines in the integrity of white matter pathways 
connecting the substantia nigra and the striatum (Chowdhury et al., 2013). In some elderly – but 
not all – administering L-DOPA restored the age-related deficits in reward learning together with 
the fMRI BOLD responses to match young adults.  
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Therefore, deficits in dopamine are seen in ageing are prominent and they affect cognition. 
Crucially, responses to dopamine treatments to target cognition also seem to affect young and 
old participants in different ways (Morcom et al., 2010). It is possible that due to the relatively 
widespread loss of dopamine network integrity in healthy ageing, studying dopamine’s effects on 
cognition is this population is particularly fruitful.  
Circadian rhythms 
Ageing is associated with multiple sleep-related problems, most commonly with poor sleep 
quality and delayed sleep onset latency. Deep sleep, or slow wave sleep, is greatly reduced in 
ageing.   
The causes of age-related sleep disturbances are not fully known. One plausible physiological 
explanation are age-related effects on brain regions regulating circadian rhythms. In the 
hypothalamus, the suprachiasmatic nucleus is a key area for the maintaining sleep homeostasis. 
Both neuron count (Roberts, Killiany, & Rosene, 2012) and neuronal firing (Nygard, Hill, 
Wikstrom, & Kristensson, 2005) in this region reduce with old age. These physiological changes 
with advanced age lead to functional decline in the suprachiasmatic nucleus and regulation of the 
24h body clock (H. C. Chang & Guarente, 2013; Satoh, Imai, & Guarente, 2017).  
Whatever the cause, the health implications of poor sleep in the elderly are concerning. Several 
processes that maintain homeostasis are activated during sleep, including clearance of metabolic 
waste and glucose regulation (Tasali, Leproul, Ehrmann, & Van Cauter, 2008; Xie et al., 2013). 
Disruptions in sleep’s restorative functions can have adverse effects on health. Both sleeping too 
little or too much is associated with increased all-cause mortality (da Silva et al., 2016; Dew et al., 
2003), with impaired sleep-wake rhythmicity of the circadian clock and high wakefulness after 
sleep onset (WaSO) score being the best sleep-related predictors of mortality in elderly (Wallace 
et al., 2018). 






In this section, I have shown that salient information increases dopamine activity and release in 
the hippocampus, ventral tegmentum and locus coeruleus. These releases seem to influence 
synaptic plasticity, consolidation, memory reactivation, and persistence in the hippocampus. 
Sleep also seems to play a pivotal role in these processes. While much is known about the 
interactions between sleep, memory, dopamine and the structure and function of the 
hippocampus, several questions remain. For example, does exogenous dopamine influence 
memory and sleep in humans? If so, which memory processes does it modulate (Figure 16)? Is 
this influence dependent on salience, sleep, or hippocampal structure? These are just some of the 
questions I will attempt to address in the subsequent chapters.  
I will report findings across two double-blind placebo-controlled trials. Given the individual 
differences and age-related changes in dopaminergic systems, here I used crossover designs to 
allow within-subject comparisons between single doses of L-DOPA and placebo. I also tested 
older people exclusively for two reasons – first, due to the drop-out of dopaminergic neurons 
that comes with old age which has been shown to affect the impact of taking dopaminergic 
medications. Second, because of the similarities with the target group with early dementia or mild  





cognitive problems, in whom we may want to try cognitive enhancement to ameliorate mild 
memory symptoms in the future.   
Several techniques that are outlined in more detail in the next chapter are used here: 
1. Behavioural tests 
a. The Remember-Know task which is the main outcome across Chapters III to VI 
b. The trail making task to control for dopamine’s effects on executive control 
2. Questionnaires 
a. Sleep questionnaires to measure self-reported sleep 
b. Mood questionnaires as a control for dopamine’s effect on mood 
3. Polysomnography 
4. Structural MRI of medial temporal lobe subregions 
a. Volumetry  
b. T2 relaxometry 
  
 
Figure 16: Memory stages and dopamine 
 
Several memory processes together contribute to successful memory formation. Each of these processes 









Aims and objectives 
Aim: 
The aim of this thesis is to investigate if dopamine’s role on modulating different 
memory processes by carefully timing the administration of L-DOPA to target different 
aspects of memory evolution: encoding, consolidation, and retrieval. A secondary aim is 
to investigate the relationship between sleep physiology, hippocampal anatomy and L-
DOPA’s effects on memory consolidation. 
Objectives: 
To assess the effect of L-DOPA compared to placebo on encoding and retrieval 
separately ((Chapter III). 
To assess the effect of L-DOPA compared to placebo on verbal memory tagging and 
consolidation (Chapter IV). 
To assess the effect of nocturnal L-DOPA compared to placebo on nocturnal sleep 
architecture (Chapter (V).  
To identify which elements of sleep architecture are associated with memory in elderly 
(Chapter V). 
To assess whether L-DOPA’s effects on sleep are associated to its effects on memory 
consolidation. (Chapter V). 
To explore the relationship between memory, sleep and hippocampal and entorhinal 
cortex volumes and T2 relaxation times (Chapter VI). 
  












Chapter II: General 
methods 
 This thesis comprises two studies: 
DARet (Dopamine & retrieval): A randomised double-blind study of levodopa’s 
retrieval effects on reinforcing learning and episodic memory. 
 Chapter III 
DOPAMIND (Targeting dopamine to treat impaired memory consolidation in 
neurodegenerative disease): A double-blind placebo-controlled trial.  
 Chapters IV, V and VI 





Ethical and regulatory approvals 
All study procedures were completed in accordance with the Declaration of Helsinki.  
The DARet study was carried out in the Brain Center in Southmead Hospital, North Bristol 
NHS Trust, Bristol, UK, and ethical approval was received by the University of Bristol Faculty 
of Health Sciences Research Ethics Committee (REF:12161).  
The DOPAMIND study was carried out at CRICBristol, University of Bristol, Bristol, UK, and 
monitored by University Hospitals Bristol on behalf of University of Bristol. Ethical approval 
was granted by the South West - Central Bristol NHS Research Ethics Committee (REF: 
16/SW/0028), by the Medicines and Healthcare Regulatory Authority (REF: 178711), and by the 
Health Research Authority 
Both studies were sponsored by the University of Bristol.  
Participants 
We recruited healthy elderly (65+ years) native or fluent English speakers with normal or 
corrected-to-normal vision. A power calculation based on previous work (J.P. Grogan et al., 
2015) suggested a minimum sample size of 26 (μ (0) = 53.2, μ (1) = 62.4, σ = 18.6) in detecting 
exogenous dopamine administration’s effects on verbal memory using the conventional 
threshold for power (α = 0.05, β = 0.80) in a similar verbal memory task to that used here. I 





aimed to test 30 people fully in both studies. This sample size is in line with previous studies 
looking at behavioural effects of dopamine on memory (Feld et al., 2014; Shohamy et al., 2006) 
 
Recruitment 
Volunteers were recruited from the BRACE Bristol Healthy Volunteer database in the North 
Bristol NHS Trust, Bristol, England, and from Join Dementia Research which is a UK based 
National Institute for Health Research maintained volunteer database. Upon contact, a brief 
phone screening was completed to rule out common reasons for exclusion.  
Study procedures took place at the Brain Center in Southmead hospital (DARet) and at the 
CRICBristol, University of Bristol, Bristol (DOPAMIND). Participants were reimbursed a small 
sum for their time, £40 for DARet (£20 per visit) and £90 for DOPAMIND (£30 per visit) in 
total, and travel expenses.  
Several people assisted in recruiting for these two studies. Major contributions were made by Dr 
James McErlane, Dr James Selwood, Dr Lisa Knight, Alex Howat, Will Mears, Nerea Irigoras 
Izagirre, John Grogan, Rachel Williams and Beth Ford. 
 
Inclusion criteria  
The inclusion criteria for DARet and DOPAMIND were the same; volunteers were over 65 
years of age, native or fluent English speakers, and had normal or corrected-to-normal vision 
allowing them to read text on a computer screen. 
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The exclusion criteria were selected to exclude anyone with clinically significant neurological or 
psychiatric conditions, such as dementia or mild cognitive impairment, as well as to ensure 
participants’ safety to take part in the two studies.  
Therefore, anyone who could not safely take L-DOPA or motilium were excluded from the 
studies reported here. Participants who took part in DOPAMIND were also screened for MRI 
eligibility and clinically significant sleep disorders.  
The full list of exclusions is given in Appendix N. 
Design and procedure 
Both studies are placebo-controlled double-blind crossover studies. Each volunteer completed 




The purpose of this study was to assess L-DOPAs effects on retrieval and encoding.  
This study was designed together with Dr John P Grogan. 
In this placebo-controlled double-blind crossover study, participants took part in two testing 
sets, each entailing two visits to the Brain Center in Southmead Hospital, Bristol, England on 
consecutive days and three follow-up phone calls (Figure 17). The testing sets were separated by 
Chapter II: General methods 




a drug washout period of at least seven days between doses. The study procedures are 
summarised in Figure 18. 
Both testing sets followed the same structure, with the exception that on one of the sets co-
beneldopa was given, and placebo on the other.  
 
Figure 17: Study schematic for DARet 
 
Volunteers were invited for two test sessions, each consisting of two consecutive days of 
testing. On the Day -1 the volunteers learnt an episodic verbal memory task, and their baseline 
performance was tested. On day 0 volunteers returned to site and they were dosed with L-
DOPA or placebo before retrieval was tested. After this they learnt another episodic memory 
task before returning home. Their recall on this task was tested immediately and three times 
over the phone following a 1, 3, and 5 days’ delays. The DARet study aimed to test the effect 
of L-DOPA on retrieval (orange, left) and encoding (pink, right).  
 
Day -1 
On the day preceding dosing, or Day -1 (D-1), volunteers were consented and screened to 
ensure they met the eligibility criteria. They then learnt two experimental tasks; a verbal episodic 
memory task and a reinforcement learning task. The latter is not reported here. The learning 
phase was followed by paper assessments, and 30 minutes later a baseline memory test.  
Where necessary, volunteers’ eligibility to take part was confirmed by a consultant neurologist 
(EJC) between D -1 and the day of dosing (D0).   
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On Day 0 (D0), volunteers returned to the test site where they were first dosed with the 
domperidone and their blood pressure and heartrate was monitored. 30 minutes later, they 
received L-DOPA. At baseline and for 2 hours following Domperidone, volunteers’ heart rate 
and blood pressure were monitored at 30-minute intervals as a safety procedure.  
1h after drug administration, retrieval was tested for both tasks. Volunteers then completed the 
digit span test (J. P. Grogan et al., 2018), and they were offered a break before learning the 
second verbal memory task. Their learning for this test was measured immediately, and again 
over the phone 1, 3, and 5 days later.  
On one of the testing sets the volunteer received a placebo and, on another L-DOPA, otherwise 










Figure 18: Summary of DARet study timeline 
 
Each volunteer received both the co-beneldopa and the placebo but on different test visits. This study was designed to test L-DOPAs effect on both retrieval (orange) 
and encoding (pink). 
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A change to the DOPAMIND procedure was made after first 6 participants had been 
tested. Refer to Appendix A for details.  
Screening 
Following initial expression of interest, each volunteer was contacted over the phone by an 
experimenter who explained the study procedure. Interested volunteers were then screened for 
common exclusion criteria and, if they seemed eligible, booked for a full screening visit.  
The screening visit started with a brief overview of the study and a tour of the sleep facilities 
before consenting. Following this, a brief medical history was recorded. If it was clear the 
volunteer was not eligible, the screening visit was terminated. Next, the participant completed 
short practice versions of the three experimental tasks (paired associates memory, verbal 
memory and motor sequence learning – note that only the verbal memory task is used in this 
thesis). A 12-lead ECG was taken and blood pressure, heart rate, body weight and height were 
recorded. Several paper assessments were also completed (Table 4, relevant paper assessments 
are also in Appendices F-J). Each screening visit took ~2.5 to 3h.  
After the screening and before the first overnight visit a letter was sent to participants’ GPs to 
inform them of participation. The participants also filled a sleep diary for 5-7 days prior to each 
overnight visit. Before they were booked for their first sleep visit, the consultant neurologist 
(EJC reviewed the screening information and confirmed eligibility.  
Sleep visits 
Each participant took part in two sleep visits. This means there were three visits in total 
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Refer to Figure 19 for a summary of the study timeline for each sleep visit. Apart from treatment 
allocation and payment, the sleep visits were identical and as follows: 
 
 
Figure 19: DOPAMIND study night timeline 
 
Each study visit began with a confirmation of continued eligibility. This study was designed to 
test whether L-DOPA during sleep affects either of two processes.   
 
Each volunteer completed two visits; on one of they received L-DOPA, on the other placebo. 
This figure is not to scale.   
 
Evening 
In the beginning of each visit, participants’ continued eligibility to take part was ensured and 
baseline blood pressure, heart rate and electrocardiogram were recorded. Where there was 
uncertainty over eligibility, the consultant neurologist (Dr Elizabeth Coulthard) was consulted.  
Volunteers was given dinner on-site, and the polysomnography set-up was started, prior to 
starting the experimental procedures. Each night’s experimental testing schedule was worked 
backwards from the volunteers’ natural bed time so that the testing began 3h and L-DOPA was 
given 2h before bed-time. 
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First, the participant completed the learning phases of the tasks, with domperidone being dosed 
in between. L-DOPA/placebo was given in a double-blind random order 30 minutes after 
learning the verbal task.  
1h after dosing, the volunteers’ memory on half the items for the paired associates and quarter of 
the items for the verbal memory task were prompted. This was followed by the Positive and 
Negative Affective Scale questionnaire as a control measure. Volunteers then had ~30 minutes 
to get settled before lights were switched off.  
During the breaks between testing and monitoring, the PSG recording was prepared.  
Dosing and monitoring 
Prescribing, dosing and monitoring were performed by a study doctor. Details of participant 
physiological monitoring is given in appendix C. 
Morning 
Upon waking, the volunteers were given a couple of minutes before the experimenters removed 
the electrodes and participants were given a chance to shower and have breakfast. Morning 
memory was performed ~12h after learning where possible. 
Visits started around 5-6PM in the evening and finished around 9-11AM the following day. At 
the end of both visits participants filled in a blinding verification form (Appendix K).  
Phone calls 
Following the visit, volunteers were contacted twice over the phone to test their memory on the 
remaining words, 3 and 5 days after learning.  
For an example of each participants’ timeline, see Figure 20. 
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MRI scans were typically taken either at screening visit or in one of the mornings after all testing 
was completed. A small proportion of volunteers were scheduled for a separate visit for the MRI 







Figure 20: DOPAMIND 
study timeline 
The second testing set is 
identical to the first one except 
for the drug allocation. Both the 
experimenter and the volunteer 
were blind to the treatment 
allocation.  
Abbreviations are explained in 
table 4. 






Both studies reported here were placebo-controlled within-subjects trials where participants were 
given L-DOPA and placebo at different test sessions in a random order. The randomisation and 
blinding procedures are given in Appendix O.  
Treatment 
In the DOPAMIND trial, participants received encapsulated co-beneldopa controlled release 
containing 200mg of L-DOPA. This form of L-DOPA is active in the system for up to ~12h.  
In the DARet trial, participants received a 150mg L-DOPA dispersible. This type of L-DOPA 
reaches tMax in ~1.5h.  
Further details about the treatment procedure is given in Appendix P.  
Remember-Know task 
The remember-know task (RKN (Tulving, 1987)) was used to assess verbal episodic memory. 
Slightly different paradigms were used in the different studies, and the delays between learning 
and retrieval varied across experiments. First, I will outline the broad principle of the tasks and 
then give an overview of the differences in administration between tasks. For summaries of 
differences between the two studies and how the drug administration relates to memory 
processes, see Table 3 and Figure 21. 
Learning phase: Volunteers learnt a list of target words presented on a computer screen in a 
random order. For the DOPAMIND study, one list of words was learnt per condition (L-DOPA 





and placebo), while for DARet, volunteers learnt two lists – one to prompt retrieval and another 
to prompt encoding. 
Test phase: Volunteers were shown a list of words with each word presented individually. Half 
of the items were targets (words present at learning) and half distractors (not present at learning). 
Participants were asked to judge whether a word was a target by judging it as ‘OLD’ (target) or 
‘NEW’ (distractor). After each ‘OLD’ judgement volunteers were asked if they recollected the 
word (‘REMEMBER’), recognised the word without recollection (‘KNOW’) or if they guessed 
(‘GUESS’). They were instructed that a ‘REMEMBER’ response should be made only when they 
recollect the context of encoding, i.e. if they remembered what they thought of when they first 
saw the word. A ‘KNOW’ response should be made where there was no recollection. If a word 
was judged as ‘NEW’, volunteers chose if they were ‘SURE’ or made a ‘GUESS’. The difference 
between ‘REMEMBER’ and ‘KNOW’ responses was explained to volunteers verbally with 
examples and then again on the computer screen before they started the task. 
  





 DOPAMIND DARet 




forgetting tagging retrieval encoding 
Total number of 
words 




1 1 0 3 
Number of times 
word present at 
learning 
 
1 1 1 2 
Instructions for 
learning 
“Is this item alive” “Read word aloud and try to 
memorise” 
Day -1 n target N/A N/A 24 N/A 
Day 0 n targets N/A 20 24 24 
Day 1 n targets 20 
40 
(20 novel, 20 
“tagged”) 
N/A 24 
Day 3 n targets 20 N/A N/A 24 
Day 5 n targets 
 
 
20 N/A N/A 24 
Table 3:  Method: Remember-Know task differences 
 
For the DOPAMIND study, volunteers learnt one list of 80 words. 60 of the words were used to assess 
memory persistence and forgetting curves, and 40 to assess saliency-tagging on L-DOPA. On Day 1 in 
the DOPAMIND study, the same targets as were tested as on Day 0, together with novel targets. 
Otherwise For the DARet study, volunteers learnt two separate lists, one with 48 words and one with 96. 
Recognition was tested with a proportion of targets (items present at learning) and a matched proportion 
of novel distractors. targets at test were always novel. Distractor words (words not present at learning) 
were never repeated twice.  
 
 








Figure 21: L-DOPA versus Placebo timing and memory for DOPAMIND and DARet 
studies 
 
 I targeted dopamine’s effects on different memory processes by carefully timing the 
administration of  L-DOPA (or placebo); timing shown as      . Across three experiments, 
volunteers learnt lists of  words (targets) on a computer screen. Each dotted colour (● ● ● ●) 
represents an individual word and colours represent lists. Their recognition memory was tested 
on the targets and unique distractors (●) using the Remember-Know paradigm either on-site 
using a computer screen of  over the phone. Memory was prompter on the day of  learning 
(D0), and/or 1, 3 and 5 days (D1, D3, D5) later. Each volunteer completed both a L-DOPA 









Remember-Know – DARet retrieval 
The purpose of this test was to study L-DOPA’s effect on retrieval. During learning on D-1 (day 
before dosing) volunteers were presented with 48 complete nouns on a computer screen. They 
were instructed to read the words aloud and try to memorise them for later. Each word was 
shown once (5s, separated by 2s fixation cross), and no responses to the words were made 
during learning. There were no breaks in the learning block (total duration = 5mins 36secs). 
Memory was tested for half of the items 30 minutes (D-1, baseline), and for the remaining items 
24 hours (D0) after learning (Figure 22). The D0 test was given when L-DOPA was at its peak 
concentration (~ 1h following dosing). In the test phases (D-1 and D0), participants responded 
using the using keyboard keys 1, 3, or 5, and they were advised to take as long as they needed to 
make a response. “1” corresponded to options on the left of the screen (‘OLD’ and 
‘REMEMBER’), “3” to options in the middle (‘KNOW’) and “5” to options on the right 




Figure 22: DARet Remember-Know 
paradigm 
 
In the DARet Retrieval Experiment recognition was 
tested using the Remember-Know paradigm  
At both tests (baseline and ON L-DOPA/ placebo), 
volunteers were shown 24 targets (present at 
learning) and 24 distractors (not present) words in a 
randomised order on the computer screen. For each 
word the volunteer had to first judge if a word was 
OLD (target) or NEW (distractor). They were then 
asked if they made a guess or if they were sure (for 
NEW judgements), or if they remembered, knew, or 
made a guess (for OLD judgements). 
  





All text was presented in ‘helvetica’ font, lower case. The nouns were from four different 
categories (e.g. countries, cars, insects), with 12 words from each category present at learning. 
During test, half of the distractors (n=12) were from the same category as the learnt items and 
half were unrelated. The words were taken from rated publicly available word-lists (Murdock, 
1976; Van Overschelde, Rawson, & Dunlosky, 2004). Different categories were used for 
different versions of the task, but this was not considered during analysis, see Appendix E for 
word lists. 
Remember-Know – DARet encoding 
The purpose of this verbal memory experiment was to assess whether L-DOPA enhances 
encoding.  Learning (encoding) took place on D0 around 1.5 hours after dosing (ON L-
DOPA/placebo). At learning, volunteers saw 96 complete nouns presented on a computer 
screen in block capital letter in ‘helvetica’ font (duration 5s, fix cross 2s). The words were first 
presented in a random order in two blocks, and then again in another random order in two 
blocks (n blocks = 4; n words per block = 48; n breaks =3; block duration = 5 minutes 36 
seconds). Therefore, each word was shown twice to enhance learning. Volunteers were 
encouraged to take a break in between blocks to reduce fatigue.  
Memory was prompted four times, immediately after learning (D0, ON L-DOPA/placebo), and 
1, 3 and 5 days after learning (D1, D3, D5). At each test, 24 unique targets and distractors were 
tested, so each target was only tested once. Test on D0 followed the same procedure as the 
DARet retrieval experiment (Figure 22). On D1, D3 and D5 the volunteer was contacted over 
the phone for a recognition test following the Remember-Know procedure. Phone calls were 
scheduled before the participant left the study site. Each word was read aloud to the participant 
and then spelled out letter-by-letter. If the participant did not hear the word, this was repeated 
over. No definitions were given.  





It is possible that fatigue from learning several lists with such short recovery periods in between 
affected performance. Furthermore, conducting tests over the phone when words were learnt on 
a computer screen may also affect performance and influence results. Memory tests were carried 
out over the phone in order to avoid burdening participants and researchers – several phone 
calls fell on weekends. To avoid confounding elements of these flaws in the study design, 
treatment order and word list orders were randomised and counter-balanced to avoid this 
influencing the study results. 
Remember-Know – DOPAMIND 
The main purpose of the DOPAMIND study was to examine the effect L-DOPA (compared to 
placebo) on consolidating and forgetting verbal information. Crucially, learning took place before 
dosing. Memory was probed four times:  
 
 
L-DOPA was active in the system during D0 test but not at other tests (Figure 21).  
During learning, 80 words, drawn from 4 lists (A-D), were presented individually in a random, 
interleaved, order on a computer screen. Each word was presented once, and the learning 
session was divided into two blocks of 40 words. To enhance encoding, volunteers were asked to 
memorise as many of the words they could and prompted with a semantic question during 
learning – “Is this alive?”. Prior to learning they were given examples of alive (e.g. ‘tree’) and 
Test Delay from learning L-DOPA active List tested 
D0 2h ON List A 
D1 12h OFF List A & B 
D3 3 days OFF List C 
D5 5 days OFF List D 





non-alive (e.g. ‘rock’) items. They were also asked if they understood the instructions and 
encouraged to ask questions. Stimulus presentation time remained fixed (3.6 seconds, 1s fix 
cross) even if no response was made. The experimenter explained to the volunteers that they 
should not worry if they made a mistake, or if they did not have the time to respond to some 
words (Figure 23). See Appendix D for detailed instructions for experimenters administering the 
task.  
On D0 (1.5h after learning), one of the lists (e.g. List A, 20 targets) and 20 distractors were 
presented to the volunteer on the computer screen. Participants responded verbally, and  
responses were recorded by the experimenter. For OLD judgements, participants were asked if 
they REMEMBER, were FAMILIAR or made a GUESS – and for NEW judgements if they 
were SURE or made a GUESS. Note that instead of the word ‘know’ participants were 
presented with the word ‘familiar’ based on volunteer feedback during piloting. When a word  
was REMEMBER, the experimenter asked for justification for the answer. An example of a 
remember response for ‘princess’ could be remembering that they judged the word as alive or 
that they thought of a royal wedding when they learnt the word. If the volunteer gave an 




Figure 23: Memory learning phase in DOPAMIND 
 
Each word was presented on the screen individually, and the volunteer was asked to read it aloud and decide 
if the word was living or not. This figure is illustrative only, in this iteration no numbers were displayed on 









remember what I thought of when I saw it’, the difference between a ‘remember’ and a ‘know’ 
was explained again and a ‘know’ judgement was recorded.  
On D1, the same testing protocol was used but this time the targets presented at D0 (List A) 
were presented again along with 20 words learned but not presented at D0 (List B) and a 
matching number of unique distractors (n novel targets = 20, n re-tested targets = 20, n novel 
distractors = 40). On D3 and D5 volunteers were contacted over the phone and tested on the 
words (Lists C and D with novel distractors). Each word was first read aloud and then spelled 
out. No definitions of words were given to avoid biasing answers, but if the volunteer offered a 
definition the experimenter could either confirm it or not. At each phone call, 20 targets and 20 
novel distractors were tested. The phone calls were 5-15 minutes in duration.  
The D1, D3 and D5 tests for novel targets were used to assess L-DOPA’s effect on 
consolidation or forgetting. The D1 novel and re-tested targets were assessed to study L-DOPAs 
effect on tagging ‘important’ memories with the rationale that when a word is presented a second 
time, it will be deemed to be more ‘worthy’ of being remembered later than a word that is 
presented once.  
Note that the order of testing lists A-D was also randomised but for clarity I will refer to them in 
alphabetical order in this thesis.  
Hardware and software 
Computerised tests were carried out on Toshiba or Dell 64-bit laptops running Windows 7 pro. 
Volunteers made responses either laptop keys in the DARet study or using a made-to-order 
response pad from The Black Box ToolKit company in the DOPAMIND study. The pad was a 
USB 2.0 device in black (202mm x 137mm) with three white round buttons (30mm diameter) 





placed a horizontal line in the middle of the box. Note that in the DOPAMIND study during 
testing, the experimenter recorded the responses. 
All experimental tasks were programmed in the MATLAB environment (2015b or 2017a) using 
the Psychophysics Toolbox V3 (Kleiner, Brainard, & Pelli, 2007). 
 
Magnetic resonance 
Hardware: MRI scans were taken on a Siemens Magnetom Skyra 3T scanner with a 32-channel 
head-coil at the Clinical Research and Imaging Centre (CRIC) at the University of Bristol, 
Bristol.  
Scanning procedure and sequences: Each volunteer underwent ~30 minutes of structural 
scanning with several sequences taken. A T1 3D magnetisation prepared rapid acquisition 
gradient echo (MP-RAGE) scan was taken using a standard sequence: acquired in sagittal plane, 
Repetition time (TR)= 2200ms; inversion time = 900ms; flip angle = 9 degrees; field of view 
(FOV) = 220 x 220 x 179 mm3; acquired resolution = 0.86 x 0.86 x 0.86mm3 after 2-fold 
interpolation in k-space; scan time = 5.07min. 
To image the hippocampus, I used a multi-contrast spin-echo sequence: acquired in coronal 
plane, TR = 4500ms; 3 echoes at TE 9.1, 72 & 136 ms, slice thickness = 1.5mm (including slice 
gap 15%), 34 slices (order interleaved), FOV = 220 x 220 x 34, acquired matrix size = 270 x 320 
x 58; in-plane resolution = .34 x.34 following 2-fold interpolation; scan time = 5:09min. During 
acquisition this scan was auto-aligned perpendicular to the hippocampal long axis, and manually 
placed to image the space from ~1cm anterior to the head to ~1cm posterior to the tail. This 
scan did not therefore cover the whole brain. I also took two diffusion -weighted images 
(duration = 2x 3 mins 15 secs) but these scans are not discussed here.  






Participants in the DOPAMIND study had full night of polysomnography recorded for both 
study nights. A standard in-laboratory, polysomnography (PSG), including video was recorded 
using Embla Sleep Diagnostic at the CRICBristol, University of Bristol, Bristol, UK, sleep facility 
recorded on Embla RemLogic software Equipment (Natus Medical Inc., California). Recordings 
were taken from 12 scalp channels (F3, Fz, F4, C3, Cz, C4, M1, Pz, M2, O1, O2, and a ground 
electrode placed approximately between Cz/P3 and C3/Pz). Eye movements were detected by 
electro-oculogram recorded from E1 and E2 sites and muscle activity by electromyogram 
recorded below the chin. I also recorded two-lead electrocardiograms over the duration of the 
night. 
Electrode locations were determined manually using the international standard 10/20/20 system. 
Electrodes were attached individually. Application time ranged from 1-2h and each recording 
started when I switched the lights off for the night and continued until an agreed wake-up time 
or until the volunteer naturally woke up. Electrodes were manually removed in the morning. All 
signals were sampled at 500Hz. 
Paper assessments 
Refer to Table 4 for a summary of all paper assessments. Further details of paper assessments are 
given in appendices.  
  








DOPAMIND DARet Purpose 
Screening questionnaire At screening visit On D-1 of first 
session 
Assess eligibility 
MRI safety questionnaire At screening and before 
scan 
N/A  




elsewhere (J. P. 
Grogan et al., 
2018). 
Beck Depression Index At screening visit   
Lille Apathy Rating scale  (Sockeel et 
al., 2006) 
N/A On D-1 of first 
session 
 
Barratt impulsivity scale (Pacini & 
Epstein, 1999) 
At screening visit On D-1 of first 
session 
 
Rational-Experiential Inventory scale 
(REIS) (Pacini & Epstein, 1999) 
At screening visit On D-1 of 
second session 
 
Pittsburgh Sleep Quality Index At screening visit N/A  
Montreal Cognitive Assessment 
(MoCA) Versions 7.1, 7.2 and 7.3, 
(Nasreddine, Phillips, & Chertkow, 
2012) 
At screening visit (only 
one version per volunteer) 




and where a score 




St Mary’s Hospital Sleep 
Questionnaire  (Ellis et al., 1981) 
Each morning of sleep 
visits 
Each visit  
Depression Anxiety Stress Scales 
(DASS) (Boyle, 1985) 





Toronto Hospital Alertness Test 
(THAT) (Shapiro et al., 2006) 
Each morning of sleep 
visits 
N/A Measure alertness 
Trails A and B (Sanchez-Cubillo et 
al., 2009) 
Each morning of sleep 
visits 
N/A Measure alertness 
Positive and Negative Affect 
Schedule (PANAS) (Zevon & 
Tellegen, 1982) 
Each morning and evening 
of sleep visits 
N/A Measures current 
mood 
Leeds Sleep Evaluation 
Questionnaire (LSEQ) 
 
Each morning of sleep 
visits 
N/A  
Sleep diary  
 
For one week prior to 
sleep visits 
N/A  
Unified Parkinson's disease rating 
scale (UPDRS) 
N/A On D-1 of 
second session 
To control for 
undiagnosed 
Parkinson’s disease 
Table 4: Method: Paper assessments  
 







Signal detection theory 
The first phase of the RKN forced-choice recognition memory task (i.e. ‘OLD’, ‘NEW’ 
judgements) was evaluated using the signal detection theory (SDT; (Birdsall & Roberts, 1965; 
Treisman, 1964)). In short, SDT can be used to explain volunteers’ response strategies for 
discriminating between signal (targets) and noise (distractors) using the distribution of ‘OLD’ 
and ‘NEW’ responses. SDT assumes that the likelihood of detecting signal and noise are 
expressed as two often overlapping Gaussian equal variance probability distributions. The more 
overlap there is between the distributions, the less likely the volunteer is to discriminate signal 
from noise. Each response in the recognition task can therefore be classified as a Hit (H), a Miss 
(M), a Correct Rejection (CR), or a False Alarm (FA). H refers to a response where an item 
present at learning was correctly identified as ‘OLD’ while a ‘NEW’ response would in this case 
be a M. A word that was not present during encoding, a correct ‘NEW’ response would be 
classified as a CR while an incorrect ‘OLD’ response would be a FA (Figure 24).  
Each volunteers’ signal detection technique can be described using D’ (dee-prime) and criterion 
(c, Figure 25). The D’ is the main outcome measures throughout Chapters III to VI. D’ describes 
discriminability between targets and distractors by quantifying how well a volunteer detects signal 
from noise, or targets from distractors – it is similar to the discrimination index and can be used 
to measure accuracy. D’ is the distance between the means of the aforementioned Gaussian 
distributions. A large D’ indicates that signal is easy to detect from noise, i.e. participants have 
good performance, while a small D’ refers to considerable overlap between the distributions.  





D’ can be considered a measure of accuracy. However, D’ does not fully explain response 
behaviours. For example, D’ could be the same for three volunteers, one of whom responded 
‘OLD’ each time, one of whom responded ‘NEW’ each time and one of whom made an equal 
number of random ‘OLD’ and ‘NEW’ responses. For this reason, c is also needed to explain the 
response tendency, as it quantifies how liberal – or likely to identify a target over uncertainty – 
the participant is in their responses. 
 Signal 
Response 
 Present Not present 
‘OLD’ 
HIT FALSE ALARM 
‘NEW’ 
MISS CORRECT REJECTION 
 
Figure 24: Signal Detection Theory: Responses possibilities 
 
 
Figure 25: Signal Detection Theory: Model 
 
D’ refers to how ability to discriminate between signal (distribution on the right) and noise (distribution on 
the left), while c refers to response bias. Here, c = 0. 
 
 





C can be thought of as the difference between a “perfect” volunteer who has no internal 
response bias, and the measured responses. When c = 0, the volunteer has no bias (i.e. p(FA) = 
p(M)), while a negative value indicates they are more likely to accept a word as a target under 
uncertainty (i.e. p(FA) > p(M), or the c line in is shifted to the left).  
They can be quantified as, 






where 𝑍(𝑝(𝐻)) and 𝑍(𝑝(𝐹𝐴)) are the z-transformed probabilities for H and FA respectively. 
The primary outcome measures were D’ and c. Secondary outcome measures were the number 
of Hs, and FAs. CRs and Ms were not considered in the analyses as they provide no additional 
information because p(H) + p(FA) = p(CR) + p(M) = 1. 
Remember-Know responses 
When analysing REMEMBER and KNOW responses, proportions of these responses were used 








H; HITS    
R; REMEMBER    
K; KNOW 






Mixed linear models (MLMs) are an extension of simple linear models, such as analysis of 
variance. The main benefits of MLMs are that they allow for non-independence and missing 
data. These models allow both fixed and random effects as opposed to fixed effects only. 
Random effects are variables that allow for grouping the data, while fixed effects can either be 
continuous or discrete non-grouping variables. If a variable is considered a random effect, each 
of its levels’ means are assumed to represent a sample of means drawn from a normally 
distributed population with a global mean and distribution. As we are dealing with only a subset 
of elderly adults from the entire population, I could fit the participants in as random effects.  
Treating participants as random factors in mixed linear modelling is standard practice in 
psychological sciences (Barr, Levy, Scheepers, & Tily, 2013; Gelman, 2005; Janssen, 2012 ; 
Magezi, 2015). 
MLMs come in varying levels of complexity. In an intercepts-only model, each participant has 
their own deviation from the group mean, but the slope to which memory scores decay over 
time or the extent to which they are affected by the treatment is assumed stable across groups. In 
other words, each volunteer has their unique “baseline” but shared “decay rate”. The next level 
of complexity is a model that fits in random slopes but not intercepts. Here, the baseline is 
assumed the same across subjects (everyone has same level of encoding) but the rate at which 
their memories decay or are affected by treatment and time are assumed to vary. Other types of 
models assume both random slopes and intercepts, consider random effect on possible 
interaction terms of the fixed effects, and account for correlativity between random slopes and 
intercepts. Mixed linear models therefore allow fitting in varying degrees of complexity, but over-
fitting the models with a modest dataset can give results that are not generalisable. Therefore, 
care needs to be taken in choosing the right model.  





Here, I aim for a maximal model fit that can be justified by the study design – this is to say the 
model should still be feasible and not include unnecessary and over-complicated interactions but 
include all possible physiologically plausible parameters. This ‘maximal’ approach is 
demonstrably most suitable for confirmatory hypothesis testing (Barr et al., 2013). Where 
possible, I fitted between-participant variability in baseline memory, rate of decay over time or 
over types of tests, and in response to the medication in our models. Memory test scores (either 
D’ or c) were used as predictors for each model. A caveat of this the maximal approach is the 
possibility of overfitting the model (Bates, 2018).  
I did not account for correlations between slopes to avoid this problem. However, some 
overfitting still occurred. Where problems with overparameterization were encountered, I 
simplified the model by removing slopes in a stepwise manner. I accepted the most complex 
model that could be used to explain our data without overfitting. An alternative approach would 
be to start with a minimal model and work ‘up’ to maximise model complexity. The resulting 
final model from either approach should be the same.  
When two equally complex models (e.g. slopes for one fixed effect but not the other) could be 
fitted as the maximal model, I chose to use the more physiologically plausible model. An 
alternative and possibly more robust approach would be to compare the model fits (for example 
the Akaike information criterions for both models) and decide on the best fit.  
MLMs were conducted on R 3.5.3 using Rstudio, lme4 (LME4-Authors, 2019) and lmerTest 
(Kuznetsova, Brockhoff, & Christensen, 2019). These packages provide diagnostic tools to 
identify overfitting, and the latter uses the Kenward-Roger approximation method for obtaining 
degrees of freedom estimations, and F and p statistics. Once models were obtained, R2 were 
calculated for models using the MuMIn version 1.42.1 (Barton´, 2018) package in R. This 





function provides both marginal (R2m) estimates of variance explained, which indicates how 
much of the variance in the response variable is explained by the fixed effects.  
In Chapter IV, I included the participants as random effects and as fixed effects I included 
treatment and the memory test delay (Day 1, Day 3 and Day 5, or Day 1 tested and re-tested, 
depending on the analysis). In Chapter V, I also considered sleep physiology measures as fixed 
effects. I included the treatment as a binary variable (L-DOPA vs placebo). All variables included 
in the model were mean centred but not scaled. 
The final mixed effects model with by-subject random intercepts and slopes was fitted using the 
following syntax in LmerTest. The practical application of this syntax is explained in detail 
elsewhere (Kuznetsova, Brockhoff, & Christensen, 2017)  
Response ∼ Delay * Treatment + (Delay + Treatment || subject) 
 
Where the response variable is the relevant memory test score (e.g. D’), Delay is the time of the test 
(e.g. Day 0, 1, 3 or 5) or type of the test (e.g. ‘tagged’ or not), and Treatment is either L-DOPA or 
Placebo. The (Delay + Treatment || subject) term refers to the random intercept for each subject 
with random slopes for both Delay and Treatment without accounting for by-subject variability for 
the interaction term.  
This can also be expressed as follows: 
Ysjk = β0i + β1X1sj + β2X2sk + β3X1sjX2sk + esjk 
Where,  
β0i = β0 +s0s  
Ysjk ∶  The response variable for the sth subject at the jth time point with k dose 





β0i :  Intercept with by-participant variation 
β1X1sj :  Slope of X1 for the s
th subject at the j
th time point 
β2X2sk :  Slope of X2 for the s
th subject with k treatment 
β3X1jX2k:  Time point * treatment interaction for the fixed effects. Note there is no 
by-subject variation included in this term. 
s0s ∶  Error term  
 
Bayesian analyses 
The above tests turn a p-value, which is the probability of the observed – or a more extreme – 
effect given the null hypothesis. It can be used to assess the probability of the observations given 
the null hypothesis, not to assess the probability of the null hypothesis given the observations. 
Traditional null hypothesis statistical testing does not address the latter.  
I addressed this issue by obtaining the Bayes Factor (BF). Table 5 gives an intuitive summary for 
how to interpret BFs. 
Another strength of Bayesian analyses is that the posterior credible intervals are predictors for 
the true value of the test statistic (Quintana & Williams, 2018). Traditional confidence intervals 
used in null hypothesis significance testing give the average confidence for the test statistic in 
hypothetical replication studies in the long run (Greenland et al., 2016). 
Bayesian statistics consider the observed data and prior beliefs, or priors, when assessing 






















Where D is the observed data, H1 is the alternative and H0 is the null hypothesis. P(D|H1) is the 
probability of the observed data under the alternative hypothesis, while P(D|H0) is the 
probability of the same data under the null. In short, BF quantifies uncertainty (i.e. how much 
more likely is the data is in one scenario compared to another).  
All Bayesian analyses were performed using JASP version 0.9.2.0 (JASP, 2018). When using 
Bayesian approaches, a prior distribution needs to be defined. The prior and the observed data 
together are then used to estimate a posterior distribution. In this thesis, I use uninformed priors 
across analyses. For the uninformed distribution I chose a Cauchy distribution with a mean of 0 
and an interquartile range of .5 [δ~ Cauchy (0, .5)]. In other words, I predicted that the δ lies 
between -.5 and .5 with a 50% confidence. I selected this one as the δs in cognitive 
neurosciences typically are within those bounds, and as I did not have an informed prediction for 
the effect sizes (Jeffreys, 1961; Marsman & Wagenmakers, 2017). 
 
 





BF10 BF01 Interpret as 
>100 < 1/100 Extreme evidence for H1 
30 – 100 1/30 – 1/100 Very strong evidence for H1 
10 – 30 1/10 – 1/30 Strong evidence for H1 
3 – 10 1/10 – 1/3 Moderate evidence for H1 
1 – 3 1/3 – 1 Anecdotal evidence for H1 
1 1 H1 and H0 equally likely 
1/3 – 1 1 – 3 Anecdotal evidence for H0 
1/10 – 1/3 3 – 10 Moderate evidence for H0 
1/10 – 1/30 10 – 30 Strong evidence for H0 
1/30 – 1/100 30 – 100 Very strong evidence for H0 
< 1/100 >100 Extreme evidence for H0 
Table 5:  Method: Bayes Factors 
 
The BF is the likelihood ratio of the observations under one hypothesis over another. This 
can be expressed either as BF10 or as BF01, where the former quantifies how likely the 
observed data are under the alternative compared to the null hypothesis, and vice versa for 
the latter. BF01 of 3 would mean that the observed data was 3 times more likely to occur 
under the null compared to the alternative hypothesis. Using this method,  I can utilise the 
observed data in assessing the likelihood of the null hypothesis (against the alternative). 
 
Note that BF10 is the reverse of BF01. This table is based on suggestions in (Jeffreys, 1961; 
M. D. Lee, Wagenmakers, E-J., , 2013).  
 








Segmentation: The open access Automatic Segmentation of Hippocampal Subfields (ASHS) 
(version: rev103, dated 12/06/2014). procedure (Yushkevich et al., 2015) was used to mask HC 
subfields and adjacent regions. This toolkit uses a machine learning approach to create a labelled 
HC subfield atlas based on manually segmented subfields. As the training set, the ASHS working 
group Atlas (dated 16/04/2014) (Yushkevich et al., 2009) was used. This set contains segmented 
maps for healthy older adults and older adults living with mild cognitive impairment with labels 
for subfields CA1, CA2, CA3, dentate gyrus, and subiculum, and surrounding regions, entorhinal 
cortex, collateral sulcus and Brodmann areas 35 and 36 (together the perirhinal cortex). The 
masks for the hippocampal subfields, and entorhinal cortex are used in this thesis.  
Following the learning phase, ASHS can be used to segment new hippocampi. The toolkit 
requires both T1 and T2 weighted scans as input with the latter having sufficient resolution for 
detecting subfield boundaries. I used the MP-RAGE and the multi-contrast spin echo sequences 
with echoes summed together to form a single T2-weighted image. 
Prior to running the ASHS procedure, brain extraction was performed for the T2-weighted 
images in FSL bet2 (Jenkinson, Beckmann, Behrens, Woolrich, & Smith, 2012; S. M. Smith, 
2002), which removes non-brain tissue from the images. The brain extractions were visually 
inspected and fractional intensity threshold was adjusted case-by-case where necessary. T2 maps 
were then created and T1-weighted images were registered to T2 space using FSL FLIRT 
(Jenkinson et al., 2012) rigid-body transformation. 





Processing took up to 25 hours per brain, following which each ASHS mask was visually 
inspected to ensure high standard. An example of how the procedure performed on this dataset 
is given in Figure 26.  
Volumetry: The main outcome for the volumetric measure was the hippocampal volume in 
mm3, which was extracted from the number of voxels within each segmented medial temporal 
lobe subregion. Left and right subfields were collapsed together for all analyses.  
T2 relaxometry: Distributions of T2 relaxation times for medial temporal lobe structures were 
obtained from the volumetric masks and T2 maps. The main T2 distribution measure was the 
standard deviation, i.e. intraindividual mask-specific standard deviation of absolute T2 relaxation 
 
Figure 26: Hippocampal segmentation procedure 
 
 





times. In other words, the standard deviation of T2 relaxation times from each voxel (derived 
from the T2 maps) in each mask (e.g. CA1) for every participant individually. Standard deviation 
was used as some attributes (e.g. increased water content) increase and others (e.g. increased 
iron) decrease T2. Both increased water and iron can be related to pathology, and if one is not 
dominant over the other, measures of central tendency can mask them out, while measures of 
distribution width do not.   
All analyses collapse across hemispheres, this brings with I the risk of losing information to do 
lateralised function. While outside the scope of this thesis, future exploratory analyses on 
lateralised hippocampal relationships with sleep may be of interest. 
Second-level 
The relationship between memory and hippocampal subfields was assessed using correlation 
analyses. Group-level analyses were performed using R versions 3.5.2 and 3.5.3 (RCoreTeam, 
2013). 
Contributions 
All MRI scanning was performed at CRICBristol, University of Bristol. Each scan was operated 
by two people: a 1st scanner who operated the scanner and a 2nd scanner who assisted during 
scans where needed. The 1st scanner screened participants, prepared the scanning environment 
and operated the scanner. 
Majority of the scans were 1st operated by me (the author) and she was present at each scan. 
Other first operators were Aileen Wilson, Alfie Wearn, Volkan Nurdal and Michael J Knight. 2nd 
operators were Alfie Wearn, James Selwood, James McErlane, Volkan Nurdan, Carlos Muños, 
Rachel Williams, Beth Ford, Will Carr, John Grogan, and George Averill. 





The scanning sequences were either standard sequences available in any SIEMENS 




Manual sleep scoring was performed in 30s epochs using standard criteria on REMLogic by Will 
Carr and Oliver Radtke, and 10% of randomly selected recordings were quality-controlled by me. 
Minutes in stage 1, stage 2, stage 3, REM. awake, asleep and total time in bed were extracted in 
minutes. Spindle characteristics were then isolated with in-house written MATLAB scripts using 
the EEGlab toolbox. Electrodes were re-referenced to contralateral mastoid and empty and high 
variance epochs were removed.  
Following this, solely data from the Cz electrode was used. First, the channel was visually 
inspected and epochs with high noise or clear artifacts were removed manually. Data was then 
filtered (high pass 11Hz, low pass 17Hz) and rectified. After this it was smoothed using a 
moving average window of 200ms. Then, data was resampled to 100Hz (from 500Hz) for 
computational efficacy. An event was automatically marked as a spindle if the threshold 
exceeded the 90th percentile for that data set (i.e. sorting data into an ascending order and 
including top 10%) for .5 – 3 seconds and a minimum .5s gap to the next / previous spindle was 
present. The spindle detection was performed by Will Carr with the help from Ullrich Bartsch. 
Contributions 
All sleep studies were carried out at CRICBristol, University of Bristol. Each night was set up 
and operated by me. Several others assisted in aspects of setting up, such as taking scalp 
measurements, gluing electrodes and removing them. The following people assisted: Alfie 





Wearn, Volkan Nurdal, James Selwood, James McErlane, Volkan Nurdan, Carlos Muños, Rachel 
Williams, Beth Ford, Will Carr, John Grogan, George Averill, Lisa Knight, Will Mears, Luke 
Emrich-Mills and Claire Durant. 
The scanning sequences were either standard sequences available in any SIEMENS 




I used the conventional two-tailed α threshold of .05. However, with multiple tests, the 
probability of false positives increases. I corrected for multiple comparisons using the Benjamini-
Hochberg procedure (Benjamini & Hochberg, 1995), which decreases the false discovery rate 
(FDR). This was performed using the p.adjust function in R.  
In the Benjamini-Hochberg procedure, dependent tests are considered together. Here, I took 
families of tests – for example each subfield correlation against a single memory score – to 
correct p-values so, that the α threshold for all the test considered together is .05. 
  





Chapter III: Dopamine 
in encoding and 
retrieval 
Data reported in this chapter was collected as a part of the DARet study.  
Introduction 
During encoding, a specific neural representation, or an engram, of learnt information is created 
(Semon, 1909; Tonegawa, Liu, et al., 2015). When the memory engram is later retrieved, at least 
in the context of explicit memories, the same patterns of neural activation that were present at 
encoding are reconstructed (Nyberg, Habib, McIntosh, & Tulving, 2000; Schacter & Wagner, 
1999). Attention, reward and previous experiences may tag memories encountered at encoding 





for preferential storage and retrieval (Redondo & Morris, 2011). I stipulate, and I will provide 
evidence in Chapters IV and V that dopamine plays a role in selecting memories to-be-kept, and 
that it does so during tagging and over periods of consolidation during sleep. Does dopamine 
only affect memory in the time after learning, or does it bias other memory stages too? 
Evidence in animals suggests that dopamine plays a role in encoding. For example, in drosophila, 
dopamine at encoding enhances learning (Berry et al., 2012; Berry et al., 2018). In mice, 
optogenetic stimulation of dopamine during encoding increases memory by enhancing 
subsequent memory reactivation during sleep (McNamara, Tejero-Cantero, Trouche, Campo-
Urriza, & Dupret, 2014). Memory reactivation is well known to support memory persistence.  
Memory reactivation can also be studied using depth electrodes in humans. In human 
intracranial recordings, the dopaminergic connections between the nucleus accumbens and the 
hippocampus, along the VTA-hippocampal loop have been shown to activate in response to 
encoding unexpected stimuli (Axmacher et al., 2010). This encoding effect was not directly 
associated with enhanced memory, but it was associated with later hippocampal activity that 
predicted memory performance. Note that these findings align well with what was seen in mice 
(McNamara et al., 2014). While in humans this was not associated with memory performance 
directly, this suggests that dopamine has the potential to bias memory.  
Using dopamine-like medications in healthy volunteers to study dopamine’s effects in 
modulating encoding has yielded further supporting evidence. Administration of dopamine 
precursor L-DOPA prior to learning, has been shown to increase theta coherence, working 
memory and memory persistence in humans (Eckart, Fuentemilla, Bauch, & Bunzeck, 2014). 
Theta activity both in the cortex and in the hippocampus supports memory encoding and biases 
spindle activity during sleep (Hasselmo, 2005; Jarovi et al., 2018) . Sleep spindle activity supports 
both memory consolidation and strategic forgetting (Cairney et al., 2018; Dehnavi, Moghimi, 





Sadrabadi Haghighi, Safaie, & Ghorbani, 2019). Therefore, the findings from these two studies 
suggest that, similar to mice, in humans dopamine at encoding may tag memories to be later 
captures for consolidation.  
However, others have found disparate effects. In Parkinson’s disease patients being ON their 
usual dopaminergic medication during encoding impaired memory compared to being OFF 
medication (J.P. Grogan et al., 2015). When taken OFF dopamine replacement therapies 
Parkinson’s disease patients’ motor symptoms return quickly. It is therefore interesting that these 
patients perform better when taken off their usual medications. Overall, evidence in support of 
dopamine biasing encoding in humans is patchy and findings so far have been inconsistent. Most 
studies that have shown dopamine medication to attenuate memory do not target encoding 
specifically (Chowdhury et al., 2012; J.P. Grogan et al., 2015; Knecht et al., 2004; Shellshear et al., 
2015). Therefore, dopamine’s role on encoding and consolidation remains unclear. 
Yet, dopamine’s effects on retrieval are likely the least studied. In rats, the D2 agonist 
haloperidol has been associated with enhanced retrieval. Sara (1986) showed that haloperidol had 
no effect on memory when injected during training, but after a 25-day retention interval, when 
injected prior to retrieval, rats produced fewer errors than rats given saline. Larger doses of 
haloperidol were associated with less forgetting (Sara, 1986). Similar effects of haloperidol in rats 
have also been found in other studies (Chugh, Saha, Sankaranarayanan, & Sharma, 1991). 
Therefore, dopamine may enhance retrieval in rats.  
To our awareness there are not many studies that specifically investigate dopamine’s involvement 
on retrieval in humans. Dopaminergic striatal regions activate during recognition retrieval (Clos, 
Schwarze, Gluth, Bunzeck, & Sommer, 2015; Han, Huettel, Raposo, Adcock, & Dobbins, 2010; 
Kim, 2013; Schwarze, Bingel, Badre, & Sommer, 2013; Spaniol et al., 2009). This suggests that 
dopamine may be involved in retrieval, particularly in recognition memory settings.  





Supporting evidence of dopamine enhancing recognition comes from a trial where healthy 
volunteers were dosed with haloperidol. In an fMRI study, Clos and colleagues (2019) showed 
that haloperidol increased recognition memory when administered to target retrieval 24 hours 
after learning. The dopamine-driven boost in retrieval was also associated with increases in 
activity in the dopaminergic midbrain (Clos, Bunzeck, & Sommer, 2019). Therefore, dopamine 
during retrieval may enhance recruiting brain regions that support recognition memory.  
To illuminate dopamine’s effects on encoding and retrieval, I composed a second double-blind 
placebo-controlled randomised trial, where exogenous dopamine administration was times 
carefully to target encoding or retrieval. I specifically sought to investigate if L-DOPA biases 
memory during encoding or retrieval. 
Method 
The method is reported in Chapter II (pg. 77). A short reiteration of the method is given here. 
Design and procedure 
In this placebo-controlled double-blind treatment-order randomised within-subjects study, 
healthy elderly participants were dosed both with 150mg of L-DOPA and placebo but on 
separate sessions. The volunteers completed two testing sessions, each spread over 1 week. The 
visits were identical except for treatment allocation (Figure 27). 
Encoding 





To test dopamine’s effects on encoding, volunteers were given L-DOPA approximately 1.5h 
before learning a word list. After learning, participants were offered a short break and 
refreshments before their memory on a quarter of the items was tested (baseline) using the 
Remember-Know paradigm (pg. 90). The rest of the items were tested 1, 3, or 5 days later, using 
the same paradigm. Therefore, L-DOPA was active in the system at learning and at the first test, 
but not at Day 1, 3, and 5 tests. As the findings from the first test would be difficult to interpret 
in light of our research aims, I did not analyse results from the immediate test.  
Retrieval 
In order to study dopamine’s effects on retrieval, participants learnt a list of 48 words one day 
before receiving L-DOPA (Day -1). Their memory was tested for half the items 30 minutes later 
(baseline) and the other half 24 hours after learning. Crucially, the 24 h test (D0) was completed 
when L-DOPA was at its peak concentration. 
 
Analyses 
Encoding: Mixed linear models were used to assess D’ (i.e. a measure of accuracy) and criterion 
(same as response bias) across time. For each model the predictor variable was D’ or criterion, 
the fixed effects were time (Day 1, Day 3 and Day 5) and treatment.  I then conducted 
confirmatory pairwise comparisons (either t-tests or Wilcoxon’s signed ranks together with 
Bayesian analyses) for all measures of interest.  
Retrieval: Pairwise comparisons (as above) were carried out for all measures of interest for the 
Day -1 (baseline day, before dosing) and Day 0 tests. 
  






Figure 27: Study timeline for testing dopamine’s effects on encoding and retrieval 
 
Participants were invited for two identical testing sessions (left and right of the 2-day gap). 
The aim of the study was to test L-DOPA’s effect on memory encoding (orange) and retrieval 
(green). L-DOPA or placebo was given in a random order on days 2 and 4. Therefore, for the 
encoding experiment Dopamine was active at learning and immediate test, but not at Day 1-5 
tests. In the retrieval experiment dopamine was not active at learning or subsequent sleep (and 
consolidation) but it was active at the subsequent 24 hours later.  
These timelines are not to scale.   
 
Bayesian comparisons: The absence of a ‘significant’ p-value cannot be used as evidence of the 
absence of an effect. However, the Bayes Factor gives the probability of the given data having 
occurred under null compared to alternative hypothesis. Here, I use the Bayes Factor to 
demonstrate our confidence in the null hypothesis. 







Thirty-seven healthy elderly (65+ years) volunteers were recruited to take part in this study. Two 
were excluded prior to dosing; one due to a contraindication, and one for participating in 
another drug trial simultaneously. Three volunteers did not complete the study; two withdrew 
consent for personal reasons and one experienced significant nausea and vomiting as a side 
effect on their second testing session. In the encoding experiment, data was missing partially for 
a further 8 volunteers either due to missed phone calls or experimenter error, and one volunteer 
was excluded entirely as their accuracy was below chance level suggesting they had 
misunderstood the task (n encoding- = 32). Further, wrong test versions were used for two 
volunteers for the retrieval experiment (n retrieval = 28). Demographic characteristics of the final 
sample are reported in Table 6 and Table 7. Note that one volunteer scored 18 on the MoCA, 
which may indicate heightened risk of having mild cognitive impairment or dementia (Carson, 
Leach, & Murphy, 2018). As this volunteer was not an outlier on any of the other tests, including 
the verbal memory test and a test of working memory (results published in (J. P. Grogan et al., 
2018)), they were included in the analyses and considered healthy. 
  









 Test day 
 L-DOPA  Placebo 
 🏠 0 📞1 📞3 📞5  🏠 0 📞1 📞3 📞5 
# of volunteers         
 1 X X X X      
 2  X  X      
 1  X    X    
 1    X   X X X 
 1      X X X X 
 1       X X  
 1        X  
 1         X 
 2      X X X X 
Table 6: Encoding and Retrieval: Missing data 
 
Crosses (X) denote missing data points for each test session with the left column denoting the 
number of volunteers affected. Remaining data for each volunteer was used except where the 
volunteer only completed one test session (n = 3, top and bottom rows)  








n = 28  
 
 
Mean  (SD) Range Mean  (SD) Range 
Age 71.1  (7.1) 65 – 92 70.9  (6.9) 65 – 92 




26.1  (3.3) 18 – 30 26.1  (3.2) 18 – 30 
Height (cm) 170.0  (10.3) 152 – 186 170.0  (10.6) 152 – 186 
Weight (kg) 75.2  (15.4) 51 – 105 75.0  (15.6) 51 – 105 
Body mass index (kg/cm2) 25.8  (3.7) 18.1 – 35.1 25.8  (3.7) 18.1 – 35.1 
L-DOPA concentration (mg/kg)  2.08  (0.44) 1.43 – 2.95 2.09  (0.45) 1.43 – 2.95 
Gender (f/m)  16 / 16  14 / 14 
Treatment order (L-DOPA/ Placebo first) 17 / 15  13 / 15 
Blinding (accurate / inaccurate / missing) 17 / 12 / 3  16 / 10 / 2 
 
 
Rationality Experientiality index (REI) scores 
 Overall rationality 3.6  (0.8) 1.5 – 5.0 3.7  (0.9) 1.5 – 5.0 
 Rational Engagement 3.8  (0.9) 1.0 – 5.0 3.8  (0.9) 1.0 – 5.0 
 Rational Ability 3.5  (1.0) 1.0 – 5.0 3.5  (1.0) 1.0 – 5.0 
 Overall Experientiality 3.1  (0.6) 2.0 – 4.2 3.1  (0.6) 2.0 – 4.2 
 Experiential Engagement 2.9  (0.7) 1.0 – 4.2 2.9  (0.8) 1.0 – 4.2 
 Experiential Ability 3.3  (0.6) 2.0 – 4.5 3.3  (0.6) 2.0 – 4.3 
 
 
Depression, Anxiety and Stress Scale (DASS) 
 
 Depression  4.2  (4.9) 0 – 18 4.0  (4.7) 0 – 18 
 Anxiety 2.0  (2.4) 0 – 11 2.0  (2.6) 0 – 11 
 Stress 5.4 (4.1) 0 – 14 5.4  (4.3) 0 – 14 
 
 
Barratt Impulsivity Scale (BIS) 
 Motor impulsiveness 21.3  (3.7) 14 – 29 20.9  (3.5) 14 – 29 
 Non-planning 22.1  (5.1) 11 – 30 21.6  (4.7) 11 – 30 
 Attentional 
  
14.6  (2.5) 10 – 19 14.4  (2.5) 10 – 19 
Table 7: Encoding and Retrieval: Demographics 
L-DOPA concentration was calculated as drug dose (mg) / body weight (kg). Volunteers were dosed with 
150mg of L-DOPA CR in the form of co-beneldopa. The volunteers for both experiments are the same 
with unique iterations of missing data, as described previously.   
  






L-DOPA at encoding did not affect subsequent memory (Figure 28Error! Reference source 
not found.). I probed recognition memory 4 times testing unique items each time: once on-site 
shortly after learning (~5 minutes later), then 1, 3 or 5 days later over the phone.  
The mixed linear model (excluding random effects) explained 15.0% of the variation in D’ (t(30) 
= -5.525, p = < .001), which was driven by the effect of time. There was no significant effect of 
treatment for neither D’ nor criterion (Table 8).  
I also found substantial evidence that L-DOPA during encoding does not affect subsequent 
verbal memory performance a day later (t(28) = - .352, p = .728, BF01= 4.6) with evidence for 
days 3 (t(25) = -2.128, p uncorrected = .043, p corrected = .129 / BF01= .7) and 5 being inconclusive 
(t(26) = - .325, p = .748 / BF01= 2.6). See Table 9. 
 
Figure 28: L-DOPA and encoding  
 
L-DOPA during encoding does not affect subsequent memory. A violin plot showing the kernel density for 
L-DOPA mediated change in D’. The change in accuracy was calculated for each volunteer as: 
D’ [L-DOPA induced effect] = D’ [L-DOPA] – D’ [Placebo] 
Therefore positive values (above the dashed line) denote better performance when L-DOPA was given at 
encoding compared to placebo, zero (dashed line) denotes no difference and negative values poorer 
performance. Note that at the time of test L-DOPA was not active in the system.  













t df p   R2m 
 
D’ D’ ~ Delay * Treatment + (Delay + Treatment | participant) 
 Intercept .975 
( .10 ) 
9.356 3 .3 <.001 
  .150  
 Delay -.545 
( .18 ) 
- 3.082 114.1 .003 
 Treatment .108 
( .08 ) 
1.311 29.4 .200 
 Delay*Treatment .002 
( .15 ) 
.016 91.3 .987 
Criterion Criterion ~ Delay * Treatment + (Treatment || participant) 
 Intercept - .083 
( .06 ) 
- 1.326 51.2 .191 
  .009  
 Delay - .149 
( .10 ) 
- 1.438 107.9 .153 
 Treatment .012 
( .05 ) 
.235 43.8 .815 
 Delay* Treatment - .059 
( .09 ) 
- .626 107.5 .532 
Table 8:  Encoding: Mixed linear models 
 
The delay (time of test; D1, D3 or D5) explained variation in D’ but not in criterion. L-DOPA 
status explained none of the variability in responses. Specific models are specified above each 
model’s results. R2m shows how much of the variance in the response variable is explained by the 
fixed effects, their interactions and the intercept.   
As none of the main effects of interest (i.e. effects of L-DOPA) were significant, these analyses 
were not corrected for multiple comparisons.   














 t p BF01  H0 vs H1 
L-DOPA Placebo  df = 28 
 D’ 1.257 
( .76 ) 
1.149 
( .61 ) 
[ - .295 – .426 ] 
 
- .352 .728 4.6  
 
 Criterion - .027 
( .35 ) 
- .083 
( .39 ) 
[ - .310 – .414 ] 
 
114* .197 4.7  
 
 Recollect  .569 
( .25 ) 
.606 
( .22 ) 
[ - .447 – .277 ] 
 
.495 .625 4.3  
 
 Familiar .220 
( .21 ) 
.161 
( .15 ) 
[ - .128 – .612 ] 
 
93.5* .291 2.2  
 
Day 3    
 
df = 25 
   
 D’ .865 
( .47 ) 
.710 
( .50) ) 
[ - .001 – .763 ] 
 
-2.128 .043 .7**  
 
 Criterion - .107 
( .40 ) 
- .126 
( .46 ) 
[ - .352 – .368 ] 
 
- .040 .968 4.8  
 
 Recollect  .442 
( .25 ) 
.461 
( .26 ) 
[ - .410 – .308 ] 
 
.289 .775 4.6  
 
 Familiar .221 
( .16 ) 
.204 
( .18 ) 
[ - .306 – .419 ] 
 
130* .820 4.6  
 
Day 5    
 
df = 26 
   
 D’ .692 
( .45 ) 
.592 
( .40 ) 
[ - .317 – .588 ] 
 
- .325 .748 2.4  
 
 Criterion - .147 
( .38 ) 
- .167 
( .33 ) 
[ - .334 – .378 ] 
 
- .148 .884 4.9  
 
 Recollect  .414 
( .25 ) 
.427 
( .30 ) 
[ - .414 – .301 ] 
 
197.5* .585 4.7  
 
 Familiar .234 
( .20 ) 
.232 
( .22 ) 
[ - .313 – .402 ] 
 
91* .614 4.8  
 
Table 9: Encoding:  Pairwise comparisons   
 
L-DOPA during encoding did not affect verbal memory performance later. δ denotes effect size for 
the paired differences derived from the Bayesian posterior distribution. Where credible intervals are 
the 95% intervals overlapping zero denote no difference. BF01 and H0 vs H1 show the probability of 
our data having been observed under the null (white) as opposed to the alternative (blue) hypothesis. 
All error % < .024 
 
* Wilcoxon test used due to non-parametric data. All samples contained zero values for paired 
differences. P-values for Wilcoxon tests for such data are less reliable 
** BF10 = 1.4  






Across the board I show moderate evidence that L-DOPA does not affect retrieval of previously 
learnt information, Figure 29. When memory was probed an hour after administration of L-
DOPA, I found no effect of L-DOPA on D’ or criterion. Instead, I found moderate evidence to 
suggest L-DOPA does not affect D’ or criterion (BF01 =4.6, BF01 = 4.9). If anything, the 
difference between the L-DOPA and placebo was more pronounced on Day -1, i.e. on the 








 T p BF01 H0 vs H1 
Day preceding   
L-DOPA Placebo  df = 27 




[ - .180 – .538 ] 
 
-1.041 .307 3.1  
 
 Criterion .114 
( .34 ) 
.196 
( .35 ) 
[ - .564 – .149 ] 
 
-1.198 .241 2.6  
 
 Recollect  .592 
( .22 ) 
.615 
( .29 ) 
[ - .445 – .264 ] 
 
178* .959 4.4  
 
 Familiar .298 
( .18 ) 
.230 
( .23 ) 
[ - .095 – .618 ] 
 
189* .741 1.9  
 
Day 0 L-DOPA Placebo  
 
df = 27 
     
 D’ 1.658 
( .55) 
1.609 
( .56 ) 
[ - .278 – .417 ] 
 
.393 .698 4.6  
 
 Criterion - .216 
( .39 ) 
- .192 
( .47 ) 
[ - .384 – .316 ] 
 
- .224 .968 4.9  
 
 Recollect  .592 
( .22 ) 
.615 
( .29 ) 
[ - .421 – .261 ] 
 
.289 .825 4.4  
 
 Familiar .298 
( .18 ) 
.230 
( .23 ) 
[ - .102 – .611 ] 
 
1.491 .147 1.9  
 
Table 10: Retrieval: Pairwise comparisons   
L-DOPA does not affect verbal memory retrieval. δ is Cohen’s delta – the standardised effect size – 
for the paired differences derived from the Bayesian posterior distribution. BF01 and H0 vs H1 show 
the likelihood of our data having been observed under the null (white) as opposed to the alternative 
(purple) hypothesis. D -1 denotes baseline performance for a recognition verbal memory test 
conducted 30 minutes after learning and prior to drug administration. All errors % < .022 
* Wilcoxon test used due to non-parametric data. All samples contained zero values for paired 




























Figure 29: L-DOPA and retrieval 
 
L-DOPA on Day 0 did not affect recognition memory performance on items learnt a day previously. 
 
Discussion 
In this chapter I provide evidence that dopamine does not alter memory performance at 
encoding or retrieval when memory is tested 24 hours later. Using a Bayesian approach to 
analyse these data, I found moderate evidence that L-DOPA active during retrieval does not 
affect memory. When L-DOPA was given before learning, I found moderate evidence that it 
does not affect recognition memory when tested immediately, the following day or five days 
after learning. However, when tested 3 days after learning I observed a small enhancement in the 
L-DOPA condition.  





Therefore, I found weak evidence that dopamine may alter encoding for information that is 
retained at longer delays. However, this effect did not survive family-wise correction for multiple 
comparison, and Bayesian analyses for day 3 were inconclusive. Dopamine may therefore weakly 
enhance encoding when tested 3 days after learning. However, there is a high possibility that this 
finding was a false positive as it did not survive multiplicity corrections and the Bayesian analyses 
were inconclusive either way.  
If true, perhaps L-DOPA increased early consolidation processes. Dopamine was active at 
periods of time following L-DOPA administration, possibly enhancing processes of early 
consolidation during this time. Second, there was no effect of dopamine on Day 1, so if 
dopamine enhances memory at encoding it is likely that the items retained on dopamine at Day 3 
were ones that, on placebo, would have been lost between Days 1 and 3. However I did not 
specifically test this hypothesis.  
The observed effect on Day 3 did not persist on Day 5 but many volunteers were performing at 
chance-level by this point, which may have masked drug effects. Therefore, if this effect on Day 
3 is real, it may be that L-DOPA at encoding, or shortly after encoding, promotes persistence of 
strongly encoded or salient information. While speculative, this interpretation also fits in with the 
drosophila literature, where dopamine has been shown to both enhance encoding and accelerate 
strategic forgetting (Berry et al., 2012; Berry et al., 2018). While this would be in line with our 
previous findings, further work is required to address this possibility.  
Previously, Clos and colleagues (2019) have found a beneficiary effect of a D2 agonist on 
encoding. This study had many key differences to ours. First, I used L-DOPA which increases 
both D1 and D2 type activity compared to a D2 agonist. Second, our participants were elderly as 
opposed to healthy young people. Age-related differences in L-DOPA responses in relation to 
memory (Morcom et al., 2010) have been previously observed, so therefore these pre-existing 





differences between the studies may explain discrepancies in results. Third, their participants 
were performing close to baseline suggesting the task they used was much more difficult. Finally, 
I used a verbal memory task as opposed to pictures. I cannot rule out the possibility that in a 
different setting L-DOPA would enhance recognition memory. 
Others have also found that while there was no difference on subsequent memory when the D2 
agonist Bromocriptine or the D2 antagonist Sulpiride were compared against placebo, memory 
performance was enhanced in the D2 agonist compared to the antagonist condition (Morcom et 
al., 2010). Therefore, there may be a small effect whereby dopamine at encoding enhances 
memory, possibly via modulation of D2 receptors.  
I also showed that dopamine at neither encoding nor retrieval affected recollection, while 
findings for familiarity were inconclusive. In this study, the way the remember-know task was 
delivered was not consistent. Some members of the research group gave instructions that could 
have promoted volunteers to judge their confidence rather than true recollection. It is possible 
this influenced our findings and when the task is delivered more robustly dopamine may 
modulate these processes at encoding or retrieval. However, when volunteers were dosed with a 
dopamine agonist or antagonist during encoding in another study, no differences were found 
between recollection or familiarity at a later test either (Morcom et al., 2010). Therefore, it is 
unlikely that dopamine during retrieval or encoding affects recollection or familiarity.  
Findings of other aspects of this study are reported elsewhere. I showed that in this study L-
DOPA affected neither working memory (digit span) nor retrieval in a reinforcement learning 
task (J.P. Grogan et al., 2019; J. P. Grogan et al., 2018). 
 






Here, I tested the effect of L-DOPA on encoding and retrieval. I found that while L-DOPA 
compared to placebo did not enhance encoding or retrieval when tested a day later, it may 
modulate persistence for strongly encoded items when tested 3 days later. However, the evidence 
for this was weak and inconclusive.  
 











Chapter IV: Dopamine 
and memory 
persistence 
Data reported in this chapter was collected as a part of the DOPAMIND study.  
Introduction 
Seemingly effortlessly, the human brain selectively stores salient details of our daily events, while 
disregarding irrelevant information – you have probably forgotten where you parked your car 
while shopping last week, but you will remember your parking slot in an airport carpark after a 
week’s holiday. When memories are made, past experiences are encoded by physical traces, or 
engrams, in the brain (Semon, 1909; Tonegawa, Liu, et al., 2015). Instead of being an analogue, 





one-to-one match with information encountered in the environment, memories are shaped and 
moulded at different stages depending on complementary information, and then reconstructed at 
retrieval (Anderson, Bjork, & Bjork, 2000; J. L. C. Lee, 2010; Nader, 2015; Nader & Hardt, 
2009). 
During memory encoding and consolidation, engrams of salient information can be tagged 
(prioritised) for storage, based either on previous knowledge, repeated exposure, or other 
associations, such as financial or emotional reward or cost (Frey & Morris, 1997a; Redondo & 
Morris, 2011). Passive re-exposure alone is unlikely to be enough. For example, repeated re-study 
after learning does not enhance subsequent memory, but testing does (Karpicke & Roediger, 
2008). Contextual information encountered at a later time-point can also retroactively tag 
previous memories (Patil et al., 2017). Tagging usually occurs within hours of encountering 
information and it increases the longevity of the tagged memory (Frey & Morris, 1997a; Pu & 
Yu, 2019).  
During sleep, spontaneous hippocampal replay prioritises tagged memories and supports offline 
memory consolidation (Clemens et al., 2007; Heib et al., 2015; Sadowski et al., 2016; van de Ven 
et al., 2016). Evidence that similar mechanisms act as a fast route for online consolidation during 
wakeful re-activation comes from several studies (Antony et al., 2017; Jadhav, Kemere, German, 
& Frank, 2012). Disrupting these events either during sleep (Ego-Stengel & Wilson, 2010) or 
awake (Jadhav et al., 2012) impairs memory retention. As the neurotransmitter dopamine is 
involved in detecting behaviourally important information (Eban-Rothschild et al., 2016; Schultz, 
1998), it might promote processes leading to memory selection. 
Dopamine is released from neurons that connect reward and memory systems within the brain 
and modulate synaptic connections and memory persistence (J. Lisman et al., 2011). Models of 
memory based on drosophila point to dual effects – dopamine enhances encoding of new 





information at the cost of triggering forgetting of competing information (Berry et al., 2012; 
Berry et al., 2018). This dopamine-induced strategic forgetting might be selective to weakly 
encoded memories. In humans with dopamine depletion, the timing of dopamine-like 
medication administration relative to learning critically determines its effects on memory 
(Coulthard et al., 2012; J.P. Grogan et al., 2015).   
Dopamine increase after learning, to target consolidation and forgetting processes, enhances 
memory persistence (Feld et al., 2014; J.P. Grogan et al., 2015). In drosophila, dopamine during 
sleep actively accelerates forgetting (Berry et al., 2015). In rats, dopamine in the hippocampus 
enhances consolidation 12h after learning, but not immediately (Rossato et al., 2009). In healthy 
young adults overnight dopamine enhances persistence of low-reward items (Feld et al., 2014) 
and in elderly dopamine during encoding and consolidation enhances memory persistence and 
recollection for weakly encoded information at a 6h delay but not at a 2h delay (Chowdhury et 
al., 2012). Together these findings suggest that dopamine plays a role in memory persistence over 
long periods but not in the short-term.  
I sought to test if dopamine biases human memory storage to maximise retention of 
behaviourally relevant information. To study the relationship between dopamine, tagging, 
forgetting and long-term memory persistence, I carefully timed administration of L-DOPA to 
increase dopamine availability within the brains of healthy older adults in a placebo-controlled 
double-blind randomised crossover experiment. Critically, L-DOPA or placebo was given after 
participants had learnt information. Here, I report two set of analyses from this clinical trial.  
In the first part (memory persistence), memory was probed for words 1, 3 or 5 days after 
learning. In the second part (tagging) I tagged a quarter of the items as salient by repeated 
exposure (recognition test with no feedback) shortly after L-DOPA administration. Memory for 
the tagged items was tested the following day together with a matched number of non-tagged 





items. Therefore, exogenous dopamine was not active in the system during learning or during 
memory tests. Dopamine was instead active during tagging and subsequent sleep.  
I hypothesised that: 
 Dopamine during sleep will enhance memory persistence particularly 3 and 5 days later. 
 Saliency-tagged information will be better retained than non-tagged information on both 
L-DOPA and placebo 
 Dopamine will increase the tagging effect by enhancing retention of salient information 
Method 
Comprehensive overview of the method is given in Chapter II (pg. 77). A short overview is 
given here.  
Note that in this chapter, I discuss data from the same study separately – crucially, some 
data between the two analyses are shared (i.e. List B).  
 
Design and procedure 
The second and third visits (sleep visits) were identical except for drug allocation. Volunteers 
arrived on site in the evening and they were re-consented and screened for eligibility. They then 
learnt 4 lists (A, B, C, and D) of 20 target words (n = 80 targets) presented on a computer screen 
one at a time (Figure 30). 30 minutes after learning they were given either an oral dose of 200mg 
L-DOPA controlled release or placebo (at different visits) to be active overnight. All evening 





events were calculated backward from usual bedtime so that L-DOPA was administered 115 
minutes prior to switching the lights off for the night. Volunteers slept on-site for a full night, 
and they were  
woken up at their usual wake-up time. Below is a short outline of the study procedures relevant 
for Parts 1 and 2.  
Part 1: Dopamine in tagging memories  
An hour after dosing, one of the lists (List A) was tagged as salient by a recognition test whilst 
ON L-DOPA (/placebo). No feedback was given. An hour after the test, and two hours after L-
DOPA was given, the volunteers went to bed. ~2h after waking up whilst OFF L-DOPA 
volunteers’ verbal memory was tested for Lists A and B together with a matched number of 





Figure 30: DOPAMIND: Verbal memory learning phase 
 
Volunteers learnt four lists of target words (List A-D, 80 words), one at a time, in a random order. During 









DOPAs effect on saliency-tagging ‘important’ memories with the rationale that when a word is 
tested, it will be deemed to be more important, and it will be preferentially remembered. 
Part 2: Forgetting 
The aim here was to assess the role of nocturnal dopamine in modulating memory persistence. 
Volunteers went to bed ~2h after receiving L-DOPA (Figure 31A). The following morning (~ 
12h after dosing), volunteers’ memory was tested on-site on one of the lists (Figure 31B).  2 and 
4 days later (3 and 5 days after learning) the volunteers were contacted over the phone for 
follow-up recognition memory tests. At test, volunteers’ memory was probes using the 
remember-know paradigm (pg 90).  Crucially, volunteers were OFF L-DOPA during learning, 
ON L-DOPA over the subsequent night and OFF L-DOPA at each testing instance.  
 
Analyses 
The primary outcome measure was the D’. I also analysed the criterion, recollection and 
familiarity separately. Drug dose was calculated as mg/kg.  
Part 1: The main outcome measure was the difference between tagged and untagged items (i.e. 
tagged minus untagged) for D’, hereafter referred to as the tagging effect. The tagging effect was 
also calculated for the criterion and the remember-know judgements.  
Part 2: Mixed linear modelling was used as described on pg. 105. I also assessed each day’s (1, 3, 
and 5) performance separately using paired comparisons, see pages 104 and 108. 
Control measures: To ascertain that any effects of L-DOPA reflected dopamine’s effects on 
memory rather than mood or alertness, participants completed the Positive and Negative 





Affective Score (PANAS) questionnaire and the Trail Making Tests A and B. The former is a 





Figure 31: Part 1 Timeline and recognition test 
 
Summary of the timeline for Part 1. Volunteers learnt lists A&B in the evening before dosing. After dosing, 
List A was tagged as salient by a recognition test. L-DOPA was given to target tagging and overnight sleep. 
The orange area denotes when L-DOPA was active in the system. Memory was tested the following day.  
Lists A and B were tested together. Each dot represents a word. The lists were tested in a random order 
with a matched number of distractors (black dots). 
These figures are not to scale.   
 
  









Figure 32: Part 2: Timeline and recognition test  
 
Summary of the timeline for Part 2. Volunteers learnt lists B-D in the evening before dosing. L-DOPA was 
given to target memory processes overnight. Memory was tested for each list separately at a 1, 3, or 5-day 
delay. The orange dotted box denotes when L-DOPA was active in the system.   
Different word lists were tested on different days using a recognition memory procedure. On days 3 and 5 
testing was performed over the phone. Each dot represents a unique word. Black dots represent distractor 
words. 
These figures are not to scale.   
 
 







I recruited healthy elderly (65+ years) native or fluent English speakers with normal or 
corrected-to-normal vision completed the study. Forty-five volunteers completed screening: five 
could not take part due to diary clashes, 2 due to incidental findings that were also 
contraindications, and 3 due to existing cardiac or medicinal contraindications. Further 14 were 
initially screened p/rior to study halt (Appendix A) and were either not eligible when the trial 
restarted, could not be contacted, refused consent or could not be booked in due to diary 
clashes. Demographic variables for the final sample (n = 35) are shown in Table 11. Where not 
otherwise stated, all available data (n=35) was used for analyses.  
Further, data for one follow-up phone call (placebo, 📞Day 5) had to be excluded due to 
researcher error (same set of distractors and targets were used as on 📞Day 3).  
  







 Mean  (SD) Range 
 
Age 68.9  (3.5) 65 – 79 
Height (cm) 166.1  (7.4) 152 – 181 
Weight (kg) 70.28  (13.0) 48 – 94 
Body mass index (kg/cm2) 25.2  (3.2) 18.5 – 32.7 
L-DOPA concentration (mg/kg) 
 
2.94  (0.54) 2.13 – 4.17 
Gender (f/m) 22 / 13 
Treatment (L-DOPA/ Placebo first) 18 / 17 
Blinding (accurate / inaccurate) * 21 / 13  
   
MoCA (Montreal cognitive assessment) 27.5  (2.5) 21 – 30 
 
Rationality Experientiality index (REI) scores 
 
 Overall rationality 3.5  (0.7) 2.3 – 4.7 
 Rational Engagement 3.4  (0.7) 2.1 – 4.6 
 Rational Ability 3.5  (0.7) 2.1 – 4.7 
 Overall Experientiality 3.4  (0.7) 2.1 – 5.0 
 Experiential Engagement 3.3  (0.6) 2.2 – 5 
 Experiential Ability 3.5  (0.7) 1.9 – 4.9 
 
Depression, Anxiety and Stress Scale (DASS) 
 
 Depression  2.1  (3.2) 0 – 11 
 Anxiety 1.8  (2.3) 0 – 8 
 Stress 6.2  (5.9) 0 – 21 
 
Barratt Impulsivity Scale (BIS) * 
 
 Motor impulsiveness 21.1  (3.6) 12 – 27 
 Non-planning 21.7  (5.3) 14 – 35 
 Attentional 14.5  (3.4) 9 – 23 
 
Pittsburgh sleep quality index 
35  (10.4) 20 – 59 
 Sleep efficiency 1.4  (1.5) 1.4  (1.5) 
 Sleep Quality 1.7  (1.6) 1.7  (1.6) 
 Daily disturbance 1.4  (0.7) 1.4  (0.7) 
Table 11: Chapters IV to VI demographics 
 
L-DOPA concentration was calculated as drug dose (200 milligrams divided by body weight 
in kilograms).   
SD = standard deviation; cm = centimetre; kg = kilogram; mg = milligram;  
f = female; m = male  
* missing data from one volunteer 





Part 1: Dopamine in tagging memories  
 A proportion of the items were saliency-tagged (List A) by a recognition test after L-DOPA had 
been given. Here, I report results for the comparisons between tagged and non-tagged items. 
As expected, the tagging effect (i.e. relative benefit of tagging, List A > List B) was seen both on 
L-DOPA (t(34) = -8.42, p< .001, BF10 = 14 300 000, n = 35) and on placebo (t(34) = -6.76, 
p<.001, BF10 = 165 589, n = 35) for accuracy (D’). In other words, tagged items were better 
retained (List A; m L-DOPA = 2.20 ± .78, m placebo = 2.19 ± .77) than other items (List B; m L-DOPA = 
1.25 ± 0.59, m placebo = 1.54 ± .11. ). Note that it is possible that this effect is not driven by 
“tagging” but by having a second opportunity to encode information.  
As was hypothesised, L-DOPA increased the tagging effect (t (34) = 2.48, p = .018, BF10 = 2.6, 
Figure 33) relative to placebo, n = 35. If both tagged and non-tagged items were considered 
together, there was no difference between the treatments (m L-DOPA = 1.7 ± .61, m placebo = 1.9 ± 




Figure 33: Dopamine and the tagging effect 
 
The tagging effect, or relative benefit of memory tagging on subsequent memory, is increased  
by dopamine when L-DOPA is given after learning but before tagging and subsequent sleep. 
  





salient memories for later. Dopamine did not impact the tagging effect for the criterion, or for 
recollected or familiar items (Table 12). 
I used parametric and Bayesian repeated measures 2x2 ANOVAs to observe the effect of tagging 
(List A vs B) and treatment (L-DOPA vs placebo) on accuracy (Figure 34, Table 12, n = 35) and 
criterion (Table 13). I found a main effect of tagging and a treatment * tagging interaction (F(34, 
1) = 6.15, p =.018, BF01 = .7 / BF10 = 1.4) for accuracy. There was a main effect of tagging on 




Figure 34: L-DOPA and memory for tagged and non-tagged items 
 
Dopamine accelerates tagging by modulating persistence of tagged and non-tagged items Dopamine both 
increases memory for tagged (left, difference not significant) and decreases memory for other (right) items. 
The paired differences between tagged (left) and non-tagged (right) items are plotted in Figure 33. 
This figure demonstrates that L-DOPA is affecting both tagged and non-tagged items but in disparate ways. 
This study has low power and for this reason the effect on either on their own is small, and the effect on 
tagged information is not significant. However, the magnitude of the effect is larger when both are 
















 t p BF01  H0 vs H1 
L-DOPA Placebo  df = 34 
 D’ 
.95 
( .67 ) 
.64 
( .56 ) 
[ .052 –  .728] 
 




( .43 ) 
.-.35 
( .35 ) 
[ - .390 – .240 ] 
 
226* .611 4.9  
 
 Recollect  
.19 
( .16 ) 
.23 
( .19 ) 
[ - .487 – .158 ] 
 




( .18 ) 
-.13 
( .18 ) 
[ - .425 – .201 ] 
 
-.741 .464 4.3  
 
Table 12: Behavioural analyses Part 1: Pairwise comparisons 
 
L-DOPA administered before tagging and subsequent sleep enhances accuracy (D’) but does not affect 
response bias (Criterion) or recollection. δ denotes effect size for the paired differences derived from the 
Bayesian posterior distribution. BF01 and H0 vs H1 show the probability of our data having been observed 
under the null (white) as opposed to the alternative (purple) hypothesis. All p-values are uncorrected. All errors 
<.001% 
* Wilcoxon test used due to non-parametric data. All samples contained zero values for paired differences. P-
values for Wilcoxon tests for such data are less reliable 



















(  .55) 
.01 
(  .52) 
  
Tagged - .34 
(  .43) 
- .34 
















Tagging 4.81 4.81 
.37 
( .05 ) 




error 2.53 .08 
    
 
 
Treatment .019 .019 
.023 
( .05 ) 




error 3.39 .10 
     
 
 
Interaction .021 .021   .26 .611 3.6 
 
  error 2.69 .08       
Table 13: Behavioural analyses Part 1: Repeated measures 2x2 ANOVA for criterion 
 
Parametric and Bayesian ANOVAs revealed a main effect of tagging and evidence against an effect of treatment 
or treatment * encoding interaction for criterion.  BF01 represents likelihoods of collecting our data under 
models that do not include the given source for variation (H0 in white) compared to models that include the 
variation source (H1 in dark). 
All df = 34, 1 
 
Control measures 
In the morning after tests for lists A and B, participants completed Trail Making A and B and the 
Positive and Negative Affective Scale questionnaire (PANAS). Participants completed PANAS 
in the evening and morning PANAS (nPANAS = 35). For the Trail Making, one volunteer had Trail 
A missing for the placebo visit and two had Trail B missing (nTRAILA = 34, nTRAILA = 33). Both 
were incorrectly administered. No differences were found in any of the measures. I found strong 
evidence that L-DOPA did not modulate neither Trail Making task nor negative affective scale 





(BF01 > 5), while the positive affective scale yielded no evidence in favour for or against an effect 








t df p   R2m  
D' D’ ~  Tagging * Treatment + ( Tagging + Treatment || participant) 
 Intercept 1.796 
( .10 ) 
18.373 34.0 < .001 
  .258 . 
 Tagging .798 
( .08 ) 
9.530 34.0 < .001 
 Treatment .139 
( .08 ) 
9.530 34.0 .107 
 Tagging * Treatment - .310 
( .13 ) 
2.480 34.0 .018 
Criterion Criterion ~  Tagging * Treatment + ( Tagging + Treatment | participant) 
 Intercept - .154 
( .07 ) 
- 2.175 34.0 .037 
  .128  
 Tagging - .371 
( .05 ) 
- 7.919 68.0 < .001 
 Treatment - .023 
( .05 ) 
-  .436 34.0 .665 
 Tagging * Treatment .049 
( .09 ) 
.521 68.0 .604 
Table 14: Behavioural analyses Part 1: Mixed linear models 
 
Response variables (D’ and criterion) were predicted using tagging (tagged versus not) and dose (top), and 
tagging and treatment (L-DOPA versus placebo, bottom) as fixed, and individual participants as random 
effects. Tagging influenced D’ and criterion, for D’ there was also a treatment*tagging interaction, but no main 
effect of treatment. Models are specified above each model’s results. R2m shows how much of the variance in 
the response variable is explained by the fixed effects, their interactions and the intercept.  Note that estimates 
are mean-centred. 
 





Part 2: Dopamine and memory persistence  
To assess L-DOPAs influence on memory persistence, I included delay (1, 3 or 5 days), 
treatment and the delay * treatment interaction as fixed effects, with participants as random 
effects (including slopes and intercepts) in a mixed linear model (Table 15). The effect of 
treatment was not significant in this model. While the model yielded non-significant results, on 
visual inspection a trend on Day 1 toward accelerated forgetting was apparent (Figure 35A, left).  
Note that the direction of this effect was the opposite from what I hypothesised. Therefore, 
planned paired comparisons were performed next.  
Pairwise Bayesian comparisons showed strong evidence that L-DOPA lowered performance on 
Day 1 (BF10 = 16.6) and substantial evidence that L-DOPA did not affect performance on Days 
3 and 5 (BF01 > 5). A paired t-test for D’ on Day 1 aligned with these results t(34) = -3.33, p = 
0.002) and remained significant after adjusting for false discovery rate (pcorrected = 0.006, including 
tests for Days 1, 2 and 3). There was no effect on the other measures (Table 16).  
Next, to assess the effect of dose (mg/kg) on memory, I performed a series of correlation for 
each day’s performance, n = 35 each. Contrary to my hypothesis, on Day 1 higher doses were 
associated with poorer performance following L-DOPA (Day 1: Spearman’s ρ L-DOPA = -.56, p < 
.001) but not placebo (ρ placebo = -.23, p = .18), and that these two relationships were different (z 
= -2.634, p = .008, (K. Pearson & Filon, 1898). This effect was significant following FDR 
correction including the correlational analyses for each day (i.e. Day 1, 3, and 5 correlations 
against dose first on L-DOPA, ntests = 3, pcorrected <.001). 
Dose was not associated with performance on other days (Day 3: ρ L-DOPA = -.06, p = .73, ρ placebo 
= -.15, p = .40;  Day 5: ρ L-DOPA = -.02, p = .92, ρ placebo = -.16, p = .36,  Figure 35B). As dose was 
calculated using bodyweight, it is noteworthy that it was not associated with performance on 





placebo. Therefore, these effects are likely to be drug-related rather than driven by differences in 
body size.  
L-DOPA therefore accelerated early forgetting possibly by only affecting information that would 
be lost in the long term anyway but did not affect strongly encoded information that would be 






Figure 35: L-DOPA and memory persistence 
 
L-DOPA accelerates early forgetting in a dose-dependent fashion 
L-DOPA (pink) accelerated the rate of forgetting between learning and day 1 but it did not affect 
subsequent memory (days 3 and 5).  
This effect was dose dependent: Higher doses were associated with accelerated forgetting on L-DOPA 
(pink) on day 1 but not any other days. This dose-dependent effect was different from the relationship 
between body weight and memory on placebo. There was no dose (or bodyweight) driven effect on placebo 
(green). Note that where the accuracy scores for a participant did not change between L-DOPA and 
placebo the dots overlap. 
 













t df p   R2m  
D' D’ ~ Delay * Treatment + (Delay + Treatment || participant) 
 Intercept .940 
( .06 ) 
14.862 34.1 <.001 
  .252  
 Delay - .809 
( .09 ) 
-8.992 33.6 <.001 
 Treatment - .031 
( .07 ) 
1.215 34.2 .233 
 Delay*Treatment .187 
( .16 ) 
-1.817 103.9 .072 
Criterion Criterion ~ Delay * Treatment + (Delay + Treatment || participant) 
 Intercept - .137 
( .08 ) 
1.761 34.0 .087 
  .009 . 
 Delay - .122 
( .06 ) 
2.042 34.1 .049 
 Treatment - .013 
( .05 ) 
-.0269 34.1 .789 
 Delay* Treatment .033 
( .10 ) 
.329 104.5 .743 
Table 15: Behavioural analyses Part 2: Mixed linear models  
 
Both the test delay and L-DOPA status explained variability in D’ while neither explained variability in criterion. 
Specific models are specified above each model’s results. R2m shows how much of the variance in the response 
variable is explained by the fixed effects, their interactions and the intercept.  The delay (time of test; D1, D3 or 


































 t p 
p-corrected 
BF01  H0 vs H1 
L-DOPA Placebo  df = 34 
 D’ 1.249 
( .59 ) 
1.544 
( .65 ) 







 Criterion .056 
( .55 ) 
.008 
( .52 ) 
[ - .293 – .569 ] 
 
351.0* .211 4.5  
 
 Recollect  .428 
( .25 ) 
.410 
( .25 ) 
[ - .253 – .375 ] 
 
.423 .675 5.1  
 
 Familiar .437 
( .27 ) 
.400 
( .18 ) 
[ - .182 – .441 ] 
 
.805 .426 4.1  
 
Day 3 
   
 
df = 34 
 
  
 D’ .855 
( .46 ) 
.818 
( .63) ) 
[ - .360 – .508 ] 
 
337.5 .313 5.2  
 
 Criterion .212 
( .56 ) 
.237 
( .56 ) 
[ - .501 – .365 ] 
 
228.0* .353 5.2  
 
 Recollect  .246 
( .23 ) 
.254 
( .25 ) 
[ - .348 – .280 ] 
 
- .248 .806 5.4  
 
 Familiar .495 
( .21 ) 
.473 
( .27 ) 
[ - .239 – .369 ] 
 
344.0* .584 5.0  
 
Day 5 
   
 
df = 33 
 
  
 D’ .584 
( .58 ) 
.593 
( .55 ) 
[ - .434 – .428 ] 
 
- .023 .982 5.4  
 
 Criterion .161 
( .55 ) 
.138 
( .49 ) 
[ - .349 – .515 ] 
 
.382 .705 5.1  
 
 Recollect  .197 
( .21 ) 
.218 
( .22 ) 
[ - .368 – .269 ] 
 
- .352 .727 5.1  
 
 Familiar .476 
( .26 ) 
.441 
( .26 ) 
[ - .209 – .440 ] 
 
.739 .465 4.2  
 
Table 16: Behavioural analyses Part 2: Pairwise comparisons.  
 
Paired comparisons between placebo and L-DOPA conditions for verbal memory performance across different 
days. Either a paired t-test or a Wilcoxon signed rank test was used depending on how data were distributed. The 
different measures refer to different signal detection theory metrics which are explained in detail in Chapter II 
(General Method). 
L-DOPA administered after learning impairs memory accuracy on day 1 but does not affect accuracy at later times. 
δ denotes effect size for the paired differences derived from the Bayesian posterior distribution. Credible intervals 
overlapping zero denote no difference. BF01 and H0 vs H1 show the probability of our data having been observed 
under the null (white) as opposed to the alternative (green) hypothesis. All p-values are uncorrected. All errors 
<.001% 
* Wilcoxon test used due to non-parametric data. All samples contained zero values for paired differences. P-values 
for Wilcoxon tests for such data are less reliable. 
** BF10 = 16.6 






Surprisingly, exogenous dopamine active after learning, but before and during subsequent sleep, 
accelerated routine forgetting when memory was tested the following day, but not after 3 or 5 
days. I expected to see a dopamine-driven enhancement on memory following delays. The 
magnitude of the accelerated forgetting was dependent on the dose: higher doses were associated 
with lower subsequent memory scores. This effect was only present after a 1-day delay but not at 
later timepoints. This suggests that dopamine accelerates the forgetting of low importance 
information that would inevitably be lost over time.  
Traditionally, forgetting was considered a passive process where information was “lost”. 
However, newer models strongly support an active, forgetting process influenced by dopamine 
(Berry et al., 2012; Davis & Zhong, 2017). These results suggest an analogous dopamine-
dependent active forgetting process in humans. Strategic forgetting may be necessary to give 
space for salient memories to become preferentially consolidated.   
The finding that L-DOPA accelerated routine forgetting on Day 1 was clear from paired 
comparison (t-tests and Bayesian tests), and rank correlations revealed that this effect was dose-
dependent. These findings were robust and survived false discovery rate adjustments. However, 
in a mixed linear model I could not see a significant effect. One possible explanation is that the 
mixed linear model structure was too complex for a small data set.  
I administered dopamine after learning but before wakeful reactivation and subsequent sleep. 
The purpose of the reactivation was to create a saliency-tag for the re-activated information. As 
hypothesised, both on dopamine and placebo, the saliency-tag enhanced recognition memory, 
and this difference was further enhanced by dopamine. I propose that this is due to a dual effect, 





where (1) online reactivation acts as a fast route for immediate and wakeful consolidation (as 
previously suggested by others (Antony et al., 2017)), and// (2), salient information is 
preferentially consolidated during sleep (Oudiette, Antony, Creery, & Paller, 2013). Dopamine 
has been shown to play a role in both of these processes: first by enhancing learning and then by 
actively accelerating routine forgetting during sleep, while sparing salient information (Berry et 
al., 2015; Berry et al., 2012). 
While our data are in keeping with previous work where dopamine’s effects on memory have 
been paradoxical depending on the timing in relation to the different memory processes (Berry et 
al., 2012; Coulthard et al., 2012; J.P. Grogan et al., 2015; Yoshinori & Rubin, 2016), other human 
studies have demonstrated disparate effects. Below I will outline some of the paradoxical or 
discrepant findings reported in the literature. While I offer some possible explanations as to why 
findings are so discrepant, due to differences in experimental setups, doses and participant 
characteristics, it might not be possible to disentangle what exactly explains these discrepancies. 
Nocturnal pramipexole enhanced memory for low but not high reward items in healthy adults 
(Feld et al., 2014). High reward information may already be tagged strongly rendering any 
beneficial effect of exogenous dopamine minute, while low-reward items may have a relatively 
larger benefit from dopamine.  
In contrast, in our study, participants did not learn to associate words with rewards. Yet it is 
possible that motivated participants deem correctly recognised words rewarding. While I did not 
provide feedback during tagging for this reason, participants were likely to be confident in at 
least some of their ‘hit’ responses. I cannot out rule that the tagging effect is explained by this 
rewarding “confidence-boost”, which is unlikely to be as strong a reward as a purposefully 
manipulated monetary prize. Our observed effects may be due to dopamine increasing 
consolidation for low-rewarded and accelerating forgetting for non-rewarded information. In line 





with this reasoning, there may be no discrepancy between our findings and those of Feld et al 
(2014), as saliency tagging may yield a reward analogous to their low reward. 
Other explanations related to the study designs, such as participant demographics, behavioural 
tasks and dopaminergic agents used may also explain disparate findings. Pramipexole targets D2, 
unlike L-DOPA which is available to all dopamine receptors. To my awareness there are no 
studies in humans directly assessing disparate effects of different receptor types on different 
memory functions, but it is likely that pharmacological agents that act on different receptor sites 
impact memory and sleep in different ways.  
The dose used by Feld et al (2014) was also equivalent to a much lower dose corresponding to a 
50mg L-DOPA-dose-equivalence compared to 200mg used here.  
When elderly participants were given 150mg of L-DOPA, memory was enhanced at a 6h delay 
(Chowdhury et al., 2012). While these findings are seemingly in stark contrast with ours, the 
effect was dose-dependent following an inverted U-shaped curve. Those with a ~2mg 
bodyweight-dependent dose benefited from the treatment while those with higher or lower 
doses did not. Doses in our study were in the region of 2.1 to 4.2 mg/kg, with an average dose 
of 2.9mg, and I found a decrease in performance with higher doses. In line with this, in young 
adults, 100mg of L-DOPA has also been found to enhance verbal learning, and this effect was 
positively associated with dose (Knecht et al., 2004). Considering these findings together suggests 
that L-DOPA may have a biphasic effect where high doses accelerate routine forgetting while 
lower doses support persistence.   
An alternative explanation for the disparate findings between these studies is the medication 
timing. The dopamine-induced memory enhancement in Chowdhury et al (2012) and Knecht et 
al (2004) could have been explained by dopamine’s actions on encoding rather than 





consolidating. It is also possible that the tagging effect reported here reflects differences related 
to re-encoding rather than saliency tagging.  
Response bias, recollection and familiarity may also be affected by dopamine during different 
memory stages or at different doses. Chowdhury et al (2012) found an increase in the rate of 
recollection (remember-hits) following 150mg of L-DOPA at encoding and consolidation. In 
Parkinson’s disease, patients’ subsequent response bias increases when they are off their usual 
medication during learning and early consolidation, to resemble the response bias seen in age-
matched non-medicated controls (J.P. Grogan et al., 2015). This suggests that dopamine during 
encoding promotes more a more conservative signal detection. This change was seen at a 1-day 
delay from learning but not at a 30-minute delay. The lack of effect in our study may be 
explained by drug timing in relation to learning, or by participant demographics. Responses to 
dopamine replacement therapies change over time, offering a possible explanation to the 
discrepancy. 
 
Limitations and caveats  
While I carefully timed the administration of L-DOPA to target sleep, I did not record plasma 
concentrations of dopamine in this study. It is possible that residual amounts of dopamine were 
present in the system at retrieval, and that dopamine during retrieval biases memory.  
L-DOPA clearance is slower in old compared to young adults (Robertson et al., 1989), but it is 
not clear how absorption changes between ages 65 and 79 (our sample age range). L-DOPA 
absorption can also be biased by physical activity or food ingestion (Baruzzi et al., 1987; Carter, 
Nutt, & Woodward, 1992). While I encouraged volunteers to not engage in vigorous physical 
activity in the two days preceding the sleep visits and I provided evening meals and breakfasts, I 





did not measure activity or food intake. Without plasma concentration levels, I could not 
account for individual effects in drug absorption and clearance. 
There are several other limitations I attempt to address in subsequent chapters. Dopaminergic 
forgetting in drosophila occurs during wakefulness (Berry et al., 2015). I administered dopamine 
while participants were awake, and they fell asleep around 2 hours later. It is possible that at least 
a portion of the dopaminergic enhancement of forgetting occurred during wakefulness, before 
sleep, and that this was triggered by saliency-tagging contextually relevant items. In Chapter V I 
will examine how nocturnal dopamine modulates sleep to address this concern.  
 
Conclusion 
Dopamine accelerates routine forgetting and saliency-tagging increases memory compared to 
untagged items. Dopamine during tagging further increases this effect. Dopamine may select 
memories for storage during sleep. Increasing the efficiency of forgetting may allow the 
prioritisation of effective consolidation of high importance items. This might be explained by 
saliency-tagging of to-be-stored information having a protective effect against forgetting, as 
found in drosophila (Berry et al., 2015).  
I found no evidence that dopamine modulates recollection, familiarity or response bias during 
tagging or subsequent sleep. Exogenous dopamine may pose a potential clinical benefit in 
boosting memory for salient information – if the optimal timing of administration can be 
established.   





Chapter V: Sleep 
Data reported in this chapter was collected as a part of the DOPAMIND study.  
Introduction 
During sleep, the brain performs several restorative actions while cycling through sleep stages. 
REM, or paradoxical sleep, is a stage during which electrophysiological measures of brain activity 
look remarkably similar to wakefulness and is closely associated with dopamine levels. Increase 
in dopamine is thought to be a key player in regulating wakefulness and REM (Eban-Rothschild 
et al., 2016; Lena et al., 2005), and, conversely, REM deprivation also elevates dopamine levels 
(Proenca et al., 2014), which in turn induces subsequent REM (M. M. Lima, Andersen, et al., 
2008).  
In Chapter IV I found that nocturnal L-DOPA plays a role in memory selection.  Evidence from 
the literature suggests that REM-related dopaminergic activity may provide a physiological basis 
for this. During REM, dopamine in the ventral tegmentum and nucleus accumbens is increased, 
mimicking the response to novelty and reward during wakefulness (Bunzeck & Duzel, 2006; 





Dahan et al., 2007; Lena et al., 2005; Maloney, Mainville, & Jones, 2002; Wittmann et al., 2007) 
which suggests that similar processes may be occurring during REM and during learning from 
novelty and reward.  Moreover, there is a direct link between REM and memory: reduced REM 
is associated with a subsequent reduction in long term potentiation and memory (Proenca et al., 
2014; Ravassard et al., 2009). Both non-REM and REM benefit memory in humans in humans 
(Schapiro et al., 2017; Siegel, 2001; M. P. Walker & Stickgold, 2004).  
Non-REM sleep is also implicated in memory processes. At and after learning, memory engrams 
can become tagged as salient based on contextual information (Kaminski et al., 2018; R. G. M. 
Morris, 2006; Pu & Yu, 2019; Redondo & Morris, 2011). Thereafter, particularly while asleep, 
newly acquired memories are strengthened for long term storage by spontaneous repetition 
(Molle et al., 2006; Stickgold, 2005; van de Ven et al., 2016; M. Y. Yang et al., 2019). Patterns of 
activation of neuronal assemblies at encoding are selectively replayed during slow wave sleep 
spindles (Peyrache, Khamassi, Benchenane, Wiener, & Battaglia, 2009). The likelihood of replay 
is increased for salient information (Singer & Frank, 2009). Spindles during slow wave sleep are 
thought to provide an accessible electrophysiological marker that relates to memory storage 
during sleep (Cairney et al., 2018; Dehnavi et al., 2019). This raises the question: 
neurotransmitters might play a role in these slow wave sleep and memory over night?  
Models of memory based on drosophila point to dual effects of dopamine – dopamine enhances 
encoding of new information at the cost of triggering forgetting of competing information 
(Berry et al., 2012; Berry et al., 2018). This dopamine-induced strategic forgetting is selective to 
weakly encoded memories: during sleep, dopamine increases strategic forgetting of non-salient 
information but spares important memories. Our behavioural findings in Chapter III align well 
with the drosophila literature.   





The increased tagging effect I found ON L-DOPA may be caused by enhanced or spared 
consolidation of saliently tagged information during REM and slow wave sleep, combined with 
forgetting which could be caused by L-DOPA potentially affecting memory-related events 
during slow wave sleep. With the tagging effect, I refer to the relative benefit in persistence for 
salient over non-salient information. The aim of this chapter is to examine the relationship 
between L-DOPA and sleep, and how they may interplay in contributing to memory persistence. 
First, I aimed to test if different sleep stages are disparately modulated by L-DOPA. I 
hypothesised that following administration of nocturnal L-DOPA, compared to placebo, (H1) 
REM duration will increase and (H2) slow wave sleep duration will decrease. Second, utilising 
data reported in Chapter IV, I explored the relationship between different sleep stages and 
spindle characteristics and memory. I hypothesised that (H3) slow wave sleep duration and (H4) 
spindle characteristics will be correlated with better memory both on L-DOPA and placebo. I 
also explored if any L-DOPA mediated changes in spindles will be correlated with the L-DOPA 
mediated increase in the tagging effect.   
Method 
The materials and data used in this chapter were collected as a part of the DOPAMIND study. 
The method is comprehensively reported in Chapter II (pg. 77). A short reiteration of is given 
here. 





Design and procedure 
In this double-blind placebo-controlled study, elderly participants completed two study nights: 
one with L-DOPA and one with placebo administration, in a random order (Figure 36). 
 
Materials 




Figure 36: DOPAMIND study visit timeline 
 
Volunteers learnt a memory task and received either 200mg L-DOPA or placebo (depending on visit), prior 
to having sleep recorded. The orange square denotes time when L-DOPA was active in the system. 
 
 





In the morning after the polysomnography, participants filled questionnaires, two of which are 
reported in this chapter: The St Mary’s Hospital Sleep Questionnaire (SMHSQ) (Ellis et al., 
1981) and the Leeds Sleep Evaluation Questionnaire (LSEQ). The SMHSQ gives six scores: 
1. Sleep efficiency: Proportion of time in bed spent asleep as a percentage 
2. Sleep onset latency: Time between settling down for the night and falling asleep 
3. Sleep latency: Overall time spent asleep 
4. Sleep maintenance: Number of times awoken at night 
5. Wakefulness after sleep onset: Sleep fragmentation, reported as minutes awake 
between falling asleep and finally waking up. 
6. Sleep satisfaction: As a percentage where 100% is extremely satisfied. 
This questionnaire has been shown to have good test/re-test reliability in patients cohorts and 
healthy volunteers (Ellis et al., 1981). In the LSEQ, participants rate previous night’s sleep 
compared to usual on questions relating to four sub-scales: getting to sleep (GTS), quality of 
sleep (QOS), ease of awakening from sleep (AFS), and early morning behaviour following 
wakefulness (BFW). Scores below 5 indicate worse and scores above 5 improved sleep and 
alertness compared to usual. The LSEQ is sensitive to changes induced by pharmacological 
agents (Parrott & Hindmarch, 1980). 
 
Analyses 
The first level analyses are outlined on page 114. In short, sleep stages were determined 
manually using standard criteria to extract the duration of each sleep stage (awake, stage 1, stage 
2, slow wave sleep and REM).  
Using the trace from the Cz channel only, spindle characteristics (amplitude, mean duration, 
frequency and density) were extracted for stages 2 and slow wave. 





Effect of L-DOPA on sleep architecture: To determine the effect of dopamine on sleep 
architecture, I performed pairwise comparisons between the L-DOPA and placebo nights. L-
DOPA mediated change was calculated as the paired difference between L-DOPA and placebo 
conditions such that positive scores indicate a relative benefit or increase on the drug. 
Effect of sleep on memory: To assess the effect of L-DOPA mediated differences in the 
relation between sleep and memory, I performed a mixed linear model together with 
correlational analyses on L-DOPA mediated changes on sleep architecture and memory.  
Results 
Participants 
Thirty-five volunteers were tested (Table 11, page 142). An outline of missing data is given here.  
Behavioural data: Data was entirely missing for the St Mary’s Hospital Sleep Questionnaire 
(SMHSQ) for two volunteers following the L-DOPA and one volunteer following the placebo 
night (nSMHSQ = 32). One volunteer on placebo, and two on L-DOPA, had omitted answers on 
the SMHSQ, so their sleep satisfaction score (SSS) could not be determined (nSSS=29). These 
questionnaires were otherwise scored. The wakefulness after sleep onset (WASO) score was 
calculated as the difference between self-reported sleep onset time and final wake up time, and 
self-reported sleep latency. Some volunteers reported less time between sleep onset and waking 
than spent asleep. For these nights, wakefulness after sleep onset was changed to 0 minutes to 
avoid negative values. There was no missing data for the Leeds Sleep Evaluation Questionnaire.  





Polysomnography: Data was partially or entirely missing for five volunteers: two due to 
technical errors at recording, neither of the nights were scored for them (nPSG = 33), and a 
further 3 could not be reliably analysed on the automated spindle detection tools (nPSGSPIN= 30).  
 
Sleep questionnaires 
There were no differences in between L-DOPA and placebo nights in subjective measures 
(Table 17). Sleep onset latency was an average ~ 10min shorter on L-DOPA but this tendency 
was not significant. Overall, volunteers reported worse sleep than usual (all LSEQ subscale mean 
scores <5) for both visits – but there was no effect of treatment. 
 
L-DOPA and sleep architecture 
Sleep stages: Sleep architecture on L-DOPA and on placebo followed a typical pattern where 
stages 2 and slow wave sleep were the most prominent across the nights (Figure 37A), with slow 
wave sleep typically dominating the first half of the night, and REM dominating in the latter half. 
L-DOPA increased slow wave sleep duration by an average of 11% (Figure 37B, Figure 38A). 
This effect was significant following Benjamini-Hochberg false discovery rate correction (pcorrected 
= .044), where sleep stages (stages 1, 2, slow wave, and REM) were included. L-DOPA did not 
modulate the duration of stages 1 or 2, total sleep time or wakefulness (BF01>3), while evidence 
against L-DOPA affecting REM duration was anecdotal (Table 18).   












 t p BF01  H0 
vs 
H1 L-DOPA Placebo  df = 31 
 
St Mary’s Hospital Sleep Questionnaire 
   
 




( 15.6 ) 
77.0 
( 22.9 ) 
[ - .378 – .275 ]  163* .156 5.1 
  




( 20.7 ) 
27.4 
( 31.6 ) 
[ - .641 – .045 ]  61.0* .060 1.2 
  




( 84.2 ) 
384.5 
( 95.1 ) 






( 1.3 ) 
2.8 
( 1.2 ) 






( 19.4 ) 
67.5 
( 15.4 ) 





( 38.7 ) 
27.8 
( 40.7 ) 











( .86 ) 
4.3 
( .96 ) 






( 1.7 ) 
3.9 
( .1.2 ) 






( 1.8 ) 
3.7 
( 1.8) 






( 1.6 ) 
4.9 
( 4.9 ) 








( 1.6 ) 
4.9 
( 1.4) 
[ - .432 – .221 ]  282.5 .600 4.8 
 
 
Table 17: Sleep: Self-evaluation  
 
We found no differences in self-reported measures of sleep quality. δ denotes effect size for the paired differences 
derived from the Bayesian posterior distribution. BF01 and H0 vs H1 show the probability of our data having been 
observed under the null (white) as opposed to the alternative (blue) hypothesis. All p-values are uncorrected. All 
errors <.06.  
GTS = getting to sleep, QOS = quality of sleep, AFS =  awakening from sleep, BFW =behaviour following 
waking.  
*Wilcoxon’s test; ** df = 28 
 















 t p 
p-corrected 








( 60.4 ) 
358.0 
( 53.8 ) 








( 46.6 ) 
110.5 
( 50.9 ) 





 Stage 1 
 
20.0 
( 8.4 ) 
21.9 
( 8.8 ) 





 Stage 2 
 
140.9 
( 51.1 ) 
140.6 
( 58.2 ) 








( 54.0 ) 
120.0 
( 51.3 ) 





 REM 70.0 
( 24.7 ) 
75.5 
( 25.1 ) 





Table 18:  Sleep: Sleep stages   
 
L-DOPA increased time spent in slow wave sleep, but it did not affect light sleep (stages 1 and 2), wakefulness, REM 
or total time spent asleep. δ denotes effect size for the paired differences derived from the Bayesian posterior 
distribution. BF01 and H0 vs H1 show the probability of our data having been observed under the null (white) as 
opposed to the alternative (black) hypothesis.  
SWS = slow wave sleep; REM = Rapid Eye Movement  
* Wilcoxon test used due to non-parametric data; ** BF10 = 4.0 
False discovery rate adjustment was performed using each sleep stage (ntests = 4) and corrected p-values were 
determined using the Benjamini-Hochberg procedure. 
 









Figure 37: Sleep stage durations  
 
Durations of different sleep stages across placebo (left) and L-DOPA (right) nights.  
L-DOPA mediated pairwise changes showed that slow wave sleep duration was increased on L-DOPA. The 
light blue line denotes no change (change = 0); datapoints to the left had shorter and to the right longer 
durations on L-DOPA  
A B 






Figure 38: L-DOPA and slow wave architecture  
 
L-DOPA mediated effects on slow wave sleep duration and spindle amplitude L-DOPA increased slow 
wave sleep duration (A) and spindle amplitude (B).  
 
Panel B: When accounting for the paired nature of the data and the non-normal distribution in the change 
– as is done by the rank test that is reported in Table 14 – the difference is clear: the change in spindle 
amplitude is observed in 25 our of 31 individuals but the mean is distorted by a single outlier. However, 
there is no difference in means in spindle amplitude between the two conditions.   
 
Sleep spindles: Spindles during both slow wave sleep and stage 2 have been associated with 
memory (Dehnavi et al., 2019; Sirota et al., 2003), but I did not find evidence to suggest that L-
DOPA affects stage 2 spindles in the pairwise comparisons Spindle characteristics were analysed 
for spindles occurring during stage 2 and slow wave sleep separately.  
During slow wave sleep, spindle amplitude was increased on L-DOPA compared to placebo 
(Figure 38B, Table 19). This effect remained following false discovery rate correction including 
density, amplitude, frequency and duration (pcorrected = .008). L-DOPA also mediated spindle 
amplitude change during stage 2, but this effect did not survive multiple comparison correction 
(pcorrected = .060). Given the consistent trend with the spindle amplitude change in slow wave 
sleep, the lack of effect may reflect inadequate power. 












 t p 
p-corrected 
BF01  H0 
vs 
H1 L-DOPA Placebo  df = 30 
Slow wave sleep spindles 





( 265 ) 
641.0 
(284 ) 
[ - .168 – .512 ]  1.03 .312 3.2 
 
 
 Density  
 
5.7 
( 2.2 ) 
5.8 
( 2.5 ) 
[ - .353 – .313 ]  249* .992 5.2 
  
 Amplitude (μA) 
 
28.9 
( 8.3 ) 
28.2 
( 8.5 ) 




 Frequency (Hz) 
 
13.6 
( .26 ) 
13.6 
( .26 ) 
[ - .422 – .242 ]  197* .327 4.6 
  
 Duration (sec) .93 
( .05 ) 
.94 
( .06 ) 
[ - .632 – .049 ]  -1.76 .088 1.3 
  






( 301 ) 
475 
( 269) 
[ - .500 – .174 ]  -1.02 .317 3.3 
  
 Density  
 
.94 
( .06 ) 
.95 
( .06 ) 
[ - .531 – .152 ]  -1.15 .260 2.9 
  
 Amplitude (μA) 
 
29.5 
( 8.2 ) 
29.0 
( 8.7) 





 Frequency (Hz) 
 
13.6 
( .24 ) 
13.6 
( .26 ) 
[ - .376 – .287 ]  -.287 .776 5.0 
 
 
 Duration (sec) 4.8 
( 1.6 ) 
4.9 
( 1.4) 
[ - .545 – .132 ]  -1.25 .221 2.6 
 
 
Table 19:  Sleep:  Spindle characteristics 
L-DOPA increased spindle amplitude.  δ denotes effect size for the paired differences derived from the Bayesian 
posterior distribution. BF01 and H0 vs H1 show the probability of our data having been observed under the null 
(white) as opposed to the alternative (blue) hypothesis. All p-values are uncorrected. All errors <.04.  
Note that the slow wave sleep amplitude effect survived multiple comparisons.  
*Wilcoxon; **BF10 = 3.6; ***BF10 = 3.2 
False discovery rate adjustment was performed using each spindle characteristic (ntests = 5) and corrected p-values 
were determined using the Benjamini-Hochberg procedure. 
 





L-DOPA, sleep and memory 
To study the effect of L-DOPA on memory, I concentrated on Day 1 D’ (which is a measure of 
accuracy) as this is where the largest L-DOPA mediated effects were found (Chapter IV). The 
focus was on the relationship between memory and slow wave duration and slow wave spindle 
amplitude. 
Sleep stage durations: To assess the relation between sleep stage duration and memory, I 
conducted a series of Spearman’s correlations between stage 2, slow wave sleep and REM 
durations against memory for tagged and non-tagged items (Figure 39, Table 20). 
Complementing the findings from the mixed linear models, slow wave sleep duration was 
associated with memory performance for the salient items only. When L-DOPA was given this 
effect disappeared (z =1.99 p = .046), as tested using a Pearson’s r-to-z transform. 
Spindles: Our main interest was on the L-DOPA mediated change in spindle amplitude during 
stage 2 and slow wave sleep against memory performance. While all memory scores (D’ for 
tagged, untagged and tagging effect) and stage 2 spindle amplitude followed a normal 
distribution, slow wave spindle amplitude had high kurtosis (>2). The L-DOPA mediated 
spindle amplitude change was associated with the L-DOPA mediated change in the tagging 
effect during slow wave sleep (Figure 40)– but not during Stage 2 (Table 21). This effect also 
survived false discovery rate adjustments (pcorrected = .045), adjusting for all comparisons between 
slow wave sleep duration and memory.  
  










Figure 39: Memory and sleep stage durations 
 
Slow wave sleep duration was associated with memory for the re-exposed / strongly encoded items on 
placebo. However, this relationship disappeared when L-DOPA was given. No other relationships between 
memory and sleep duration were observed.  
Note that all relationships were assessed using Spearman’s rank correlations and the fitted lines are for 
illustration only. The only correlation that was found was between slow wave sleep duration and memory 
for the tagged items. The relationship between slow wave sleep duration and tagged information was wiped 
out on L-DOPA (z =1.99 p = .046). 
REM = rapid eye movement; SWS = slow wave sleep.   
 
  L-DOPA  Placebo 





  Non-tagged (D’) 
Sleep stage (min) ρ p  ρ p 
 Stage 2 .005 .980 -.260 .150  
 REM .008 .970  -.036 .840  
 Slow wave sleep .065 .720  .320 .071 
   
  Tagged (D’)  
ρ p   ρ p 
p-corrected 
 Stage 2 -.041 .820  -.360 .040 
.120 
 REM .026 .890   -.200 .250  
 Slow wave sleep .043 .810   .450 .009 
.054 
Table 20: Sleep: Sleep stage duration and memory correlations 
 
Slow wave sleep and memory for the tagged items were correlated on placebo but not on L-DOPA. 
Corrected p-values shown in purple were obtained using the Benjamini-Hochberg procedure and 
including each analysis in the bottom portion of this table. The top portion was not corrected for as 
there were no statistically significant observations.  
  
  
Figure 40: L-DOPA, the tagging effect and spindle amplitude  
 
L-DOPA mediated change in the tagging effect against spindle amplitude The light blue line denotes no 
difference on L-DOPA. Negative values were lower on L-DOPA than on placebo. Both tagging and spindle 
amplitude increased on L-DOPA, and these two increases were associated with one another. Note that a 
Spearman’s rank correlation was used to analyse these data and the line is fitted only for illustration 
purposes. Correlations between spindle amplitude and re-exposed and other items (not change) are shown 
in Table 17. 
 
 





In post-hoc analyses, I also looked at the relationship between spindle density (number of 
spindles per minute), duration and frequency against the three different memory scores (tagged, 
untagged and tagging effect). The complete analyses are reported in Appendix M. In short, I 
found no relationship between L-DOPA mediated changes in density, duration or frequency of 
spindles in either stage 2 or slow wave sleep and memory measures (tagged, untagged or tagging 
effect for D’).  
Inclusion of stage 1: I did not account for the relation between stage 1 sleep and memory for 
various reasons:  
1. Stage 1 sleep duration is short and there is little variability in this stage 
2. No spindles take place during stage 1 
3. There were no L-DOPA mediated changes in the duration  




  Tagged (D’)  Non-tagged 
(D’) 
 Tagging effect 
Spindle 
amplitude (μA) 









 Stage 2 .270 .142  .006 .973  .230 .195  
 Slow wave sleep .312 .088  -.231 .211  .438 .015 
.045 
Table 21:  Sleep: L-DOPA mediated changes and memory 
 
Corrected p-values shown in purple were obtained correcting for each Slow wave sleep 
analysis reported  in this table (n tests  = 3) using the Benjamini-Hochberg procedure 






I found several interesting L-DOPA mediated effects on sleep characteristics and their 
relationships with memory. First, in this sample, L-DOPA increased slow wave sleep duration 
and slow wave spindle amplitude. Second, slow wave sleep duration was associated with memory 
performance for salient information, but the relationship was lost on L-DOPA nights. Third, L-
DOPA mediated changes in spindle amplitude were associated with the L-DOPA-induced 
increase in the tagging effect.  
 
L-DOPA and sleep 
I hypothesised that L-DOPA would increase REM and decrease slow wave sleep duration. 
Instead, L-DOPA increased slow wave and had no effect on REM duration in an elderly sample. 
This preliminary finding is interesting because advanced age reduces slow wave sleep and 
disrupts sleep (Redline et al., 2004). Multiple protective and adaptive processes take place during 
sleep, many of which are associated with deep sleep (L. Xie et al., 2013). 
One of these restorative actions is the flushing of the β-amyloid peptide out of the central 
nervous system into the cerebrospinal fluid flow (CSF) (Y. E. Ju et al., 2017). During the day, 
levels of central β-amyloid increase. In turn, at night – particularly during slow wave sleep – the 
levels are decreased. β-amyloid becomes pathological when the homeostasis of clearance is 
disrupted (H. A. Pearson & Peers, 2006). In old age, both slow wave sleep and the nocturnal β-
amyloid clearance are reduced (Y. F. Huang et al., 2012). When these peptides are not sufficiently 
cleared, they accumulate in the extra cellular space, disrupting the chat between neurons and 





eventually causing cellular death (Benilova, Karran, & De Strooper, 2012; Murphy & LeVine, 
2010; Selkoe & Hardy, 2016). 
To complete the vicious cycle, plaques of accumulated β-amyloid disrupt hippocampal memory 
consolidation by reducing slow wave sleep (Mander et al., 2015). As the β-amyloid load increases, 
the restorative benefit of sleep decreases (Bateman, Wen, Morris, & Holtzman, 2007). Human 
PET imaging has shown that even a single night of sleep deprivation increases β-amyloid in the 
hippocampus and thalamus (Shokri-Kojori et al., 2018). In healthy elderly, chronic poor sleep is 
associated with reduced CSF β-amyloid (Sprecher et al., 2017), and with increased cortical 
amyloid burden (Sprecher et al., 2015). Reduced CSF β-amyloid is a marker of poorer amyloid 
clearance and increased central build-up.   
It is not clear whether poor sleep causes for β-amyloid to accumulate, if β-amyloid causes poor 
sleep, or if both are influenced by some other age-related or pathological process. However, 
more recent evidence shows that specifically disrupting slow wave sleep increases amyloid 
burden (Y.-E. S. Ju et al., 2017). In one study (Y.-E. S. Ju et al., 2017), CSF β-amyloid samples 
were taken from healthy adults in the morning after a sleep of targeted slow wave activity 
disruption or a sham. Participants whose slow wave activity had been disrupted specifically 
showed a reduction in CSF β-amyloid – this effect could not be seen following sham sleep 
disturbance. This evidence strongly indicate that not only does sleep have a causal role in 
increasing amyloid burden – at least transiently – this effect is also specific to processes that take 
place, at least predominately, during slow wave sleep.  
Accumulation of cortical β-amyloid is a key marker of Alzheimer’s disease pathology (Selkoe & 
Hardy, 2016). Impaired sleep increases risk and severity of Alzheimer’s disease, likely by 
disrupting β-amyloid clearance (Lucey & Bateman, 2014). This suggests that pharmacological 
agents targeting slow wave sleep to enhance cognition may be most useful in healthy elderly or 





those at risk of developing memory impairment. Here, I showed that L-DOPA increases slow 
wave sleep – the stage of sleep most important in clearing β-amyloid. The benefit of L-DOPA in 
reducing amyloid load remains to be seen, however.  
Few studies have attempted to disentangle the effect of dopamine-medication on sleep in healthy 
individuals. In contrast to our findings, in young healthy men, a single dose of the D2 agonist 
pramipexole delivered nocturnally reduces slow wave sleep and REM, and increased Stage 1-2 
durations, without affecting total sleep time (Feld et al., 2014). In other words, deep sleep and 
REM decreased while participants spent more time in light sleep. Others have shown that in 
healthy young adults, the D2 agonist ropinirole reduces sleep onset time (Ferreira et al., 2002) 
and pramipexole increases daytime somnolence at 3.5h and 5.5h delays from administration 
(Micallef et al., 2009), suggesting that D2 agonists may promote sleep.  
While there were no significant differences in the sleep questionnaire measures, sleep onset 
latency was on average reported to be shorter on the L-DOPA night. This coupled with the 
increase in slow wave sleep suggests that L-DOPA at this dose promoted somnolence. On the 
Leeds Sleep Evaluation Questionnaire, participants tended to report worse-than-usual sleep 
across visits. This finding was not surprising, as participants were sleeping in an unfamiliar 
hospital environment with electrodes attached to their scalps. 
L-DOPA also increased slow wave sleep spindle amplitude. Spindle amplitude is shaped by the 
interplay between the thalamus and the cortex (Contreras, Destexhe, Sejnowski, & Steriade, 
1997) and increased spindle amplitude is associated with a wider topographical expression of 
spindles (Nir et al., 2011). Measuring spindles by amplitude has been shown to have better test-
retest reliability than spindle density (Cox, Schapiro, Manoach, & Stickgold, 2017). In a sample of 
over 11 000 individuals, spindle amplitude was shown to be stable across individuals overall, but 
to also decline with age (Purcell et al., 2017). Spindle amplitude in this study was more closely 





linked to sigma power than other spindle characteristics. Sigma power is often referred to as a 
sleep “fingerprint” because it is highly stable within individuals (De Gennaro, Ferrara, Vecchio, 
Curcio, & Bertini, 2005).  
Spindle amplitude also correlates positively with subsequent memory (Mednick et al., 2013). 
Therefore, spindle amplitude is a useful metric likely to convey information about how multiple 
brain regions are working synchronously to forget irrelevant and retain important memories. 
 
L-DOPA, sleep and memory 
I hypothesised that slow wave sleep duration will be positively correlated with memory both on 
L-DOPA and placebo. Instead, I found a relationship between slow wave sleep duration and 
memory only for saliently tagged information, but this effect disappeared with L-DOPA. There 
was no relationship between slow wave sleep duration and memory for non-tagged items in 
either conditions.  
Spindles during slow wave sleep are indirectly associated with hippocampal replay, the 
anatomical underpinning for memory storage (Molle et al., 2006; M. Y. Yang et al., 2019). 
Different spindle characteristics, such as amplitude, are associated with enhanced memory 
persistence (Mednick et al., 2013). It may not be possible or worthwhile to replay all memories 
during sleep. 
Instead, memories are selectively replayed causing selective memory retention (Blaskovich, 
Szollosi, Gombos, Racsmany, & Simor, 2017). 
L-DOPA-mediated change in slow wave sleep spindle amplitude was associated with the tagging 
effect. In Chapter IV I showed that both on dopamine and placebo, information tagged as 
salient was better retained than non-salient information, and that this difference was enhanced by 





dopamine. I proposed that this is due to dopamine increasing both wakeful reactivation – that 
acts as a fast route for online consolidation (Antony et al., 2017) –  and salient information being 
preferentially consolidated during sleep (Oudiette et al., 2013). The relationship between spindle 
amplitude change and the tagging effect suggest that dopamine may mediate this effect 
overnight. Dopamine has been shown to play a role in both of these processes: first by 
enhancing learning and then by actively accelerating forgetting during sleep (Berry et al., 2015; 
Berry et al., 2012).  
While sleep spindles during slow wave sleep are well linked to memory, this study is the first to 
illuminate the behavioural relevance of spindle characteristics and their relationship to dopamine. 
The magnitude of the difference between the effect of dopamine on memory performance for 
salient and non-salient information was associated with an increase in spindle amplitude.  
There are two possible explanations for this. First, dopamine generally enhances spindle 
amplitude which in turn enhances the way in which memory is biased in favour of salient 
information. Second, tagging before sleep alters spindle amplitude to reflect the changes that 
have taken place during tagging.  
Learning alone is sufficient to change both sleep architecture and spindle characteristics. For 
example, in after intense motor memory training, both stage 2 duration and spindle density have 
been reported to increase (S. M. Fogel & Smith, 2006). These changes have also been shown to 
be associated with theta coherence during learning (S. M. Fogel, Smith, & Beninger, 2009). 
Therefore, it is plausible that dopamine during repeat exposure to the stimuli “tagged” or 
earmarked the word-list to be preferentially repeated in sleep. Therefore, the spindle amplitude 
change may be a secondary effect to dopamine’s effects during wakeful re-learning.  
Spindle amplitude has also been associated with enhanced memory retention in a motivated 
forgetting task (Blaskovich et al., 2017) and a tagging paradigm involving re-test (Heib et al., 





2015) suggesting that spindle amplitude may be associated with selecting memories for later 
retention. During tagging by re-test, theta coherence – which is associated with enhanced 
encoding – is increased. The change in theta coherence during the memory, compared to a 
control, task predicted increased spindle amplitude and subsequent memory (Heib et al., 2015). 
Therefore, learning can not only influence later spindle density but also amplitude of spindles.  
In line with this it is possible that dopamine during tagging enhanced encoding-or-retrieval-
related theta activity which triggered changes in sleep architecture and subsequent memory. In 
the absence of EEG recordings from the tagging phase, I cannot ascertain if dopamine enhanced 
theta. It is possible that here, I manipulated processes during learning that then had a subsequent 
effect on sleep. The data presented in this thesis is not sufficient in disentangling whether 
dopamine is directly influencing learning, sleep, or both. 
In humans, evidence that behaviourally salient information benefits from sleep is abundant (Hu, 
Stylos-Allan, & Walker, 2006; Oudiette et al., 2013; Rauchs et al., 2011; Saletin, Goldstein, & 
Walker, 2011; Sterpenich et al., 2009; Wilhelm et al., 2011). While there are fewer studies 
examining the role of dopamine in slow wave sleep, rewarded information is preferentially 
replayed during this slow wave sleep but not during REM (Lansink, Goltstein, Lankelma, 
McNaughton, & Pennartz, 2009; Pennartz et al., 2004). Salient memories are also preferentially 
consolidated by replay (Fischer & Born, 2009).  
This suggests that either dopamine plays a role in slow wave sleep regulation or that dopamine 
during learning tags memories, and these tags are utilised later in a process that no longer 
requires dopamine release. It is unlikely that tagging of 20 words would have influenced slow 
wave sleep with an average 11% increase.  






Dose may introduce a biphasic effect of dopamine on sleep. Smaller doses of central D2 agonists 
apomorphine or bromocriptine are associated with increased REM and slow wave sleep in rats, 
while larger doses have the opposite effect. The D2 agonist pergolide also has a biphasic effect 
on slow wave sleep and wakefulness but it inhibits REM at all given doses (Monti, Hawkins, 
Jantos, Dangelo, et al., 1988; Monti et al., 1989). A word of caution is required when interpreting 
rodent studies. Rodent sleep is ultradian rather than circadian in nature. Differences in human 
and rodent sleep/wake cycle regulation are likely. Sleep disturbances in human Parkinson’s 
disease typically precede disease onset, often by decades (Videnovic & Golombek, 2013). This 
suggests that either too much or too little dopamine can have a detrimental effect on sleep 
integrity, which may affect cognition and memory.  
The disparate findings may be explained by dose-dependent effects, differences in tasks and 
study paradigms. 
Limitations and future directions 
Age-related changes in sleep architecture are well reported. Ageing decreases the duration of 
deep sleep, and the number and amplitude of spindles (Nicolas, Petit, Rompre, & Montplaisir, 
2001) – with some reporting a nearly 50% reduction in spindle amplitude with advanced age 
(Crowley, Trinder, Kim, Carrington, & Colrain, 2002). The reasons for age-related decrease in 
spindle amplitude is not fully known. Whatever the cause, enhancement of slow wave sleep 
duration or architecture could yield clinical benefits. 
Our current findings may have implications for prevention of Alzheimer’s disease and other age-
related diseases affecting sleep. However, the potential of L-DOPA in augmenting disease 
progression in neurodegenerative diseases affecting sleep and memory needs to be further 
assessed in longitudinal clinical trials in at-risk individuals. Slow wave sleep is reduced through 





ageing and may be affected early in Alzheimer’s Disease (Matthew P. Walker, 2009). Interrupting 
slow wave sleep is proposed to hinder clearance of β-amyloid from the brain and β-amyloid 
plaques are one of the pathological changes in Alzheimer’s Disease (Y.-E. S. Ju et al., 2017; L. 
Xie et al., 2013). Through increasing slow wave sleep duration and spindle amplitude with 
nocturnal dopamine, I open up a new therapeutic avenue for Alzheimer’s disease prevention – 
repurposing L-DOPA to prevent Alzheimer’s. Future clinical trials with longer term 
interventions in healthy elderly and those at risk are needed to ascertain any potential clinical 
benefit of L-DOPA on amyloid clearance.  
It is not clear whether the association between L-DOPA mediated increase in spindle amplitude 
and the tagging effect is mediated by dopamine’s influence on tagging, sleep, or both. Future 
studies are needed to ascertain L-DOPAs effects on tagging by recording EEG during tagging 
and encoding, and by manipulating L-DOPA timing to target tagging.  
It is possible that sleep-mediated effects other than L-DOPA affected performance here. 
Participants were sleeping in an environment that was novel to them and several participants 
reported that their sleep was worse than usual during the study nights. It is likely that this would 
have had an impact on memory related processes, particularly on the first night.  
This could have been counteracted somewhat by introducing an acclimatisation night. It could 
be argued that an added acclimatisation night would have made this study more robust by 
making sleep more naturalistic. However, the participants were already asked to spend two nights 
in a hospital to take part and it is not clear if the benefit of including an acclimatisation night 
would have outweighed the cost on participants and the research budget.   
Furthermore, in this trial, treatment order was counterbalanced and randomised: half of the 
participants received L-DOPA and half received placebo on their first visit. While not including 
an acclimatisation night likely reduced sleep quality during study visits, the effect would have 





been similar on L-DOPA and placebo conditions. Therefore, it is unlikely the dopamine-induced 
changes on sleep physiology and memory can be explained by these other sleep-mediated effects 
on memory. 
Furthermore, while unlikely, it is possible that discrepancies in sleep scoring affected some my 
findings in this chapter. Manual sleep staging requires intimate knowledge of sleep physiology 
but even with expert raters using the AASM scoring system, the inter-rater agreeability is only 
around 80% (Danker-Hopfe et al., 2009). Here, manual scoring was performed first by two 
raters (Will Carr and Oliver Radtke), neither of whom are experts. Then, I manually quality-
controlled 10% of nights rated by each rater by visual inspection. Even when precautions are 
taken, there is a large margin of error in both inter- and intra-rater reliability. 
Furthermore, each participant was rated by the same person in batches. In other words, each 
individual participants’ L-DOPA and placebo nights were rated together in one go. While this 
approach makes rating easier – as the rater’s eye will adapt to the participant’s individual sleep 
“fingerprint” – this also introduces possible bias. As L-DOPA altered sleep architecture and 
characteristics, it is possible that the raters were trying to guess which treatment was allocated to 
which night.  
Reflecting to earlier Chapters 
Taking these findings together with the findings from Chapters III and IV, suggest that 
dopamine’s effect on memory may be reliant on sleep. In Chapter III I did not find reduced 
memory for the encoding condition a day after learning. Therefore, the finding that L-DOPA 
accelerated forgetting during sleep is unlikely to have been driven by dopamine during the 
tagging phase in that experiment. In Chapter III (DARet), I tested a proportion of the items 
following learning, proposedly tagging those items as relevant. While these items were not re-
tested in the DARet study, had the ‘tagging’ phase biased accelerated forgetting in the 





DOPAMIND study, I would expect to see poorer memory for the tested items on Day 1 in the 
encoding experiment. Instead, I saw no effect of L-DOPA. 
However, I did not have a control experiment in which the setting would have been the same 
except for the involvement of sleep. This question could be addressed using a different 
experimental setup in which participants receive L-DOPA both during a 90-minute nap and 
during an equal amount of time spent awake. If dopamine’s memory modulating effects are 
specific to sleep, one would expect to see L-DOPA-driven changes in consolidation and/or 
forgetting processes in the nap condition but not in the awake condition.  
Conclusion 
Together, our findings suggest that saliency-tagging increases the likelihood that an item is 
remembered. Dopamine during tagging further increases this effect. During subsequent sleep, 
dopamine increases both the duration of slow wave sleep and the coherence of thalamocortical 
communication and causes more synchronous cortical firing during spindles. I propose that this 
increase in coherence is associated with more selective hippocampal replay. However, to my 
awareness, this hypothesis is yet to be directly studied using direct recordings from the 










Chapter VI: Sleep, 
memory and the medial 
lobe 
Data reported in this chapter was collected as a part of the DOPAMIND study.  
Introduction 
During sleep, memories are processed through interactions between the medial temporal lobe 
structures and the cortex (Squire et al., 2015). In the absence of these structures, including the 
hippocampus, memories do not become consolidated (Scoville & Milner, 1957). There is a great 
deal of fluctuation in healthy brain morphology between individuals while longitudinal changes 
within participants are small and slow in comparison. Similarly, compared to the large variability 





between individuals in sleep electrophysiology (Tucker, Dinges, & Van Dongen, 2007; Werth, 
Achermann, Dijk, & Borbely, 1997), there is relatively little fluctuation in night-to-night sleep 
physiology within individuals (De Gennaro et al., 2005; Lewandowski, Rosipal, & Dorffner, 
2013). It is likely that interpersonal variations in sleep physiology are interlinked with the 
underlying brain anatomy.  
During sleep, structures of the medial temporal lobe play a role in supporting memory longevity 
(Cairney et al., 2018; M. Y. Yang et al., 2019). Long term memory persistence relies on efficient 
communication between brain structures that support encoding, consolidation, strategic 
forgetting, and retrieval. The medial temporal lobe in particular plays a key role in memory, with 
interconnected substructures having unique roles along the stages of the memory processing 
pathway. The medial temporal memory system includes of the hippocampus (comprised of 
subfields CA1, CA2, CA3, dentate gyrus and subiculum), and adjacent cortical regions including 
the entorhinal, perirhinal and parahippocampal cortices (Squire, 1992). A hallmark symptom of 
damage to these structures, particularly the hippocampus, is profound memory loss (i.e., 
amnesia). 
A classic case is patient H.M. (Scoville & Milner, 1957), whose hippocampi were removed 
bilaterally to treat severe epilepsy. His surgery led to a severe amnesia and almost complete 
inability to form long lasting memories (Squire, 2009). While short-term (immediate) memory 
was unaffected, this damage caused severe anterograde amnesia with little or no effect on 
cognition otherwise. Since, similar symptoms in patients with hippocampal damage have been 
described by others (Annese et al., 2014; Rempel-Clower, Zola, Squire, & Amaral, 1996; Zola-
Morgan, Squire, & Amaral, 1986). In rats with hippocampal lesions, immediate memory is intact 
while delayed memory is impaired (Clark, West, Zola, & Squire, 2001). Typically, hippocampal 
damage mediated memory impairment generalises across sensory modalities and affects 





declarative memory selectively (Squire, Stark, & Clark, 2004). Medial temporal lobe structures 
therefore play a key role in episodic memory persistence over long delays. 
Recognition memory tests can be used to assess memory persistence. Recognition memories are 
thought to be the outcome of two separable processes – recollection (remembering) and 
familiarity (knowing). The former refers to conscious recollection of the learning context, while 
familiarity refers to recognising information as familiar in the absence of recollection. These are 
thought to be analogous to episodic and semantic memories (Brown & Aggleton, 2001). For 
example, you may know that the capital of Finland is Helsinki in the absence of conscious 
recollection of having learnt this information. The type of information recognised is unimportant 
– rather what matters is whether a recollection of the learning context is present.  
Familiarity and recollection memories are thought to be supported by different medial temporal 
lobe structures. The perirhinal and lateral entorhinal cortices have been associated with the 
familiarity component of recognition memory, whereas the hippocampus is associated with the 
recollection component (Bird, 2017; Yonelinas et al., 1998). The hippocampus is intimately 
involved in binding together associations, such as learnt items and learning contexts. Meanwhile, 
the adjacent perirhinal and entorhinal cortices can recognise familiar items in the absence of 
recollections for associated information. Note that there is some controversy as to whether these 
two processes are truly separate and some argue that both familiarity and recollection require the 
hippocampus, e.g. (C. N. Smith, Wixted, & Squire, 2011; Wixted & Squire, 2010).  
Attempts to illuminate the role of medial temporal lobe structures in the different recognition 
memory processes have been made using structural MRI. In one study the total volume of the 
hippocampus and entorhinal cortex was not associated with recognition overall. Yet, 25% of age-
related changes in recollection memory could be explained by differences in total hippocampal 
volume (Schoemaker et al., 2017). This study did not isolate different substructures of the 





hippocampus, so it is not clear which age-related hippocampal volumetric changes are driving 
this finding. 
The hippocampus consists of several subfields with dissociable functions (de Wael et al., 2018; 
Dillon et al., 2017). Structurally, different domains of memory and cognitive ability are more 
strongly associated with individual subfield than total hippocampal function (Travis et al., 2014; 
Uribe et al., 2018). In fMRI, activity within the CA1 and CA2/CA3/dentate gyrus (as one 
subregion) was associated with processes that bind memories and contextual associations 
together (Dimsdale-Zucker, Ritchey, Ekstrom, Yonelinas, & Ranganath, 2018), suggesting that 
these subfields may support the recollection component. Yet, the role of individual hippocampal 
subfield volumes and integrity remains unclear. It is also not clear how age-related differences in 
the structure and integrity of hippocampus and its subfields contribute to those sleep-related 
events that support memory persistence.  
Only a handful of studies to date have examined the relationship between sleep and medial 
temporal lobe morphology in healthy human subjects. In children, self-reported overall sleep 
duration has been positively associated with total hippocampal volume (Taki et al., 2012). In 
healthy young adults sleep architecture was associated with anterior corpus callosum volume 
(Buchmann et al., 2011), while slow wave sleep amplitude has been associated with grey matter 
morphology (Reinhard et al., 2014; Saletin, van der Helm, & Walker, 2013). In healthy ageing, 
cortical thinning mediates the effect of age-related changes in spindle amplitude (Dube et al., 
2015) and in young adults hippocampal volume has been associated with memory-related spindle 
activity (Saletin et al., 2013). Decreased spindle amplitude likely reflects a reduction in cortical 
connectivity during sleep. While volumes of different subfields are associated disparately with 
different cognitive functions their involvement with sleep is not well established. 





Whereas earlier work has focused on hippocampus as a whole, more recent studies have focused 
on subfield-specific effects of sleep.  Medial temporal lobe structures are known to be associated 
with memory-related sleep events during both REM and slow wave sleep (Louie & Wilson, 2001; 
Rauchs et al., 2005; Stickgold, 2005; M. A. Wilson & McNaughton, 1994). Sharp wave ripples, 
which mediate memory, are seen primarily in the CA1 and CA3 regions. Temporally CA3-1 
ripples are preceded by CA2 activity, while during ripples CA2 activity is suppressed (Kay et al., 
2016). During wakefulness, entorhinal cortex primes CA2 enhancing likelihood of replay – while 
during sleep ripples are predominately triggered by activity in the CA3 (Oliva, Fernandez-Ruiz, 
Buzsaki, & Berenyi, 2016). In vitro, activity in the subiculum can also precede ripples (Norimoto, 
Matsumoto, Miyawaki, Matsuki, & Ikegaya, 2013). These regions are therefore likely to be 
associated with sleep spindles. The volume of CA2-CA3-dentate gyrus (grouped as one subfield) 
can also predict cognitive vulnerability in response to sleep deprivation in humans (Saletin et al., 
2016). Ultimately during sleep, CA1, CA2, CA3, the subiculum and the entorhinal are all 
associated with ripple and replay.  
The volumes of different hippocampal subfields can be studied using magnetic resonance. In 
addition to volumetry, T2 relaxometry can be used to assess subfield tissue integrity. The T2 time 
is influenced by the presence of different molecules in the tissue. Importantly, it is increased 
when with more water in the tissue. As an intuitive analogue, a bruised apple will have faster T2 
relaxation due to increased water content, yet the volume is unaffected by bruising. T2 relaxation 
times are sensitive to early stages of dementia pathology, and they can predict disease 
progression (Callaghan et al., 2014; Knight et al., 2019; Tang et al., 2018). Early neurobiological 
changes associated with age and pathology that are missed out by looking at the volumes alone 
can thus be detected with T2 relaxometry.  





The aim of this chapter is to examine the volumetry and relaxometry of the hippocampal 
subfields and the entorhinal cortex in relation to memory, sleep and the dopamine-induced 
effects on memory and sleep architecture. To that end, I hypothesised that;  
 Volumes and T2 relaxometry measures of hippocampal subfields and entorhinal cortex 
are correlated with recognition memory accuracy 
 Volumes and T2 relaxometry measures of CA1, CA3, dentate gyrus, and subiculum are 
correlated with recollection 
 Volume and T2 relaxometry measures of Entorhinal cortex are correlated with familiarity 
 CA1, CA2, CA3 and subiculum will be associated with sleep spindle densities 
 Subfield volumes will be associated with the L-DOPA mediated changes in memory and 
sleep characteristics. 
I also explored the relationship between sleep stage durations and spindle characteristics and 
volumetry and T2 relaxometry. 
Method 
The method is reported comprehensively in Chapter II. In short, volunteers took part in a 
double-blind randomised controlled trial where single doses of L-DOPA 200mg and placebo 
were given nocturnally in a random order. Polysomnographic recordings were obtained both 
from the L-DOPA and the placebo nights. Participants also completed memory tests as 
described on page 90. On one of the visits, a structural magnetic resonance scan was taken in 
order to assess hippocampal subfield volumes and relaxometry, as described on page 99. 






The first objective was to assess the relationship between medial temporal lobe subregional 
volumes and relaxometry. Volumes were measured in cubic millimetres and relaxometry was 
measured as the width of the intraregional T2 relaxation times (standard deviations). I ran a 
series of correlations between subfield volumes and relaxometry and accuracy, familiarity and 
recollection on days 1, 3, and 5 in the placebo condition. Next, I examined the relationship 
between sleep stage durations and spindle densities, and subfield volumes. I included time spent 
in Stages 2, slow wave and REM sleep in minutes – but not stage 1 – and I included spindle 
densities during stage 2 and slow wave sleep. Spindle densities were calculated as the average 
number of spindles per minute.  
Finally, I wanted to see if hippocampal subfield volumes were associated with the dopamine 
mediated changes in memory scores or sleep characteristics. To achieve this, I assessed the 
relationship between subfield volumes and L-DOPA-mediated changes in day 1 forgetting (D’ 
for non-tagged items), the tagging effect, slow wave sleep duration and spindle amplitude.  
Any findings were false discovery rate adjusted, considering all subfields, using the Benjamini-
Hochberg procedure.  
Note that the volumes used in this chapter are raw volumes and they were not corrected for 
intracranial or total brain volume.  






Participants and descriptive statistics  
Two of the 35 participants who completed the study could not have MRIs due to metal implants 
(nMRI = 33). Visual inspection of subfield segmentation confirmed that the algorithm performed 
well. Two scans could not be segmented to a good standard from initial scans – one due to 
movement and another due to poor scan alignment around the hippocampal /axis during 
scanning. These two volunteers were re-scanned 6 and 7 months after testing. All other 
volunteers were scanned between the screening visit and end of final sleep visit. All analyses in 
this chapter include 33 participants. For descriptive statistics see Table 11 on page 142, and 
Table 11, Figure 41.  
Distributions CA1, CA2, subiculum and the entorhinal cortex volumes were normally 
distributed. CA3 and dentate gyrus were not, so non-parametric tests were used. In the 
behavioural measures accuracy (D’) and recollection (remember-HITs) on Day 3 and recollection 
on Day 5 were not normally distributed. From sleep measures minutes in sleep stages (Stage 2, 
slow wave sleep and REM) were normally distributed. Spindle density during stage 2 and the L-
DOPA mediated effect on stage 3 spindle amplitude were both had high kurtosis. All T2 
relaxometry distributions (standard deviations) were considered non-normal.  
I note that volume distributions varied between subfields. I do not know the explanation for this, 
but possibilities include anatomical variability of the effects of age and disease on subfield 
volume or a technical anomaly (which we have done our best to eliminate). Exploring this could 
be the basis of future work. 





 Mean  (SD) Range 
Volumetry (mm3)  
 CA1 2241  (304) 1756 – 3099 
 CA2 31  (9) 13 – 52 
 CA3 122  (37) 77 – 231 
 Dentate gyrus 1560  (252) 1204 – 2620 
 Subiculum 699  (79) 569 – 880 
 Entorhinal cortex 888  (118) 651 – 1126 
 
T2 relaxometry (SD) 
 
 CA1 22.6  (2.1) 19.2 – 30.7 
 CA2 19.6  (3.2) 14.6 – 30.3 
 CA3 22.6  (2.9) 15.8 – 32.0 
 Dentate gyrus 22.2  (2.0) 19.7 – 29.3 
 Subiculum 25.1  (1.8) 21.2 – 29.8 
 Entorhinal cortex 23.9  (2.1) 21.0 – 29.1 
Table 22: MRI: Descriptives 
 
N = 33; CA1-3 = Cornu Ammonis SD = standard deviation 
 







Figure 41: Medial temporal lobes substructure volumes 
 
 
Medial temporal lobe structures and memory 
Correlations between subfield volumes and memory initially revealed a negative relationships 
between CA2 volume and day 1 memory both for non-tagged and tagged items (Lists A and B, 
Table 23, Figure 42). These correlations disappeared upon correcting for multiple comparisons 
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Table 23: MRI: Subfield volumes and memory. 
 
Correlation coefficients and p-values. Note that red-shaded associations did not survive false 
discovery rate correction. 
 
*Spearman’s test used 












Figure 42: Memory accuracy on Day 1 and CA2 volume 
 
The relationship for Day 1 accuracy plotted separately for tagged and non-tagged information. Note that 
neither of these relationships remained following false discovery rate correction.  
 
Medial temporal lobe and sleep 
Sleep stage durations: Correlations between subfield volumes and sleep revealed several 
relationships (Table 24). After correcting for false discovery rate, slow wave sleep duration was 
negatively associated with the CA2 (pcorrected = .040), the dentate gyrus (pcorrected = .004) and the 
entorhinal cortex (pcorrected = .040) volumes (Figure 43A). As both hippocampal subfields and 
sleep architecture can be affected by body size, I performed partial correlations controlling for 
body weight (kg). I found that controlling for body weight did not affect the results for slow 
wave sleep duration against CA2 (r = -44, p = .017), dentate gyrus (r = -.38, p = 0.44) or 
entorhinal cortex (r = -.37, p = .048) volumes. 
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Table 24: MRI: Subfield volumes and sleep 
 
Correlation coefficients and p-values. Note that red-shaded associations did not survive false 
discovery rate correction. 
 
*Spearman’s test used 
 
  









Figure 43: Slow wave sleep and medial temporal lobe   
 
A: Slow wave sleep duration was associated with volumes of CA2, dentate gyrus and entorhinal cortex. 
Note that the correlation between deep sleep duration and dentate gyrus was calculated using a Spearman 
correlation. The line is fitted as an illustration and does not reflect the underlying analyses.  
B: Spindle density in slow wave sleep was associated with CA2 and subiculum volumes.  
C: Note that neither of these relationships remained following false discovery rate correction.     
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Multiple stepwise linear regression was then calculated to predict slow wave duration from 
subfield volumes using the following formula:  
SWS duration = C + β*BW + β*CA2v + β*DGv + β*ECv 
Where SWS duration : slow wave sleep duration in minutes 
C : constant 
BW : Body weight (kilograms) 
v : volume (mm3) 
DG : Dentate gyrus 
EC : Entorhinal cortex 
The end equation (F(1, 28) = 6.81, p = .014, R2 = .17) included CA2 volume, but not body 
weight, entorhinal cortex or dentate gyrus. Slow wave sleep duration reduced by 2.8 minutes with 
each mm3 decrease in CA2 volume. It is possible that the other subfields were filtered out of the 
model due to intercorrelations between subfield volumes. Note that the dentate gyrus volume 
was not normally distributed. This could also affect the outcome as the above regression model 
is linear.  
Mediation analysis: Slow wave sleep duration was associated with both CA2 volume and 
memory for the tagged items, and CA2 volume was associated – albeit weakly and only before 
correcting for comparisons – with memory for the tagged items. I explored if CA2 volume 
mediates the effect between slow wave sleep duration and memory accuracy for the salient items. 
For the following analysis, I only included participants who had all three variables (MRI, 
polysomnography and memory scores) leading to a sample size of 31. Note that this is a small 





sample for mediation analyses yielding is possibly underpowered. The following regression 
analyses were first performed: 
D’ ~ SWS;    R2 = .12, p = .033 
CA2v ~ SWS;    R2 = .17, p = .012 
D’ ~ CA2v;    R2 = .10, p = .049 
D’ ~ SWS + CA2v;   R2 = .13, p = .052 
Where CA2v is the CA2 volume in mm3, SWS is slow wave sleep duration in minutes, and D’ is 
the day 1 memory performance for tagged memories (List A, on placebo). The relationship 
between slow wave sleep duration and the tagged accuracy disappeared when CA2 volume was 
included in a regression model (p = .152). Next, using the ‘mediate’ toolbox on R, I performed a 
bootstrapped causal mediation analysis using 1000 samples, I found no average causal mediation 
effect (ACME; β = .002, p = .260), average direct effect (ADE; β =.004, p = .310) or total effect 
(β = .006, p = .070). In other words, despite finding a trend, I did not find that the relationship 
between slow wave sleep duration and memory for salient information was reliably mediated by 
CA2 volume.  
Spindle characteristics: As spindle densities during stages 2 and slow wave sleep are frequently 
associated with memory consolidation, relationships between spindle densities in both stages 
were analysed against hippocampal subfield volumes. There were no associations between stage 
2 spindle densities and subfield volumes. After false discovery date, slow wave spindle density 
and CA2 (pcorrected = .024) and subiculum (pcorrected = .042) volumes were positively correlated 
(Figure 43B). After correcting for body weight, the associations between slow wave sleep spindle 
density remained for both CA2 (r = .537, p = .004) and subiculum (r = .507, p = .007) remained. 





Multiple stepwise linear regression was then calculated to predict slow wave spindle density from 
subfield volumes using the following formula:  
Spindle density = C + β*BW + β*CA2v + β*SUBv  
Where SWS density : number of spindles per minute during slow wave sleep 
C : constant 
BW : Body weight (kilograms) 
v : volume (mm3) 
SUB : Subiculum 
The end equation (F(1, 28) = 9.8, p = .004, R2 = .25) included CA2 volume. Slow wave spindle 
density increased by .17 spindles per minute with each mm3 decrease in CA2 volume. The 
subiculum volume and body weight were not included in the model. It is possible that subiculum 
volume was not included due to being correlated with CA2 volume. 
T2 relaxometry: I analysed T2 relaxometry against Stage 2, slow wave sleep and REM durations 
and spindle densities during both stage 2 and slow wave sleep. Initially, I found negative 
relationships between REM duration and T2 relaxometry distribution in the entorhinal cortex, 
and between Stage 2 slow wave spindle density for the dentate gyrus and the entorhinal cortex 
(Figure 43C). These associations did not survive false discovery rate correction (pcorrected = .174; 
pcorrected = .606; pcorrected = .093, respectively). 
 





Medial temporal lobe and L-DOPA mediated 
effects 
To observe the relationship between hippocampus and dopamine, I performed correlational 
analyses between subfield volumes and L-DOPA mediated changes in memory and sleep. 
Contrary to my hypotheses, I did not find any relationships between hippocampal volumes and 
drug-responses, Table 25. 
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Table 25: MRI: The hippocampus and L-DOPA 
 
Correlation coefficients and p-values.  




I sought to investigate the relationship between medial temporal subregion volumes and integrity 
in relation to memory and sleep. I found several interesting associations between medial 





temporal lobe structures and sleep. Interestingly, the integrity or volume of hippocampal subfield 
or entorhinal cortex were neither associated with recognition memory nor its subcomponents.  
However, majority of these findings did not remain significant after correcting for multiple 
comparisons. Furthermore, these analyses reported in this chapter are exploratory and the 
sample size is small. The study overall was powered for behavioural effects, not for hippocampal 
subfield volume analyses. Therefore, these findings are likely to contain at least some false 
positives and care and caution should be taken when interpreting these results.  
 
Hippocampus, entorhinal cortex and sleep 
Slow wave sleep duration was negatively associated with CA2, dentate gyrus and entorhinal 
cortex volumes. Slow wave sleep spindle density was also associated with CA2 and subiculum 
volumes but not with these regions’ tissue integrity nor with measures of other subfields. CA2 
volume was the best predictor of both slow wave sleep duration and spindle density.  
The role of the CA2 region in human cognition and sleep is relatively poorly understood. Its 
small size make its study difficult and majority of protocols for segmenting hippocampal 
subfields attach it to the adjacent cornu ammonis regions (Bender et al., 2018; Wisse et al., 2017). 
While its segmentation is now possible using structural MRI, scanning sequences need to be 
carefully optimised for sufficient resolution. Not only is this region smaller than other subfields 
of the hippocampus but it is also relatively resistant to damage (Dudek, Alexander, & Farris, 
2016). Indeed, focal CA2 lesions are scarcely reported in the literature. Due to the 
aforementioned caveats in the resolution of available MRI techniques, focal lesions to the CA2 
could also not be reliably identified until recently. The CA2 is, however, intimately involved in 
memory consolidation (Dudek et al., 2016).  





While its role in regulating sleep stage durations is not clear, the CA2 is involved in several 
memory processes that are also supported by sleep. CA2 is mostly studied in animals, where this 
region instigates hippocampal ripples and replay during wakefulness and sleep (Kay et al., 2016; 
Oliva et al., 2016) possibly via modulation from the entorhinal cortex (Oliva et al., 2016). In 
mice, CA2 is necessary for social recognition memory but does not affect sociability (Hitti & 
Siegelbaum, 2014), and it is involved in synaptic tagging and capture (Dasgupta et al., 2017). 
While this replay occurs also during the night, it is not clear that this activity is slow wave sleep 
dependent. However, it aligns well with our finding that CA2 volume is associated with spindle 
amplitude increase.  
Regression models showed that CA2 volume was the best predictor of both slow wave sleep 
duration and spindle density, with no other structure volumes or body weight being included in 
final models.  
However, as I used linear regression, and as medial temporal lobe sub-structure volumes are 
intercorrelated with one another, I cannot conclude that the dentate gyrus, entorhinal cortex and 
subiculum are not associated with measures of sleep. Instead, it is likely that as CA2 was to be 
the most strongly correlated subfield, it “hid” the relationships between sleep measures and 
volumes of other structures. This phenomenon is known as multicollinearity or collinearity: it 
occurs when two or more independent variables are correlated with one another. As a more 
intuitive example, when trying to predict individuals’ body mass using different measures, jean 
size and waist circumference may both be strong predictors of body mass. However, as jean size 
and waist circumference are strongly associated with one another, one may mask the effect of the 
other. In a model predicting body mass, jean size may not add much value above and beyond 
waist circumference. Therefore, in the final model, it is unlikely that both jean size and 
circumference would be included. However, that is not to say that both aren’t associated with 
body mass.  





Likewise, while CA2 was the best predictor, it does not mean that other subfields aren’t also 
involved or important in predicting sleep architecture. Note that predicting here does not refer 
to a causal relationship.  
Each of the identified correlations between subregion volumes and slow wave sleep duration and 
spindles are anatomically plausible. For example, in humans, connectivity between the subiculum 
and cortical regions is increased during spindles (Andrade et al., 2011).  
Interestingly, the relationship between slow wave sleep duration and hippocampal subfield 
volumes was negative. Larger CA2, dentate gyrus and entorhinal cortices were associated with 
shorter slow wave sleep durations. This is paradoxical as reductions in either hippocampal 
volumes or slow wave sleep are associated with poorer health outcomes in old age (Ancoli-Israel, 
2005; Devanand et al., 2012; M. M. S. Lima, 2013; Shokri-Kojori et al., 2018; Videnovic & 
Golombek, 2013; Vitiello & Borson, 2001).  
However, I did not directly test this hypothesis and therefore, this is speculative. The effects 
observed in this chapter are small and it is possible that these are false positive findings. To be 
sure, these findings should be replicated in other samples. It is difficult to explain the negative 
correlations in light of currently available evidence. However, and while speculative, it is also 
possible that both subfield volumes and slow wave duration are mediated by some third, 
unmeasured variable.  
What might mediate such a disparate relationship between hippocampal structure and sleep? An 
alternative explanation is that those with larger CA2s have more efficient slow wave sleep – 
which aligns well with our finding that they also have higher spindle densities. During a shorter 
slow wave duration, those with larger CA2s can achieve more restoration. The first half of the 
night is typically dominated by slow wave sleep. It is possible that after slow wave sleep’s 
homeostatic mission has been fulfilled, other sleep stages take over in healthy individuals. Larger 





hippocampal subfield volumes may be indicative of healthier sleep physiology. To this end, 
increased slow wave sleep may also act as a shield against detrimental effects of early 
hippocampal volume loss. 
CA2 is anatomically located so that it has the potential to influence memory: it receives input 
from the entorhinal cortex and CA3, and primarily projects to the CA1 (Caruana, Alexander, & 
Dudek, 2012). The supramammillary nucleus of the hypothalamus also projects to CA2, as well 
as CA3 and the dentate gyrus (Magloczky, Acsady, & Freund, 1994). Suppressing the 
supramammillary nucleus reduces theta amplitude, effectively disrupting cortico-hippocampal 
functional connectivity (Kirk & McNaughton, 1993). In other words, this region modulates 
encoding-related spike-time coordination between cortical regions and the hippocampus, in a 
process that likely involves the CA2 (Caruana et al., 2012). In animals the modulation of this 
pathway is associated with learning (Ito, Moser, & Moser, 2018; Oddie, Bland, Colom, & Vertes, 
1994). In humans, theta activity during learning may tag salient information to be preferentially 
stored during sleep (Heib et al., 2015; Pu & Yu, 2019; Vertes, 2005).  
In humans, theta during learning is positively correlated with spindle coherence during slow 
wave sleep (Heib et al., 2015). The number of spindles during sleep is also increased following 
learning of salient compared to non-salient information (Wilhelm et al., 2011). In Chapter IV I 
showed that slow wave sleep characteristics (duration and spindle amplitude) were associated 
with memory for salient information. In this chapter I found that CA2 volume was associated 
with reduced slow wave sleep duration and increased spindle density but not memory after 
correcting for multiple comparisons. The link between spindle density and CA2 volume may 
reflect CA2’s involvement in instigating subsequent sleep memory-associated spindles during 
wakefulness.  





Finally, while medial temporal lobe sub-structures are likely to orchestrate sleep architecture, it is 
possible that sleep is driving the morphological changes reported here. Using whole brain voxel-
based morphology, Taki et al (2012) showed that healthy children with poor sleep had reduced 
grey matter in the hippocampus, and insomnia is associated with reductions in CA3/dentate 
gyrus volumes in adults (Neylan et al., 2010). While these results are also correlational, Poor sleep 
is likely to affect brain morphology.  
I propose that medial temporal lobe sub-structures might drive the effects observed here on 
sleep. First, the relationship between slow wave sleep duration and hippocampus is to the 
opposite direction of what would be expected if poor sleep was reducing hippocampal volume. 
Second, our sample consisted of healthy elderly adults who reported being good sleepers. This 
was defined by asking them whether they had self-reported sleep problems and by excluding 
anyone who slept under 5.5h per night. It is unlikely that in this sample poor sleep would have 
caused morphological changes to brain structure.  
However, it is possible that participants in our sample have had poor sleep previously in their 
lifetimes. It is not clear if this, or other lifestyle factors not accounted for in here could have 
affected hippocampal volumetry. In addition, these findings were correlational in nature: it is not 
clear if hippocampal volumetry has an adverse or positive effect on sleep, or if poor sleep leads 
to changes in hippocampal volume.  
Long-term large cohort studies assessing the relationship between hippocampal volume and 
integrity against sleep architecture may shed light to the directionality of this relationship. These 
studies may also be powerful in addressing the transiency of this relationship: if hippocampal 
volumes are indeed associated with sleep architecture, are these changes adaptive and transient 
or do they persist in the long term?   
 





The hippocampus, entorhinal cortex, sleep and 
memory 
I sought to investigate the relationship between medial temporal region substructures and 
recognition memory. Contrary to what was expected, there were no associations between 
volumes or relaxometry and recognition memory performance after correcting for false 
discovery rate. Nor did I find any evidence to support a relationship between volumetry and L-
DOPA-mediated changes in memory or sleep characteristics. To our awareness, no other studies 
have investigated hippocampal morphology and tissue integrity in relation to recognition 
memory over time courses spanning multiple days, or in relation to drug responses. It is 
important to note that I powered our study on the effects of dopamine on memory and 
therefore, these imaging correlations should be viewed as exploratory, rather than confirmatory. 
I also assessed if hippocampal subfield CA2 volume mediated the relationship between slow 
wave sleep duration and memory for tagged items using a mediation analysis. CA2 volume was 
associated with both slow wave sleep duration and memory for tagged items (although not after 
correcting for false discovery rate), and slow wave sleep duration and memory for tagged items 
were also associated with one another. While I found that the relationship between slow wave 
sleep and memory disappeared when controlling for CA2 volume, the effect of this mediation 
was not significant. Fogel et al (2017) found that age-related changes in hippocampal grey matter 
volume were associated with both sleep spindles and offline skill enhancement in a procedural 
motor learning task (S. Fogel et al., 2017). While they did not perform a mediation analysis, they 
suggested that hippocampal grey matter was modulating motor learning via spindle 
enhancement. It is noteworthy that a mediation analysis is correlational in nature and does not 
make any assumptions about causality. 





Sleep spindle density is associated with memory persistence. While subiculum volume associated 
with spindle density, it was not associated with memory in this study. Others have found that 
subiculum and pre-subiculum volumes are associated poor executive function and with an 
increased risk of dementia (Evans et al., 2018). It is possible that spindle density mediates the 
subiculum’s effects on other cognitive functions.  
Both memory recollection and familiarity have been associated with medial temporal structures, 
with the former being primarily hippocampal (Brown & Aggleton, 2001; Diana et al., 2007; 
Duzel et al., 2003; Manns, Hopkins, Reed, Kitchener, & Squire, 2003; Merkow, Burke, & 
Kahana, 2015; Rugg & Yonelinas, 2003; Suzuki, Miller, & Desimone, 1997; Yonelinas et al., 
1998). Contrary to our hypotheses, I found no relationship between either recollected or familiar 
items and medial temporal lobe structures. This is in contrast with several others who have 
found recognition memory or memory persistence to be associated with subfield volumes 
(Bender, Daugherty, & Raz, 2013; Bennett, Stark, & Stark, 2018; Hartopp et al., 2018; Shing et 
al., 2011; Yassa et al., 2010). Differences in segmentation procedure and sample characteristics 
may explain the discrepancies. For example, many of the other studies have had larger samples, 
wider age-ranges for subjects and they have used larger subfield mask (e.g. combining CA3 and 
dentate gyrus and not segmenting CA2) and lower resolution MRIs.  
In the present study, I also explored the effects of dopamine-mediated changes in memory and 
sleep against hippocampal subfield volumetry. Dopamine within the hippocampus mediates 
memory persistence (J. Lisman et al., 2011), possibly by guiding memory selection. In Chapters 
IV and V, I described how overnight L-DOPA enhanced memory selection in this sample. While 
I did not observe associations between drug-mediated effects on memory and medial temporal 
lobe sub-structure volumes or integrity, I found several associations between brain morphology 
and tissue state that were associated with aspects of sleep architecture known to underlie 
memory. Sleep architecture and memory were together modulated by L-DOPA. The lack of a 





relationship between volumetry and relaxometry measures does not mean that hippocampus is 
not driving these processes. As I did not record hippocampal activity directly using techniques 
that allow localising signal to the hippocampus, I cannot ascertain whether L-DOPAs 
modulatory effects are driven by this region.  
 
Limitations  
It is possible that this chapter contains false positive findings. While care was taken to correct for 
multiple comparisons, due to the moderate sample size and number of statistical tests, correcting 
for all analyses performed in this chapter would have inflated false negative findings. Instead, I 
only corrected for false discovery rate for all subfields. While, the relationships between subfield 
volumes and slow wave duration and spindles are anatomically plausible, caution should be taken 
when interpreting these findings.  
Sample characteristics may have introduced further bias. First, I only tested 35 participants, some 
of whom were not included in all analyses and our study may have been underpowered. For 
example, it is possible that CA2 volume is associated with memory for salient information via a 
pathway that is mediated by slow wave sleep characteristics, but a larger sample is needed to 
determine this. Second, I had strict inclusion and exclusion criteria due to the study involving 
MRI, overnight stays and pharmacological agents. This led to a sampling bias toward very 
healthy elderly. Our sample may therefore have less age-related pathology, and therefore less 
variability in brain tissue integrity.  
There are several limitations with using MRI to study brain structure. Perhaps most importantly, 
structural correlations between behaviour do not allow segmentation of task characteristics to 
study individual processes or stages of cognitive function. It is possible that MRI volume and 
relaxometry predict memory encoding and consolidation but when all memory processes are 





studied together the added noise of other cognitive processes involved masks this effect out. 
Functional magnetic resonance may be better suited to answer questions about different stages 
of memory. Importantly, correlational neuroimaging studies do not offer information about the 
necessity of a region to perform a function. While I found associations between hippocampal 
morphology and sleep, and structure integrity and memory, I cannot know to what magnitude 
these regions are involved in these processes.  
The resolution of our scans was within the sub-millimetre range, which is high in the MRI 
context but low in the context of the hippocampus. Your hippocampus is likely smaller than 
your ring finger, and when divided into subfields measurement errors in the range of a couple of 
voxels can bias volumetry and relaxometry outcomes. In pathology, hippocampal subfield 
segmentation is guided by anatomical boundaries that are not seen in MRI (Wisse et al., 2017). 
The measurement of medial temporal lobe structures by magnetic resonance is coarse in 
comparison to histopathology. 
While volumetry is a widely adapted method for quantifying brain morphology, pooling results 
across studies on medial temporal subregion volumetry is challenging due to heterogeneity in 
study designs and analysis approaches. Different research groups use different tools for 
segmenting the hippocampus and its subfields. For example, the role of the CA2 in humans is 
not well understood and majority of available hippocampal subfield segmentation procedures do 
not separate the CA2 from the adjacent CA3 and dentate gyrus (Wisse et al., 2017). The 
FreeSurfer and ASHS pipelines used here is likely the most widely adopted (Wisse et al., 2017; 
Worker et al., 2018) 
Conventions over normalising subfield volumes to total brain volume or intracranial volume also 
vary. Head-sizes vary between individuals and this variation is positively associated with 
differences in intracranial, total brain and regional brain volumes (Jack, Petersen, Obrien, & 





Tangalos, 1992; Synek & Reuben, 1976; Wolf et al., 2003). People with larger intracranial cavities 
are likely to have larger hippocampal subregions. Correcting for total intracranial volume in 
structural brain imaging studies reduces individual variability in total brain volume (Whitwell, 
Crum, Watt, & Fox, 2001).  The caveat of correcting for intracranial volume or total brain 
volume is that it introduces an additional source of noise in the data. This is unlikely to be a 
problem with larger sample sizes but as I was interested in small subfields and I had a moderate 
sample size. Furthermore, due to movement during scans in one participant, and poor scan 
alignment in another, two participants’ intracranial or total brain volume could not be 
determined. In a small sample size not including two participants would have largely reduced the 
statistical power in this study.  
For these two reasons, I decided to not correct for intracranial volume. While the correlations 
observed in this study remained after correcting for body weight, it is possible that controlling 
for intracranial volume and brain volume would produce disparate results. Therefore, correcting 
for intracranial volume or total brain volume may have been a more robust approach.  
White matter structures such as corpus callosum volume and hippocampal-fornix connections 
have also been associated with sleep and memory (Buchmann et al., 2011; Hartopp et al., 2018). I 
only explored the relationships between medial temporal structures and memory and sleep. A 
natural next step is to extend the scope outside of the medial temporal lobe and assess the 
relationship between diffusion tensor imaging data, cortical thickness (Dube et al., 2015), long 
term memory persistence and sleep.  
Perhaps the largest limitation of this chapter is that the study was not powered for hippocampal 
subfield correlations. Therefore, the risk of false positives is increased and the findings should be 
taken with caution and replicated in independent samples.  






Mnemonic functions of the medial temporal lobe are an outcome of the interactions and actions 
of its component subregions. Here, I showed that larger CA2, dentate gyrus and entorhinal 
cortex volumes were associated with reduced overall slow wave sleep duration. Surprisingly, I did 
not find any relationships between subfield volumes or tissue integrity and memory or L-DOPA 
mediated changes in memory and sleep.  
 
  












Chapter VII: General 
discussion 
Human brains selectively store knowledge about the world to optimise future behaviour. We 
automatically rehearse and contextualise or discard information to create a robust collection of 
facts and events. To achieve this, the memory system, which involves several medial temporal 
lobe regions, biases memory persistence in favour of important information during sleep. The 
two double-blind randomised controlled trials reported in this thesis were designed to carefully 
target different stages of memory evolution and sleep with dopamine in old age. I aimed to 
examine the relationships between dopamine, memory, sleep and the hippocampus.  
Broadly, I found that L-DOPA modulates processes involved in selecting information to-be-kept 
overnight – L-DOPA accelerated the rate of forgetting newly learnt information, but memories 
tagged as salient were shielded from this effect. Strikingly, both these effects were also associated 
with changes in slow wave sleep architecture.  
In contrast, L-DOPA did not affect encoding or retrieval when memory is tested a day later. 
Several medial temporal lobe substructures were also associated with differences in sleep 





architecture. However, these findings were exploratory, and the effects were small and weak. 
Furthermore, and unlike hypothesised, hippocampal subfield volumes or T2 relaxation times, 
were not associated with memory or the effectiveness of L-DOPA. 
These results have been discussed in relation to one another through earlier chapters. In this 
chapter, I will draw further overarching conclusions about these findings and discuss their 
implications.  
Behavioural findings 
Perhaps my most striking finding is that L-DOPA nocturnally selects salient information for 
storage at the cost of accelerating clearance of unimportant information. L-DOPA after learning 
accelerated forgetting, but not if information was tagged as salient. Specifically, I found that 
nocturnal L-DOPA increased the difference between remembering re-exposed, or “tagged”, and 
not re-exposed items. The effects of L-DOPA were seen one – but not three or five – days after 
learning.  
These findings therefore suggest that L-DOPA accelerates forgetting of information that would be 
lost later anyway. In other words, information that would be remembered over a longer delay 
anyway was not affected by L-DOPA, as evidenced by a lack of effect on days 3 and 5. Instead, 
weakly encoded or stored information that would be forgotten over longer delays, was forgotten 
quicker, as evidenced by lower memory performance (D’) on Day 1. Furthermore, I found that 
L-DOPA did not increase forgetting of tagged information that was more strongly encoded by 
presenting the information twice.  





I suggest that these effects are explained by dopamine enhancing memory selection both during 
tagging and during subsequent sleep.  
There were two important limitations to this interpretation. First, dopamine’s effects on biasing 
memory could equally be due to dopamine enhancing encoding. I interpreted my findings as 
dopamine biasing the tagging of salient information as opposed to enhancing all encoding equally. 
Memories were tagged as salient by a re-test. It is therefore possible that rather than affecting 
tagging, dopamine affected re-encoding.  
The second limitation to our interpretation was that dopamine may have biased memory during 
retrieval. Residual amounts of L-DOPA could still have been present centrally at the 12-hour 
test, affecting performance then rather than during tagging or nocturnal sleep. I did not measure 
dopamine levels in plasma, so I cannot exclude this possibility.  
However, in Chapter III I show findings from another placebo-controlled randomised trial that 
indirectly refute these alternative explanations.  
Specifically, in the DARet study (Chapter III), I showed that L-DOPA does not bias encoding or 
retrieval. This was based on the observation that when I administered L-DOPA to target 
encoding (and early, wakeful, consolidation), and retrieval separately, it did not change memory 
when performance was tested a day after learning. The evidence against an effect 1 day after 
learning was moderate, as indicated by the Bayes Factors (Table 5, page 110). Specifically, these 
analyses showed that the data collected 1 day from learning, regardless of whether L-DOPA was 
active at encoding or retrieval, were 4.6 times more likely to have been collected from a null than 
the alternative distribution.  
My findings therefore robustly show that L-DOPA does not affect encoding or retrieval, when 
information is tested 24 hours after learning. However, there was a small trend-level effect 3 days 
after learning. I suggest that this finding was a false positive as the effect was small and did not 





survive multiple comparison correction, but further replication is needed to establish this with 
certainly. Considering the findings from the DOPAMIND study (Chapters IV and V) in light of 
the DARet study (Chapter III), I suggest that dopamine was influencing tagging, sleep-related 
consolidation or both, and that the observed effects cannot be explained by dopamine’s 
influence on encoding or retrieval.  
My findings also align well with drosophila models that have robustly shown that dopamine 
overnight increases forgetting (Berry et al., 2015; Berry et al., 2012; Berry et al., 2018), and with 
several studies in humans showing that dopamine enhances memory when learnt information are 
either associated with rewards (Feld et al., 2014), or when information is repeatedly learnt 
(Knecht et al., 2004; Shellshear et al., 2015). Others have interpreted their findings as dopamine 
having an overall effect on encoding or consolidation. I offer an alternative explanation, that 
dopamine biases memory for salient information by enhancing tagging processes either during 
learning or shortly after.  
The concept of increased forgetting is still emerging, and it is not yet clear whether this is due to 
direct degradation of engram or additional noise or reduced precision of storage and recall. 
Limitations of the tagging manipulation 
A further important limitation in this thesis is interpreting repeat exposure as behavioural 
tagging. To reiterate: the purpose of the evening test of a portion of the items (List A) was to 
“tag” them as salient by repeat exposure. Participants knew they would be tested on these items 
again, and this manipulation was to act to strengthen the pre-existing memory trace for these 
items (List A). However, as participants had formed memories of the other lists earlier, it is 
possible that a repeat exposure of some of the words encouraged participants to actively rehearse 
the non-tagged words as they knew they would be tested later. Therefore, it is possible that the 
manipulation here did not increase saliency of the tagged information.  





Another caveat is that between learning and re-test participants may have forgotten items. If 
items were either forgotten or not encoded in the first place, the tagging manipulation would 
have just acted as initial encoding. Although I attempted to out rule this explanation by showing 
in DARet (Chapter III) that L-DOPA does not affect encoding, this is a real concern and further 
complicates interpreting the findings from the DOPAMIND study.  
The tagged word list (List A) may therefore include both items that were genuinely tagged as 
important, items that were just repeat exposed (i.e. re-learnt but no saliency was attached to 
them) as well as items that were only really encoded once due to either forgetting between testing 
and learning, or due to not encoding them at all during learning.  
Considering these limitations, these data become more difficult to interpret. While in the control 
study (DARet, Chapter III) I did not find any effect of L-DOPA during encoding but it is 
possible that this was due to other differences in the study, such as fatigue, time of the day, or 
other factors to do with the study design. However, due to the lack of any effects in DARet on 
encoding when memory was tested 1 day later it is unlikely that encoding effects alone explain L-
DOPA’s effects on memory. 
A plausible alternative explanation is that re-exposure, rather than salience tagging, explains the 
observed effects. It is possible that merely seeing the same information alters a disparate route 
for encoding that can be modulated by dopamine. Indeed, others have shown that medications 
that increase dopamine levels in the brain enhance learning of items over several learning trials 
and occurrences (Knecht et al., 2004; Shellshear et al., 2015). 
However, in the current studies I did not account for these important limitations. An alternative 
study design that would have allowed for me to better disentangle these effects could have been 
more powerful. The current design could have been improved by having a different 
manipulation for tagging, such as a reward element. This should be considered for future studies.  
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Furthermore, a condition in which no items are repeat tested would have allowed for me to 
disentangle if the accelerated forgetting observed for list B was triggered by the List A test, or if 
this was unrelated. 
Dopamine, sleep and memory 
Nocturnal dopamine increased duration of slow wave sleep as well as slow wave spindle 
amplitude, as reported in Chapter V. Importantly, both effects were associated with dopamine’s 
effects on memory. Slow wave sleep duration was associated with memory performance for 
salient information, but not when L-DOPA active in the system. L-DOPA also was associated 
with the tagging effect – i.e. the relative memory benefit of salient compared to non-salient 
information – nocturnally, and this association was also correlated with slow wave spindle 
amplitude. However, the relationship between sleep physiology and the behavioural measures 
was correlational and therefore I cannot ascertain if this association is causal. 
Slow wave spindles are indirectly associated with hippocampal replay, which likely is an 
anatomical substrate for, at least some types of, systems consolidation (Molle et al., 2006; M. Y. 
Yang et al., 2019). It may not be possible or worthwhile to replay all memories during sleep. 
Instead, sleep selectively consolidates some information over others based on behavioural 
salience (Blaskovich et al., 2017; Himmer et al., 2019; Lipinska, Bolinger, Thomas, Baldwin, & 
Stuart, 2019; Schapiro et al., 2017). Different spindle characteristics, such as amplitude, are also 
associated with enhanced memory persistence (Mednick et al., 2013). Therefore, my findings are 
consistent with dopamine biasing memory selection during sleep.  
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Spindle amplitude reflects enhanced communication and coherence between cortical nodes 
during spindles. When memories are successfully stored in the long term, they become more 
integrated in cortical nodes and less reliant on the hippocampus. As memories are consolidated, 
the underlying neural activity required for their retrieval becomes more reliant on cortical 
connectivity and requires less hippocampal recruitment (Brodt et al., 2016). This is important 
because increased spindle amplitude reflects more coherent cortical activation during spindles. 
Therefore, spindle amplitude is likely to be a measure of the kind of processes that support 
information migration from hippocampal to cortical networks.  
This type of consolidation can also happen rapidly during learning in some circumstances, for 
example when information is congruent with previous experiences or rehearsed (Coutanche & 
Thompson-Schill, 2014; Himmer et al., 2019; McClelland, 2013). Crucially, sleep is required to 
make this kind of rapid consolidation last (Himmer et al., 2019). Therefore, the tagging effect is 
likely to be facilitated by fast online consolidation that is subsequently stabilised overnight. In 
Chapter V I showed that slow wave sleep duration facilitated this kind of learning, but L-DOPA 
wiped this effect off. It is possible that this was due to L-DOPA enhancing rapid consolidation 
during tagging, however I did not directly test this hypothesis. Perhaps once memories have been 
fast-tracked to the cortex during wakeful consolidation, they do not further benefit from 
increased slow wave sleep, but instead rely on spindle characteristics. 
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Dopamine’s dual effect  
Considering the findings across these chapters together, I suggest that L-DOPA modulates 
memory through a dual process, where it enhances memory tagging by fast mapping online 
consolidation, and later stabilises these effects during sleep, see Figure 44. 
 
Figure 44: Dopamine has a dual role in memory selection 
 
Some salient information is earmarked as important by a neural tag. Some of this happens during initial 
encounter and dopamine enhances this effect. During sleep, dopamine modulates selective memory 
processes that are biased toward tagged information. This leads to enhanced synchronisation in cortical 
firing patterns during spindles. Together these two processes affect subsequent memory. Salient information 
is now much more likely to be remembered, and this effect is increased by dopamine.  
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Implications and future directions 
My findings raise several questions about the neurobiological effects of dopamine. First, if 
dopamine does enhance the tagging process, this should be detectable during tagging as 
enhanced theta activity. Theta during and after learning is associated with processes that increase 
memory for salient information (Jarovi et al., 2018; Pu & Yu, 2019). Crucially, the relative 
increase in theta coherence is also associated with subsequent sleep spindle amplitude increases 
and memory success (Heib et al., 2015). The model I have suggested (Figure 44) holds that L-
DOPA enhances saliency-tagging together with subsequent memory processes. If correct, L-
DOPA should enhance theta coherence during tagging. Crucially, I did not record EEG during 
learning, only during subsequent sleep. Future research is needed to address this question.  
To determine whether the dual process hypothesis holds true, L-DOPA needs to be timed to 
target tagging and consolidation separately, and scale EEG needs to ideally be recorded during 
tagging.  
In addition to ascertaining L-DOPA’s effects on tagging and sleep separately, the functions of 
different dopamine receptors remain unknown. Most studies examining the relationship between 
dopamine, memory and the hippocampus have focussed on D1 neurons, which are the most 
abundant and behaviourally salient in the hippocampus (Hansen & Manahan-Vaughan, 2014; 
Roggenhofer et al., 2010). D2-like neurons seem to also be associated with memory-related 
behaviours (Feld et al., 2014; Franca et al., 2015; Nyberg et al., 2016; Salami et al., 2019), it is 
possible that different receptors modulate behaviour in different ways. In this thesis, I used 
medication, L-DOPA, that excites both D1 and D2 receptor types.   






I explored the possibility that memory and sleep could be modulated by a readily available 
medication, L-DOPA, in a positive way, that might bring clinical benefits in ageing. This may be 
a potential future direction for this research: to observe the efficacy of long-term L-DOPA use 
in reducing age-related pathology. In this section I suggest directions for future research. The 
current data alone is not sufficient in guiding clinical practice.  
L-DOPA’s effect on slow wave sleep has several potential implications as a therapeutic route to 
target age-related cognitive decline. L-DOPA increased slow wave sleep duration by 11% in this 
sample of elderly adults. Slow wave sleep is known to support several restorative functions in 
humans, ranging from stabilizing mood, anxiety and satiety to clearing brain amyloid and 
regulating insulin (Li et al., 2018; Reutrakul & Van Cauter, 2018; Shokri-Kojori et al., 2018). 
Ageing is associated with reduced sleep, increased incidence of sleep disorders and enhanced risk 
of developing cognitive problems including dementia. Age is the largest risk factor for 
dementias. An imbalance in amyloid homeostasis, leading to increased amyloid accumulation in 
the brain, increases dementia risk further.  
The long-term benefits of L-DOPA in modulating age-related risk factors for poor health are 
not presently known. Our findings together with studies that have shown that L-DOPA 
accelerates learning over five consecutive days (Knecht et al., 2004; Shellshear et al., 2015) 
suggest that L-DOPA may have clinical utility. Therefore, future trials targeting slow wave sleep 
with L-DOPA in ageing may have disease modifying implications and be of clinical benefit.  





I also found that L-DOPA enhanced processes involved in memory selection. Future studies are 
needed to ascertain if these effects may have potential clinical benefit to people living with mild 
memory problems.  
Any medication that can cross the blood brain barrier can potentially also alter sleep architecture. 
Commonly prescribed pharmacological sleeping aids are often not the most suited for elderly 
adults and may not be suited as a long-term option for disease modification. First, patients tend 
to build tolerance over time, and for this reason treatment should be restricted to 4-5 weeks to 
target poor sleep (Wortelboer, Cohrs, Rodenbeck, & Ruther, 2002) – with the exception of 
melatonin (Cardinali, 2018). Second, most common sleeping pills actually reduce slow wave 
activity as well as time spent in slow wave sleep and in REM (Achermann & Borbely, 1987; 
Borbely, Mattmann, Loepfe, Strauch, & Lehmann, 1985). Third, several common sleeping pills, 
such as benzodiazepines and diazepam, have been associated with increased falls in elderly 
(Cumming, 1998; Ryynanen, Kivela, Honkanen, Laippala, & Saano, 1993), increasing fracture 
risk in the elderly (Cumming & Klineberg, 1993; Cumming et al., 1991). While there is little 
evidence that L-DOPA reduced falls in healthy ageing, it may moderately reduce them in 
Parkinson’s disease (Abraham Lieberman et al., 2019; F. C. Chang et al., 2015). L-DOPA does 
not seem to increase risk of falling by promoting somnolence.  
L-DOPA is a readily available, safe, and widely used medication which has the potential to 
impact on sleep efficacy. It may be safer to use than commonly prescribed sleeping pills, 
especially in the elderly population.  
Further research is required to determine whether L-DOPA has clinical utility in targeting 
memory and sleep.  
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Sleep and the medial temporal lobe 
I also explored the relationship between medial temporal lobe substructures, memory and sleep 
in Chapter VI. The findings reported in in this chapter were exploratory in nature and all 
observed effects were small.  
The function of the medial temporal lobe is an outcome of the interactions and actions of its 
component subregions. Hippocampal subfield volume and integrity change with age, and these 
changes are associated with memory. In Chapter VI, preliminary evidence showed that shorter 
slow wave sleep durations may be associated with larger CA2, dentate gyrus and entorhinal cortex 
volumes. Slow wave sleep spindle density was also associated with CA2 and subiculum volumes. 
In contrast to what I expected, I did not see any relationships between medial temporal lobe 
substructure integrity and sleep, nor did I find any associations between substructures and 
memory. Although the relationship between hippocampal subfield volumes and sleep were 
associated with the same sleep characteristics modulated by dopamine, I found no association 
between subregion volumes or integrity and the dopamine-mediated effects reported in Chapters 
IV and V. Note that all the MRI structural analyses had low power and findings from this 
chapter should be taken with a pinch of salt.   
Therefore, the hippocampus and the entorhinal cortex are associated with sleep architecture. 
However, it is not clear whether subregion volumes are affecting sleep stage durations and 
spindles, or if differences in sleep efficiency can, over time, shield the hippocampus against 
atrophy.   






In this thesis I have shown evidence to support that L-DOPA enhances routine forgetting but 
selectively stores salient information. These effects were associated with increased slow wave 
sleep and slow wave spindle amplitude. Together, these findings suggest that saliency increases 
the likelihood that an item is remembered, and that dopamine further increases this effect. 
During subsequent sleep, dopamine increases the coherence of thalamocortical communication 
and causes more synchronous cortical firing during spindles. I propose that this increase in 
coherence is associated with more selective hippocampal replay. As a result, nocturnal dopamine 
biases later retention for salient items. These findings have potential clinical impact. 
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APPENDIX A: STUDY HALT AND PROTOCOL CHANGES 
 




Overview: Initially, the DOPAMIND study had three study arms: Ropinirole 8mg, co-
beneldopa (containing L-DOPA 200mg), and placebo. Five volunteers were dosed with 
ropinirole and each of them experienced significant nausea and vomiting for up to 24 
hours after dosing, despite having received 10mg of domperidone to mitigate nausea 
first.  
After first two participants had experienced nausea, the study protocol was amended 
to increase the maximum domperidone dose from 10mg to 30mg. Ropinirole 
continued to cause vomiting and nausea despite the increased domperidone dose on 
two participants. One of the participants dosed with domperidone experienced a 
significant serious adverse event temporally associated with the domperidone 
administration. The participant experienced an asymptomatic prolonged QT interval, 
observed in routine ECG measures with an onset after 30mg of domperidone had 
been given. The prolongation of the QT interval continued overnight and was still 
present the following morning. Cardiac side effects have been reported in participants 
over the age of 65 taking domperidone routinely at a 30mg or above daily dose.  
This resulted in a trial halt during which significant protocol changes were made: 
The ropinirole arm of the study was withdrawn 
Domperidone maximum dose was reduced to 20mg 
Four participants from block 1 completed 3 visits, one participant completed two visits 
from this block (co-beneldopa and placebo) and one just the ropinirole visit. The 
participant who only completed the ropinirole visit was recruited again after the study 
halt and allocated another participant number to complete the study. The data 
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DIX B: DARet drug blinding procedure 
Standard Operating Procedures for Medication Blinding 
Version 2: 14th April 2016 
 
DARet1 is a double blind randomised study, in which each volunteer is completes to two 
conditions; drug (domperidone + Madopar) and placebo. Both drugs are water soluble and 
therefore blinding will be completed by offering medication mixed with cordial. Each volunteer 
gets two cups of cordial. The person designated to blinding the pharmaceuticals will be 
referred to as the blinder in this SOP.  
The experimenter will provide the blinder with an envelope that contains information on the 
condition. The envelope must be opened out of sight from the researcher and the person 
completing the blinding must hold onto the envelope until the volunteer leaves the research 
facility, so that emergency unblinding can be completed by contacting this person.  
The researcher will provide the blinder with the following equipment: 
- Envelope addressed with the participant ID and visit number 
- Yellow cordial 
- Purple cordial 
- Plastic cups 
- Measuring cup (20ml) 
- Oral syringes (10ml) 
- Madopar tablets (two jars) 
- Domperidone liquid 
- Vitamin tablets 
The blinder must adhere to following the steps when preparing the medication.  
 
1. Wash hands 
2. Mixing the cordial 
 Using the 20ml measuring cup, measure 40ml of purple cordial into one and 40ml of yellow 
cordial into the other. Do not dispose of the measuring cup as this will be washed and used 
again.  
3. Opening the envelope 
The envelope will state the volunteer participant number and the visit day. The researcher 
will ensure the blinder receives the correct envelope. The blinder will ensure the researcher 
will not see contents of this envelope.  
• If the envelope indicates the volunteer is in the placebo condition proceed to 4 
• If the envelope indicates the volunteer is in the medication conditions, proceed to 5
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4. Placebo 
The purple mix is done. You do not need to add anything to this.  
Get a fraction of a vitamin tablet that equals around ¼ or 1/5 of a tablet, and add this to the 
yellow mix. If you notice the colour of the mix changing, mix a new cup with less vitamin.  
You may need to crush a vitamin tablet to do this. These tablets are easy to crush so this can 
be achieved by hand.  
If there are less than four oral syringes, dispose of one and notify the experimenter of how 
many are left. If there are more than four, do not dispose any. 
As the placebo takes less time to prepare than the drug, please wait at least 30 seconds 
before you proceed to step 6.  
5. Medicine 
Using an oral syringe, measure 10ml of Domperidone (the liquid in a glass bottle) and add 
this to the purple mix.  
Add two Madopar tablets to the yellow mix. There are two jars, add one tablet from each. 
Wait a moment for the Madopar to dilute. Some residue may be visible on the juice. Do not 
worry about this. 
6. Fill with water 
Fill both plastic cups with water (up to roughly the third ‘line’ from the top).  
7. Take juice mixes to the researcher 
Once you have provided the juice mixes to the researcher, ensure you can be contacted by 
the researcher at any point when the research volunteer is on site, in case there is need for 
emergency unblinding. You may leave the Brain Centre but make sure the researcher has 
your number. 
8. Disposing of materials 
Envelopes. Ensure you have the envelope with its contents on you until the volunteer has left 
the study site. After this time you may dispose of the envelope securely. You can do this by 
placing it in a confidential waste bin or disposing of it somewhere where the researcher 
cannot see it (for example your home). 
Syringes. The oral syringes should be disposed of so that the researcher cannot see them. 
You can do this by placing them in a lidded bin in any of the clinic rooms or the day ward, as 
long as this is not the room where the researcher will be conducting the experiment. Do not 
dispose of these in the Brain Centre office or toilet bins as there is a chance the researcher 
will see them.  
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DOPAMIND medical cover information 
 
Blue areas indicate responsibilities allocated to the medical cover (MC) and the blue box shows when the MC is 
needed on site. All the timings are dependent on the “Lights out” time, which is the time when the volunteer 
typically goes to bed, typically 10-12PM. The MC is expected to be available to stay on site for 3 hours and will 
be reimbursed £125 for their time per night. If our volunteers have very incongruent bedtimes we might need 
cover for a longer period (and we adjust reimbursement accordingly). All testing takes place at CRICBristol (in St 
Michael’s hospital).  
The MC is responsible for: 
• Drug logs 
• Prescriptions 
• Eligibility review (based on re-screen) 
• Monitoring (ECG, BP, HR)  
• Dosing  
• Filling and signing relevant pages on the case report form (CRF) 
 
An on-call neurologist (typically the PI, Liz Coulthard) will be available for advice over the phone throughout the 
evening. Their phone number will be in the CRF. The PI will also be liable in the highly unlikely case anything 
went wrong.  
Each volunteer will have been screened and signed off as eligible by the PI prior to sleep visits. The MC will only 
review continued eligibility. Where the medical cover is a nurse ECGs will be interpreted by the clinical cover 
remotely and the prescription(s) will be written beforehand.  
The most likely side effect we may experience is nausea and vomiting from the co-beneldopa. Other side effects 
are very unlikely at current doses. We always have an additional 10mg of domperidone we can give to 
volunteers if they present with nausea, and you should not hesitate to use that.  
Before starting, the MC will need to present evidence of good clinical practice, a signed and dated CV and a 
declaration of ability to perform basic life support (or an ABLS certificate). They will also need to be signed off 
on the delegation log and they will need to read and sign the SOP for monitoring and dosing.   
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DARet study 
(relevant section from testing SOP used by experimenters) 
You need to have someone not involved in the testing for this participant perform the drug/placebo 
preparation. The instructions are in ‘Drug Preparation SOPV2.docx’. [ APPENDIX B] 
Begin Testing 
1. Sign consent form 
2. Go through continuance criteria 
Drug/placebo administration 1 
3. Go to day ward and measure blood pressure and heart rate (t0) 
4. Administer domperidone/placebo (purple drink) 
5. 30 minute delay 
6. Can’t be unattended, but can be left in day ward if other staff members are around. Check on them 
occasionally 
Drug/placebo administration 2 
7. After 30 minutes take BP and HR again (t30 – 30 minutes after baseline) 
8. Administer madopar/placebo (orange drink) 
9. Can’t be unattended, but can be left in day ward if other staff members are around. Check on them 
occasionally  
10. Wait 30 minutes and check BP and HR again (t60) 
11. Wait another 30 minutes and check BP and HR again (t90) 
12. Begin testing session 
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NOTE THAT ONLY THE RELEVANT SECTIONS OF SOPs ARE INCLUDED HERE. 
Participants learn a list of 100 words and delayed recognition is tested using the Remember-Know 
paradigm.  
Remembering refers to the conscious recollection of information while knowing refers to a sense of 
familiarity. It is important to note that this is not a measure of certainty. Some have suggested that 
remember responses are analogous to episodic memories and know responses are analogous to 
semantic memories. The testing of this task is performed using a vigorous protocol to ensure 
participants understand the difference between remembering and knowing.  
In the learning block, a white fixation cross is shown for 1000ms and then a word is presented in red 
font on a black background for 2600. The participants are initially shown a practice version with 5 
words to learn, and a 5 word test, to get used to the lay out of the task.  
The participants are instructed to try to remember the words, along with selecting if they think the 
word is ‘alive’ – ‘yes’ or ‘no’, via button press. There are 80words (presented in a randomised order).  
Stimuli selection 
All words were drawn from the MRC psycholinguistic database (Wilson, MD, 1988) and 
controlled for concreteness (range 100-700, mean 438) and word length (4-8 letter). Only 
concrete nouns were selected. This yielded a database of 1985 from which 480 words (3x test 
versions, 100x distractors, 80x test words) were drawn at random. These were then split across 
test groups at random. A number of t-tests were run to ensure the lists were matched for 
frequency, imageability, word length and proportion of animate versus non animate (alive or not) 
items in each list.   
 
Learning – RKNLearnIncidental 
In the learning block, a white fixation cross is shown for 1000ms and then a word is presented in red 
font on a black background for 3600ms. During learning participants are instructed to try to 
remember the words, along with selecting if they think the word is ‘alive’ – ‘yes’ or ‘no’, via button 
press. There are 80 target words (presented in a randomised order). The purpose of the question is to 
get participants to think about the meaning of the word, as this will help them remember the words 
later. If they press ‘yes’ or ‘no’ before 3600ms the word will remain on the screen until 3600ms has 
elapsed. If they do not respond within 3600ms the word will disappear and the next trial will begin. 
Script: 
You will see a series of words presented on the computer screen. 
Your task is to remember them later. We will test your memory by 
showing you a word on the screen and asking you if the word was on 
the list you see next, so you don’t need to be able to freely recall 
all the words.  
While you try to memorise the words we will ask you if each item is 
‘alive’ or not. For example, a tree would be alive and a rock would 
not be alive. The reason we ask this is to get you to think about 
the meaning of the words as we know this will help you remember them 
later. Not all of the words are easy to categorise, so if you are 
unsure, make your best guess. We do not mark your performance on the 
alive/not judgements. 
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We will test your memory on these words later today, tomorrow 
morning and then again over the phone 3 and 5 days later. Please 
read the instructions on the screen and let me know if you have any 
questions once you have read them.  
[Give the volunteer time to read the instructions and answer any questions] 
     On-screen instructions: 
 
'You will see a series of words displayed in the centre of the screen in 
red. 
 
You will decide if each word is alive using left and right buttons. 
 
Try to remember the words, as you will be tested on them later. 
 
























Testing – RKNTestIncidental 
At test, participants see a word on the screen and have to say if it is on the list they learned. The experimenter 
will use the button box to make responses on the volunteers’ behalf. If they respond ‘yes’ then they must 
decide whether the word is ‘remembered’, ‘familiar’ or ‘guessed’. They are instructed to respond ‘remember’ if 
they can recollect what they thought of when they saw the word on the screen. They respond ‘familiar’ if they 
do not have an actual memory of the word but it seems familiar, and ‘guess’ if they are purely guessing. If they 
respond ‘no’ they must decide if they are ‘sure’ or if they made a ‘guess’. The below diagram summarises the 
response options.  This diagram can be given to the participants.  
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20 target words are tested (with 20 novel distractors) at each test. In the morning test, to assess 
reconsolidation, the 20 target words that were tested the previous night are assessed together with 20 novel 




You will see a series of words presented on the computer screen. For each 
word your task is to determine if the word was on the list you learnt in 
the evening. If you say that the word was on the list, we will then ask you 
if you remember the word, if you are familiar with it, or if you are making 
a guess.  
The difference between remembering and being familiar is not simply how 
confident you are. These refer to different types of memories. If you 
Was this word on the list? 
MALARIA 
NO                                        YES 
1                                              5 
FELL 
REMEMBER        FAMILIAR        GUESS 
1                      3                     5 
MALARIA 
SURE                               GUESS 
1                                              5 
1 5 
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remember a word, you should be able to explain how you remember it. For 
example, if you saw the word ‘giraffe’ maybe you remember thinking about 
the giraffe and the rolling pin from the other task, or thinking about 
whether the giraffe was alive or not. If you are familiar with a word, you 
can be just as certain it was on the list, but not have any recollection of 
when you saw it. So for a familiar response you would not be able to 
explain how you know it was on the list. And a guess is a guess.  
I will be making all the responses for you, and each time you say you 
remember a word I will ask you how you remember it.  
If you say a word was not on the list we will ask you if you are sure or if 
you made a guess.  
Please read the instructions on the screen and let me know if you have any 
questions once you have read them. 
[Most do not have any questions. Sometimes during test volunteers insist on having a memory even when they 
cannot say how they remember the item. These are ‘familiar’ responses. This task is difficult for some 
volunteers to understand.] 
 
Script for the morning: 
You will see a series of words presented on the computer screen. For each 
word your task is to determine if the word was on the list you learnt in 
the evening. If you say that the word was on the list, we will then ask you 
if you remember the word, if you are familiar with it, or if you are making 
a guess. If you say it was not on the list I will ask you if you are sure 
of if you are making a guess.  
If you think a word you see now was on either of the lists you saw last 
night, then it would have been on the original list. All the distractor 
words are novel, so there are no tricks to this list and you are not asked 
to say whether you saw a word in one list but not the other. If you think 
you have seen a word before, make a ‘yes’ response.  
I will be making all the responses for you, and each time you say you 
remember a word I will ask you how you remember it, just as last night. 
Please read the instructions on the screen and let me know if you have any 
questions once you have read them. 
[Complete the test as it was completed the night before] 
 
RKN phone calls 
The phone call tests are run similarly to the RKNTest they complete on the computer, except that the words are 
read aloud by the experimenter, over the phone. Detailed step-by-step instructions on set-up are given in 
‘DOPAMIND Phone Call RKN Test SOP.docx’. 
Each word is read aloud clearly, and the participant must decide if the word was on the list they learned in the 
evening and answer ‘yes’ or ‘no’. If ‘yes’, they will then decide if they ‘remember’, if it is ‘familiar’ or if it is a 
‘guess’. Again, ‘remember’ refers to recalling extra details of the memory, and they must explain what it is they 
remember.  If they say ‘no’, they should then say whether they are ‘sure’ or ‘guess’.  
They should have been given a paper diagram showing these responses, which should also have the times of 
their phone calls written on it.  
You can repeat the word as needed, or spell it out, but cannot give a definition or use it in a sentence. 
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This can be run either on MATLAB (the same as the computer tests), via excel, or on a paper copy. 
For matlab, run RKNTestIncidental in the command window, and fill in the participant and version details. Then 
run as normal. 
For excel, open the ‘\DOPAMIND\Task Development\DOPAMIND\RKNtask\long term test version A.xlsx’ (or 
version B or C - check version number), and go to the appropriate sheet for the version (e.g. sheet A1 or B4). 
You need to randomise the order of the words, so double click on cell A2 and press enter, then highlight cells 
A2:C41, right click on column A and select ‘sort’ by ‘smallest to largest’. This will ensure the target and distractor 
words are presented in a random order. Save this file with the participant ID and version number in the name 
(e.g. ‘RKNTestIncidental_PPID101_SesNo1_VersA1_20183112’, replacing the PPID (e.g. 115), Session (1 or 2), 
Version (e.g. B3), and date in yyyymmdd format (e.g. 4th May 2018 becomes 20180504)). During the test, 
record their responses by putting a number 1 in the appropriate cell under ‘yes’ or ‘no’ then under 
‘remember’,’famililar’ etc. There MUST be 2 responses per row. 
For paper copy, go through the same steps for setting up the excel file, and after saving it, print out the cells 
A1:J42 – use Print Setup to print the gridlines to make it easier to fill in. After completing the test, you will have 
to enter the data back into excel, so make sure you have saved the file with the words in the same order as the 
printed version to make this easier. If you haven’t done this, you will have to put the words (and their word 
numbers) into excel by hand, in the order they were presented. 
Script: 
Hello, my name is [NAME] from the DOPAMIND study at CRIC. I’m calling to do 
the word test. Is now a good time? Do you have the diagram we gave you with 
the responses on it? 
This test will be like the ones you did in CRIC. I will read a word out, 
and you will decide if it was on the list you learned the other evening. 
The words I read out will either have come from that list you learned or 
they will be brand new words you did not see at all when you came into 
CRIC. 
If you think the word was on the list you read out, please say ‘yes’ and 
then whether you ‘remember’ the word, it is ‘familiar’ or a ‘guess’. 
‘Remember’ responses mean you can recall extra details about the word such 
as what you thought, or what words came before or after it. If you cannot 
recall any extra details, but are sure it was on the list, it is ‘familiar’ 
and if you are not sure it is a ‘guess’. 
If you think the word was not on the list you learned, say ‘no’ and then 
‘sure’ or ‘guess’. 
I can repeat the word as many times as you need, and spell it out for you, 
but I cannot give you a definition or use it in a sentence. 
Do you have any questions before we begin? 
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DOPAMIND Phone Call RKN Test SOP 
 
This document contains instructions for running the RKN test over the phone for the DOPAMIND study. 
These tests are done on day 3 and day 5 after each sleep visit. 
 
Booking 
1. Each call takes 10-15 minutes. Book the phone calls in for a time that suits the participant and yourself 
(or whichever experimenter will be running the phone calls). 
2. Write the times and dates of the phone calls on the back of the ‘RKN Diagram’ paper and give this to 
the participant. 
3. Create a calendar event for each phone call and invite whoever is doing the phone call, and also invite 
Hanna Isotalus to it so she has a record of all phone calls. 
a. This calendar event should include the version letter and number for each phone call test, the 




Before the phone call starts you need to setup for the test. You can run the test either on Matlab, Excel or a 
hard copy (e.g. paper print out of excel). 
1. Matlab: 
a. If using a button box, plug this in 
b. Open matlab 
c. Make sure you are in the ‘\DOPAMIND \Task Development\DOPAMIND\’ folder 
d. Double check the participant ID, test number and version number and letter 
e. Run ‘RKNTestIncidental’ 
f. Enter the details 
g. Leave it on the instruction screen until the phone call starts 
h. When you begin the test, press the button as instructed on the screen, and the appropriate 
buttons to record the responses.  
2. Excel: 
a. Open Excel 
b. Double check the participant ID, version letter and number 
c. Open the appropriate version of the excel file– i.e. if the test is version B3 then open 
‘\DOPAMIND\Task Development\DOPAMIND\RKNtask\long term test version B.xlsx’ 
d. Move to the appropriate sheet in the file – i.e. sheet ‘B3’. 
e. You now need to randomise the order of the words 
i. Double click on cell A2 
ii. Press enter 
iii. This will randomise the cells A2:A41 
iv. Highlight the cells A2:C41 
v. Right click on column A 
vi. Click ‘Sort’ 
vii. Click ‘Sort Smallest To Largest’ 
viii. This will randomise the order of column C – the words. 
f. Use ‘File’ -> ‘Save As’ to save this file as 
‘RKNTestIncidental_PPID101_SesNo1_VersA1_20183112’, replacing the PPID (e.g. 115), 
Session (1 or 2), Version (e.g. B3), and date in yyyymmdd format (e.g. 4th May 2018 becomes 
20180504). 
g. Move the cursor to cell D2 to start. 
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h. During the test, put a number 1 in the appropriate boxes for ‘yes’ or ‘no’, and then the box for 
‘remember’ etc 
i. EACH LINE MUST HAVE ONLY 2 BOXES FILLED IN!!!!!!!!!! 
3. Hard-copy: 
a. If you will not have access to a computer, you can print out a copy of the Excel sheet and fill 
this in by hand. You will need to then copy this data back into excel afterwards. 
b. Follow steps 2a-2f to randomise the word order for the appropriate version, and save the file 
(this will make it easier to enter the data later). 
c. Expand column B so that you can see the ‘word number’ 
d. Print cells A1:J42 – MAKE SURE YOU HAVE THE WHOLE LIST OF WORDS!!!! 
i. When printing, use ‘Print Setup’ to include the gridlines on the printout 
e. Make a note of the participant’s name and phone number if you may not have access to them 
later. 
f. When doing the word test, tick a box for ‘yes’ or ‘no’ and then one more box for secondary 
response (e.g. ‘remember’ or ‘guess’). There should be 2 ticks per line. 
g. After testing, you will need to enter the data back into an excel file. 
i. If you saved the version you printed, open that one 
1. Ensure the words are in the same order 
2. Enter the responses, putting a number 1 in the boxes 
3. There should be 2 responses per line 
4. SAVE THIS FILE 
ii. If you did not save the version you printed, you will need to put the words in the 
excel sheet into the same order as it was on the printed copy 
1. You can use ‘sort’ and the column of numbers on the printed sheet to do 
this if you know how 
2. Otherwise, enter the number (from Column B ‘Number’) and the word 
(Column C ‘WORD’) into the excel sheet 
3. Enter the responses as a number 1 – there should be 2 responses per line. 
4. Repeat for each word 
5. SAVE THIS FILE – See naming convention in Step 2f 
 
Test instructions 
These are the instructions to give to the participant at the start of each phone call test. 
1. Call the participant 
2. Introduce yourself and say you are calling to do the memory test 
3. Check that they have time to do the test 
a. If they don’t, or if they do not pick up, try to call back at a later point on the same day 
4. If they are happy to continue, you need to give them instructions mentioning: 
a. You will read out a list of words, some of which were on the list they made the ‘alive/not alive’ 
judgements about, and the others of which they won’t have seen at all during the testing. 
b. If they think the word was on the list, they should say ‘YES’ and then ‘REMEMBER’, ‘FAMILIAR’, 
or ‘GUESS’ 
i. ‘REMEMBER’ is if they can recall extra details about the word e.g. what they thought 
when they saw it, what came before or after etc. You must ask them what it is they 
can remember about each word they say REMEMBER for. If they cannot say what 
they can recall, then suggest it is FAMILIAR instead. 
ii. ‘FAMILIAR’ is if they are sure the word was on the list, but cannot recall any extra 
details (see above). 
iii. ‘GUESS’ is if they are not sure. 
c. If the think the word was not on the list, they should say ‘NO’ and then ‘SURE’ or ‘GUESS’ 
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d. You can repeat the word as many times as necessary, or spell it out for them, in case they do 
not hear it properly. But, you cannot give them any definitions or use it in a sentence. This is 
because many of the words have multiple meanings and you do not know which meaning they 
remembered it as. 
i. You may want to spell out certain words even if they don’t ask you to – especially for 
short words, words with homophones (e.g. STARE/STAIR) or if the phone-line is poor 
quality. You can also spell them out using the phonetic alphabet if needed (e.g. A for 
alpha, T for tango). 
5. Ask if they have any questions, and begin. 
Running the test 
1. Read the word 
2. Spell or repeat if necessary (see above, 4d) 
3. Record their responses in matlab/excel 
4. If they change their mind after making a response, this is allowed, so you can just edit this in 
excel/paper copies. If you are running it on matlab and have already pressed something else, just make 
a note of the word and what their response should be, and email Hanna about it. 
5. Do not try to sway their judgements about words if you happen to know what the correct response 
should be – always say them in the same tone of voice, and keep any prompts the same for targets and 
distractors. 
6. At the end of the test: 
a. Confirm the time/date of their next phone call or visit (if there is one) 
b. Thank them for their timeistration SOP DARet1 
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Remember-know 
Participants learned a list of words and delayed recognition was tested. In the learning block, a white 
fixation cross was shown for 2000ms and then a word was presented in white font on a black 
background (Figure 5.3) for 2000ms. The participants were instructed to read the word aloud and try 
to remember it. There were 48 words (presented in a randomised order), drawn from four semantic 
categories (e.g. trees, countries, weather phenomenon, body parts); 12 words from each.  
To test learning a recognition task was used. Participants saw a word on the screen and had to say if it 
was ‘old’ or ‘new’ via button press (Figure 2). If they responded ‘old’ then they had to decide whether 
they ‘remembered’, ‘knew’ or ‘guessed’. They were instructed to respond ‘remember’ if they could 
actually remember seeing the word on the screen, or reading it aloud or what they thought when 
they saw it. They responded ‘know’ if they did not have an actual memory of the word but it seemed 
familiar, and ‘guess’ if they purely guessed. If they had responded ‘new’ they would have to decide 
‘sure’ or ‘guess’. 
There were 48 words in the test, 24 of which were targets from the learning block and 24 of which 
were new distractors (see Appendix Table A.3 for the words used in each version). Of the 24 new 
words, 12 were from the same 4 categories as the learning words (e.g. trees, countries, weather 
phenomenon, and body parts), 3 from each, and the other 12 were from unrelated categories. 
 
   
FIGURE 2  DIAGRAM OF THE REMEMBER-KNOW TEST.  THE LEARNING TRIALS ARE SHOWN ON THE LEFT, AND THE 
TEST TRIALS ON THE RIGHT. 
The target words and semantically related distractors were drawn from two word lists (Murdock, 
1976; Van Overschelde, Rawson, & Dunlosky, 2004), and the unrelated distractors from the Toronto 
Noun Word Pool (Friendly, Franklin, Hoffman, & Rubin, 1982). The unrelated distractors were chosen 
so that none fit any of the semantic categories used in the study. The frequencies of the words were 
compared with a univariate ANOVA  (for 36/192 target words and 23/96 related distractor words the 
frequencies could not be found, this was mainly for cities/countries, animals, boats and kitchen 
utensils). The difference between frequencies of targets and distractors approached significance (F (1, 
323) = 3.601, p = .059) with targets having lower frequencies. When the semantically related and 
unrelated distractors were grouped separately, there was a significant (Bonferroni corrected) 
difference between related and unrelated distractors (p = .004), unrelated distractors and targets (p 
= .003) but no difference between related distractors and targets (p = 1). This means that the targets 
and related distractors were equally as frequent words, but that the unrelated distractors were more 
frequent words than the other two groups. As word frequency affects recognition memory (Brébion, 
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David, Bressan, & Pilowsky, 2005; Park, Reder, & Dickison, 2005), this is not ideal, and the effects of 
this will be addressed in the discussion. 
Four versions of the test were created with new words in each (no words occurred in more than one 
version). Participants completed the learning block, and two test blocks, one after 30 minutes and 
one after 24 hours. The second test had the other 24 words that did not appear on the 30 minute 
test, and all new distractor words. 
Learning 
I say:  
You’re going to see a list of words on the screen. For each word, you will have to read it out loud and 




Now we’re going to test you on the words you learned earlier. You’ll see a word and have to decide if 
it was on the list you read out loud earlier (i.e. it’s an OLD word), or if it wasn’t on the list (i.e. it’s 
NEW). 
If you decide it’s OLD, you’ll have to say whether you REMEMBER it, KNOW it or GUESS. The 
difference between remembering and knowing is whether you can recall anything about it, or if you 
just have a sense of familiarity about it. For example, if you see someone on the street and you can 
recall their name, or where you last met, that would be a REMEMBER response. However, if you 
recognised them, but couldn’t recall their name, or where you knew them from or where you last 
met, that would be a KNOW response. And if it was a pure guess, then press GUESS. 
And if you pressed NEW, you’ll be asked if you were SURE or GUESSed.  
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Database searched: MRC psycholinguistic database 
Accessed September, 2016 
 
Words searched by: 
 
Concreteness (range 100-700, mean 438) = 400 - 700  
Comprehensive syntactic category = NOUN 
Word length = 4-8 letters 
 
480 randomly selected from 1985 
Randomised using random number generator, and split in to 6 groups: 
3 x sets of distractor words (100 each) 





Frequency (KFFRQ) - measure of frequency in language 
Concreteness (CNC) 
Imageability (IMG) 
Word length (NLET) 
Inanimate/animate word (Animate) 
 
Results in -t-tests.txt files for each variable 
 
Inanimate = 1, animate = 0. No significant difference in proportion inanimate 
between groups.  
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Version 1 targets 
Word CNC IMG KFFRQ NLET CSYN RN 
FAMILY 525 577 331 6 N 0.7776905 
STAR 574 623 25 4 N 0.4195123 
COMPANY 424 426 290 7 N 0.6953901 
SWEEP 476 513 15 5 N 0.78569521 
INCENSE 499 555 2 7 N 0.95797438 
NURSE 588 617 17 5 N 0.41077601 
EDGE 465 495 78 4 N 0.60144248 
ICICLE 569 526 1 6 N 0.43386703 
LINKS 454 454 7 5 N 0.65575717 
MOUNTAIN 616 629 33 8 N 0.62344649 
SELLER 444 427 6 6 N 0.68561063 
TWEEZERS 590 619 - 8 N 0.62037132 
MOVIE 590 571 29 5 N 0.3753811 
DUCK 606 632 9 4 N 0.65798276 
ULCER 558 516 5 5 N 0.33834753 
RIBBON 600 563 12 6 N 0.87726555 
TICKET 590 574 16 6 N 0.12665878 
BROTHER 585 589 73 7 N 0.4760468 
MARCH 440 497 120 5 N 0.10823534 
LIMB 590 580 5 4 N 0.59536936 
LETTER 577 595 145 6 N 0.28749628 
FOIL 509 495 20 4 N 0.83328444 
JUMP 449 506 24 4 N 0.43472038 
DYNASTY 406 386 5 7 N 0.04465784 
MANURE 644 534 6 6 N 0.30087794 
CAGE 593 585 9 4 N 0.66855998 
CRYSTAL 587 579 23 7 N 0.69433876 
SOPRANO 497 535 6 7 N 0.32827687 
WATCH 487 525 81 5 N 0.94160774 
TIMBER 578 553 19 6 N 0.25912384 
ALGAE 545 424 7 5 N 0.58361547 
BOOTH 556 486 7 5 N 0.33495688 
TORNADO 644 591 1 7 N 0.03608038 
DRUG 555 564 24 4 N 0.57688664 
IODINE 576 508 18 6 N 0.02643328 
CARAVAN 539 562 8 7 N 0.86206998 
HERO 428 483 52 4 N 0.28137359 
SETTLER 533 528 3 7 N 0.63816102 
VODKA 576 613 - 5 N 0.91974612 
BOURBON 570 606 8 7 N 0.55622143 
NAIL 598 588 6 4 N 0.37992311 
HEEL 579 597 9 4 N 0.6015143 
TEST 520 528 119 4 N 0.42087697 
SALARY 456 452 43 6 N 0.70321106 
WEAPON 560 546 42 6 N 0.54826699 
KETTLE 602 594 3 6 N 0.05761774 
WIND 552 535 63 4 N 0.78563931 
SACK 582 548 8 4 N 0.98262205 
HARNESS 563 513 10 7 N 0.39289319 
HAWK 623 591 14 4 N 0.56973325 
HORN 618 566 31 4 N 0.99187891 
DRESS 595 595 67 5 N 0.93575812 
APPENDIX E: WORD LISTS FOR DOPAMIND 
 
APPENDIX PAGE 18 
 
ANIMAL 587 575 68 6 N 0.75065276 
SILK 538 510 12 4 N 0.60255075 
OVEN 593 599 7 4 N 0.00027783 
ASPIRIN 574 542 3 7 N 0.0720831 
POPE 593 576 40 4 N 0.21815235 
COLUMN 520 491 71 6 N 0.53625956 
MUCUS 565 570 2 5 N 0.94203231 
NERVE 488 486 12 5 N 0.95056153 
PLANK 592 598 7 5 N 0.84701924 
GASKET 525 487 4 6 N 0.78359895 
MAPLE 534 511 7 5 N 0.39921713 
GRAVE 535 619 33 5 N 0.53202194 
PRIZE 474 517 28 5 N 0.46544407 
OPIUM 552 487 16 5 N 0.62664598 
VESSEL 571 525 16 6 N 0.6528884 
SPEECH 453 447 61 6 N 0.59873327 
BLADE 584 568 13 5 N 0.53664393 
TEETH 618 611 103 5 N 0.01444932 
TUNNEL 555 578 10 6 N 0.64439578 
WORLD 532 560 787 5 N 0.59798935 
NEST 557 571 20 4 N 0.16795943 
SWELL 411 410 7 5 N 0.4296664 
GRAVEL 587 569 9 6 N 0.48686868 
TASK 409 410 60 4 N 0.53359044 
BUSH 585 549 14 4 N 0.707428 
PROPERTY 460 466 156 8 N 0.76470776 
PAPER 599 590 157 5 N 0.3802828 
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Version 1 distractors 
GLACIER STATUE EARTH SLEET 
TOMATO RICE STRAND NICKEL 
ABDOMEN SQUEAK BANNER PIGEON 
CRUCIFIX CAVE RACKET LAKE 
HOBBY SHOE BACTERIA LORD 
CAVERN VINEGAR MAIDEN NATION 
MOUSE QUAKE HYMN SHIVER 
MEDICINE PODIUM FORT VEHICLE 
LIFT STOVE BEAN ARTIST 
WALNUT JAIL HOUND GADFLY 
CEREMONY WAVE ARROW CHERRY 
SHOVEL INDIAN AXLE BATTLE 
BUFFER STOOL CLOVER FROCK 
LOOT WIGWAM CHILD RHAPSODY 
CHEEK MOTHER FLUTE MIRROR 
VEIL BLISTER PHONE FACTORY 
LOTION LEAD RADIO CANNON 
MULE CANOE DOCTOR OYSTER 
STEEPLE GARBAGE BIRD MANKIND 
WORK TOASTER RAKE CAMERA 
WIRE WICKET MILK IGNITION 
COTTON BEARD UNIFORM BIBLE 
ONION FUEL BANANA STORM 
FLOCK VIOLET VIOLIN BRANCH 
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Version B targets 
Word CNC IMG KFFRQ NLET CSYN RN 
CITIZEN 455 445 30 7 N 0.62125315 
IVORY 571 529 17 5 N 0.42768221 
PALETTE 565 437 5 7 N 0.69584421 
DISEASE 504 487 53 7 N 0.87741572 
CHINA 578 597 69 5 N 0.72552419 
CHOIR 567 567 8 5 N 0.04023133 
NOVEL 529 547 59 5 N 0.15084077 
ARCHERY 470 550 1 7 N 0.88962047 
SPECIMEN 481 417 24 8 N 0.77231011 
BENCH 614 555 35 5 N 0.49887357 
ESTATE 541 474 51 6 N 0.41236174 
TEAR 504 550 11 4 N 0.99871589 
BORDER 444 453 20 6 N 0.60049009 
HARD 425 460 202 4 N 0.26490238 
HOTEL 591 597 126 5 N 0.28712155 
POLLEN 584 526 11 6 N 0.37446559 
CARRIAGE 576 529 11 8 N 0.55233116 
COSTUME 544 538 10 7 N 0.63879656 
MORNING 515 579 211 7 N 0.84767042 
STICK 604 517 39 5 N 0.51170625 
SWARM 406 488 3 5 N 0.76444367 
WRITE 446 548 106 5 N 0.37961763 
CANDY 602 601 16 5 N 0.98908211 
HUSBAND 549 537 131 7 N 0.34642469 
SPECK 484 503 7 5 N 0.53944705 
DUCHESS 568 525 1 7 N 0.41255198 
INVADER 485 419 1 7 N 0.73769252 
MOON 581 585 60 4 N 0.89344872 
FOUNTAIN 593 602 18 8 N 0.2462212 
PYRAMID 615 613 2 7 N 0.71154758 
WEDDING 509 594 32 7 N 0.90809052 
CHALK 634 601 3 5 N 0.25658903 
SULTAN 563 541 3 6 N 0.70323256 
WALLET 584 617 6 6 N 0.03636808 
FAIRY 433 536 4 5 N 0.33214816 
COLLAR 622 582 17 6 N 0.86161709 
EARL 500 435 12 4 N 0.6500271 
WOOL 608 586 10 4 N 0.82810093 
BERET 578 517 - 5 N 0.77259066 
CARROT 622 577 1 6 N 0.04721404 
BRASS 577 524 19 5 N 0.4072141 
DOLLAR 575 611 46 6 N 0.42375795 
PYTHON 580 559 14 6 N 0.65373504 
PEAR 634 590 6 4 N 0.68807519 
AUTHOR 502 460 46 6 N 0.0660602 
GENTRY 452 462 1 6 N 0.45009962 
DAMSEL 544 551 1 6 N 0.77998607 
RIDGE 547 543 18 5 N 0.34520657 
AVENUE 539 564 46 6 N 0.50076406 
RHYME 434 475 3 5 N 0.56586328 
LIME 590 563 13 4 N 0.20049344 
ROBIN 637 615 2 5 N 0.62496588 
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STOCKING 551 555 1 8 N 0.18233298 
CLAM 564 541 3 4 N 0.78801261 
BAYONET 600 548 6 7 N 0.36210065 
SCORPION 590 596 - 8 N 0.52943374 
HIGHWAY 575 581 40 7 N 0.60985419 
FILM 604 562 96 4 N 0.53358287 
SOAP 598 600 22 4 N 0.0114836 
RECTOR 517 494 33 6 N 0.64511765 
WALK 452 505 100 4 N 0.84730126 
NEWS 437 484 102 4 N 0.59609322 
TOILET 586 603 13 6 N 0.02400484 
REFLEX 402 476 4 6 N 0.9136434 
TROUT 617 617 4 5 N 0.07823542 
DUST 550 549 70 4 N 0.47598977 
COOKIE 634 600 1 6 N 0.22901282 
MENU 555 613 5 4 N 0.16734743 
TRAIL 511 525 31 5 N 0.79104466 
MUSCLE 573 553 42 6 N 0.33742786 
CAROL 535 499 2 5 N 0.35723784 
WALRUS 629 590 1 6 N 0.73824496 
OXYGEN 484 430 43 6 N 0.22004256 
PLUG 558 583 23 4 N 0.94275856 
PORK 585 522 10 4 N 0.39307345 
CLOSET 599 525 16 6 N 0.95104557 
FOAM 577 600 37 4 N 0.60311278 
MILEAGE 421 460 15 7 N 0.71042793 
CANAL 598 588 3 5 N 0.94400366 
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Version B distractors 
SHAWL SUNSHINE WILLOW LITRE 
STADIUM SPINACH SMILE PILL 
POSTER FLEA SELF EAGLE 
PROFILE BUBBLE BEGGAR FOREST 
MARBLE SPRING CATTLE CHURCH 
OFFICE STRIPE LIAR TENT 
SCHOLAR TRIPOD GERM TROUPE 
LIGHTER HATCHET TEACHER CHEESE 
LEADER NEPHEW TEMPLE CORN 
QUARTER COIL VOTER SOUP 
GUARD PLANET SCOUT DUMMY 
SOIL MIXER PENNY FACE 
NATURE BASKET SERVANT GINGHAM 
SNAKE BLOOM VISITOR CIDER 
COFFIN BEACH HALL PIER 
NECKLACE CURLER SKATE FLOAT 
COURT SWORD MEAT DRAIN 
MINNOW DIRT VAULT COMPOSER 
SCARLET BRICK YAWN HUMAN 
FOREHEAD MAROON DECK SATIN 
BODY SEDATIVE VALLEY GONDOLA 
CRUMB INCOME CIRCLE PESTLE 
CONTRACT WOMB BOMB COFFEE 
CATFISH MACARONI MURAL SILVER 
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Words used in the retrieval phase of the DARet study.  
Remember/Know Task version 1. 
Target words 
Distractor words 
Related words Unrelated words 
ankle angelfish knee vapor 
hip eel lung witness 
foot carp hand herald 
tooth trout ear traffic 
wrist mackerel rib kitten 
lip blowfish eye echo 
chest catfish fir feather 
thigh shark cypress basket 
toe swordfish birch butter 
head sturgeon maple armour 
liver marlin spruce ribbon 
arm goldfish redwood blessing 
oak silk tuna navy 
evergreen mohair salmon Acid 
sycamore velvet minnow Water 
beech polyester cod Station 
cedar fleece halibut Event 
balsam flannel sardine Minute 
elm satin corduroy Product 
willow suede linen Button 
walnut leather tweed Helmet 
hickory cashmere cotton Moment 
teak wool spandex Candle 
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Remember/Know Task version 2. 
Target words 
Distractor words 
Related words Unrelated words 
ladle blizzard rollingpin Empire 
grater tornado spatula District 
knife mist sieve Refuge 
cup thunder blender Letter 
fork storm tongs Journal 
dish sleet toaster Captive 
spoon sunshine cantaloupe puzzle 
bowl hail papaya wagon 
stove wind honeydew motor 
kettle rain cherry resort 
pan flood raisin arrow 
colander lightning mango habit 
tangerine afganistan drizzle treasure 
grape cuba clouds fever 
prune switzerland snow spirit 
pear norway fog pillow 
strawberry finland typhoon dinner 
apple egypt frost career 
grapefruit iraq mexico gesture 
banana brazil venezuela banner 
orange ethiopia peru pitcher 
plum  australia canada acre 
watermelon iran  sweden college 
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Remember/Know Task version 3. 
Target words 
Distractor words 
Related words Unrelated words 
california hall alabama sandwich 
florida cellar tennessee ticket 
texas ceiling mississippi monkey 
new jersey kitchen kansas market 
arizona stairway massachusetts agent 
maine livingroom kentucky errand 
alaska floor bay barrel 
ohio office ocean tunnel 
colorado room glacier total 
nevada chimney volcano column 
hawaii closet cave prison 
michigan  wall mountain pontoon 
desert sailboat window rattle 
lake cruiseship hearth record 
river Yacht corridor canvas 
stream speedboat bedroom fortune 
gully Canoe cupboard heaven 
ravine Rowboat bathroom soldier 
canyon Motorboat raft level 
geyser Tugboat barge device 
crater Submarine dinghy blanket 
valley paddle boat boundary bubble 
tundra battleship titanic contest 
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Remember/Know Task version 4. 
Target words 
Distractor words 
Related words Unrelated words 
honda los angeles corvette circle 
toyota chicago cadillac fountain 
bmw rome chrysler machine 
chevrolet mumbai nissan penny 
jeep montreal mitsubishi angle 
porsche tokyo subaru survey 
lexus moscow chlorine model 
volkswagen berlin calcium patent 
ferrari stockholm lithium credit 
audi jerusalem copper cannon 
mazda cairo neon marble 
volvo vancouver aluminium concert 
oxygen fly copenhagen powder 
hydrogen ant brussels anchor 
carbon spider paris captain 
helium bee madrid orchard 
nitrogen mosquito naples poem 
gold beetle venice temple 
iron ladybird firefly couple 
silver grasshopper dragonfly carriage 
sodium butterfly hornet chapter 
potassium wasp caterpillar needle 
sulfur moth centipede picture 
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APPENDIX E: II Word lists DARet1 Encoding 
ankle ladle california honda  hip grater jersey toyota 
foot knife texas bmw  tooth cup maine chevrolet/chevy 
wrist fork arizona jeep  lip dish ohio porsche 
chest spoon alaska lexus  thigh bowl nevada volkswagen 
toe stove colorado ferrari  head kettle michigan audi 
liver pan hawaii mazda  arm colander lake volvo 
oak tangerine desert oxygen  evergreen grape stream hydrogen 
sycamore prune river carbon  beech pear ravine helium 
cedar strawberry gully nitrogen  balsam apple geyser gold 
elm grapefruit canyon iron  willow banana valley silver 
walnut orange crater sodium  hickory plum waterfall potassium 
teak watermelon tundra sulfur  aspen raspberry cellar zinc 
angelfish blizzard hall los angeles eel tornado kitchen chicago 
carp mist ceiling rome  trout thunder livingroom mumbai 
mackerel storm stairway montreal  blowfish sleet o?ce tokyo 
catfish sunshine floor moscow  shark hail chimney berlin 
swordfish wind room stockholm sturgeon rain wall jerusalem 
marlin flood closet cairo  goldfish lightning cruiseship vancouver 
silk afghanistan sailboat fly  mohair cuba speedboat ant 
velvet switzerland yacht spider  polyester norway rowboat bee 
fleece finland canoe mosquito  flannel egypt tugboat beetle 
satin iraq motorboat ladybird  suede brazil paddle grasshopper 
leather ethiopia submarine butterfly  cashmere australia boat wasp 
wool iran battleship moth  lycra india kayak cockroach 
knee rollingpin alabama nissan  ear blender kansas corvette 
lung spatula tennessee mitsubishi rib tongs massachusetts cadillac 
hand sieve mississippi subaru  eye toaster kentucky chrysler 
fir cantaloupe bay copper  maple cherry volcano chlorine 
cypress papaya ocean neon  spruce raisin cave calcium 
birch honeydew glacier aluminium redwood mango mountain lithium 
minnow drizzle window madrid  sardine fog bedroom copenhagen 
tuna clouds hearth naples  cod typhoon cupboard brussels 
salmon snow corridor venice  halibut frost bathroom paris 
corduroy mexico raft caterpillar cotton canada titanic firefly 
linen venezuela barge centipede spandex sweden catamaran dragonfly 
tweed peru dinghy flea  denim portugal pontoon hornet 
vapor empire boundary powder  navy refuge rattle circle 
witness district sandwich anchor  acid journal record fountain 
herald letter ticket captain  water spirit canvas machine 
traffic captive monkey orchard  station pillow fortune penny 
kitten puzzle market poem  event dinner heaven angle 
echo wagon agent temple  minute career soldier survey 
feather motor errand couple  product gesture level model 
basket resort barrel carriage  button banner device patent 
butter arrow tunnel chapter  helmet pitcher blanket credit 
armour habit total needle  moment acre bubble cannon 
ribbon treasure column picture  candle college contest marble 
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APPENDIX F: Trail making   
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Leeds Sleep Evaluation Questionnaire 
 
Please dissect the line where appropriate.  
A line dissected in the middle indicates no change to normal. 
 

















I feel less 
sleepy than 
usual 

















































How did you feel when you woke up? 
 








How do you feel now? 
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APPENDIX K: Blinding verification form 
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DARet1 Testing SOP 
All files stored on: 
N:\Doctors Folder\Neurology\BRACE neurology\Research Projects\Dopamine & Retrieval Site File 
  




Computer setup – same for all sessions 
1. Turn on & log in (socs-stop and st87df_### for Dell laptops) 
2. Open matlab, and make sure ‘current folder’ is  
‘C:\Users\socs-stop\Documents\DARet1\Data\X’ where X is the ppID for this participat 
Day 1 session 
1. Answer any questions the patient has 
2. Ask them to sign the consent form 
3. Go through the screening form 
4. Give them the patient information card 
5. Fill in the front of the pro-forma (incl medications + dosages) 
a. The versions should already be filled out for the later pages 
Begin Testing 
GainLoss 
1. Give participant instructions about the task 
2. Say ‘you’re going to start with the Practice trials’ and give them the instructions 
3. Run GLPratice(ppID,sesNo, versNo) with the relevant numbers 
4. Ask if they have any questions. 
a. Don’t talk through trials, but do keep an eye on them to make sure they understand how to do the 
task 
5. Now run GLLearn(ppID,sesNo,versNo) 
 
6. Novel Pairs Test 
a. Give instructions 
b. Run GLTestA(ppID,sesNo,versNo) 
Remember Know 
7. Give learning instructions 
8. Run RKNLearn(ppID,sesNo,versNo) 
30 min delay – paper tests 
9. Now complete paper tests (record versions & times on pro-forma) 
a. MoCA 




10. Now say ‘we’re going to test you again on the symbols task. Give instructions 
11. Run GLTestB(ppID,sesNo,versNo) 
Remember-know delay 
12. Give instructions 
13. Run RKNTestA or B with (ppID,sesNo,versNo) 
Sleep questionnaire 
14. Give SMHSQ 
Admin 
15. Confirm time & travel arrangements for tomorrow 
16. Get details for taxi if booking is needed 
 
#################### 
APPENDIX L: DARET TESTING SOP  
APPENDIX PAGE 40 
 
Day 2 session 
You need to have someone not involved in the testing for this participant perform the drug/placebo preparation. 
The instructions are in ‘Drug Preparation SOPV2.docx’. 
Begin Testing 
13. Sign consent form 
14. Go through continuance criteria 
Drug/placebo administration 1 
15. Go to day ward and measure blood pressure and heart rate (t0) 
16. Administer domperidone/placebo (purple drink) 
17. 30 minute delay 
18. Can’t be unattended, but can be left in day ward if other staff members are around. Check on them 
occasionally 
Drug/placebo administration 2 
19. After 30 minutes take BP and HR again (t30 – 30 minutes after baseline) 
20. Administer madopar/placebo (orange drink) 
21. Can’t be unattended, but can be left in day ward if other staff members are around. Check on them 
occasionally  
22. Wait 30 minutes and check BP and HR again (t60) 
23. Wait another 30 minutes and check BP and HR again (t90) 
24. Begin testing session 
Testing session 
 GainLoss 
25. Give instructions 
26. In Matlab, run GLTestC(ppID,sesNo,versNo) 
Remember-know 
27. Give instructions 
28. Run RKNTestB or A (ppID,sesNo,versNo) 
Paper assessments 
29. Now complete paper tests (record versions & times on pro-forma) 
a. Digit span 
b. SMHSQ 
c. Any tests not done on day 1 (these can also be given during medication delays if needed) 
Long-term remember-know learning 
30. This is for the long-term RKN tests which will be done over the phone 
31. Confirm they are OK to do the phone calls and set times for them (record on sheet + calendar) 
32. Give instructions (same as before) 
33. Run LongTermRKNLearnA or B with ppID and sesNo (no versNo) 
34. Now give the testing instructions 
35. Run LongTermRKNTestA or B with ppID, sesNo and versNo 
Admin 
Make sure the phone calls are booked in 
36. Check how they are feeling 
37. Confirm the date for the next sessions 
38. If returning by taxi, see them into the taxi and pay for it 
 
Phone calls 
1. 1 day (24 hours) after day 2 LongTermRKNLearn 
a. Call them 
b. Ask how they were after yesterday’s session 
c. Open up the ‘long term test version A.xlsx’ or version B, as appropriate 
d. Give instructions 
e. Read each word loudly and clearly 
f. Record their response 
i. You need a response for OLD/NEW and then REMEMBER/KNOW/GUESS or 
SURE/GUESS 
g. Confirm the time of the next call 
h. Thank them 
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2. 3 days (72 hours) after day 2 LongTermRKNLearn 
a. Same as previous call (except for b.) 
3. 5 days (120 hours) after day 2 LongTermRKNLearn 
4.  
Days 3 and 4 + phone calls 
Same as days 1+2+phone calls session, except different versions of task and digit span given. 
Digit span and SMHSQ are done each day, but all other paper assessments are done just once. 
To transfer the data to the hard drive  
1. Plug the hard drive in to the computer 
2. Copy all the .txt, and .mat files created for this participant in the working folder you selected back at the 
beginning 
3. Copy these to the N drive folder 
N:\Doctors Folder\Neurology\BRACE neurology\Research Projects\Dopamine & Retrieval Site 
File\Data\ 
and to the hard drive  
4. If there isn’t already a folder for that participant, copy the ‘PPID’ folder and rename it 
5. SAFELY EJECT THE HARD DRIVE!!!!!!!!!!!! 
ONS BETWEEN SPINDLE CHARACTERISTICS AND MEMORY 
APPENDIX M SLEEP CORRELATIONS  
APPENDIX PAGE 42 
 
Normality tests 
All behavioural measures (tagged, non-tagged and tagging effect for D’ across L-DOPA and placebo) were normally 
distributed. For stage 2, spindle density on placebo and frequency change between L-DOPA and placebo were the 
only measure where kurtosis was >2, other measures (duration and frequency) were normally distributed. For slow 
wave sleep spindles all characteristics except spindle amplitude and density change were normally distributed.   
Pearson’s correlations between slow wave and stage 2 spindles against memory performance on L-DOPA and on 
placebo revealed no further associations between spindles and memory.  
L-DOPA spindle amplitude against memory 
      Stage 2  Slow wave sleep 
Non-tagged   
Pearson r  -0.037   -0.059    









p-value   0.984   0.891    








p-value   0.878   0.903    
 
 
Placebo spindle amplitude against memory 
      Stage 2  Slow wave sleep 
Non-tagged   
Pearson r  0.281   0.283   









p-value   0.188   0.226   
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L-DOPA induced changes in spindle characteristics against memory 
No effects.  
 
Stage 2      Tagging effect Non-tagged  Tagged  










p-value   0.648   0.245   0.700    










p-value   0.099   0.053   0.735    
Frequency  
 








p-value   0.957   0.791   0.370    
 
Slow wave sleep      Tagging effect Non-tagged  Tagged  
Density   
Spearman's rho   -0.088   0.147   0.052    
p-value   0.635   0.430   0.779    
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Exclusion criteria 
Participants did not have: 
 clinically significant neurological or psychiatric diagnoses as assessed by self-report and 
questionnaires during the screening visit. They were considered clinically significant if they 
could either interact with drug effects, sleep or memory tests.  
 a diagnosis of mild cognitive impairment or dementia to ensure participants would be able 
to perform the memory tasks.  
 undiagnosed skin lesions  
 sensitivity to levodopa, benserazide, or domperidone. 
 lactose intolerance, galactosemia or glucose/galactose malabsorption. 
 galactose intolerance. 
 Lapp lactase deficiency. 
 diagnosis of Huntington’s Chorea. 
 clinically significant intention tremor.  
 known prolactin-releasing pituitary tumour (prolactinoma). 
 diagnosis of glaucoma. 
 a history of, or current, malignant melanoma.  
 current cancer treatment. 
 diagnosed unstable diabetes (people with stable type 2 diabetes diet-controlled diabetes 
were included) 
 severe endocrine, hepatic, renal, pulmonary, or cardiac disorder. 
 diagnosed electrolyte disturbances. 
 known peptic ulcers. 
 history of a heart-attack or prolongation of cardiac conduction intervals, or any other 
cardiac problems as taking domperidone increases risk of said problems. 
 childbearing potential or pregnancy. 
Participants were also excluded if they were taking any of the following: 
 dopaminergic medications. 
 noradrenergic, serotonergic, or anticholinergic medications started or changed within the 
past 3 months. 
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 monoamine oxidase inhibitors (MAO-I), except if selective MAO-A or MAO-B inhibitors 
are given alone. MAO-A and MAO-B inhibitors given together are equivalent to non-selective 
MAO-inhibition and therefore volunteers taking both MAO-A and MAO-B were not 
included. 
 cholinesterase inhibitors, except if the participant was on stable treatment (at least 3 
months). 
 antihypertensives containing reserpine. 
 ferrous sulphate on the day of dosing. 
 opioids or sympathomimetics (e.g. amphetamines, epinephrine/adrenaline) unless if the 
participant was able to abstain on the day of dosing. 
 diazepam or other benzodiazepines, unless none taken for prior 3 days or stable dose was 
maintained for more than 3 months. 
 ketoconazole, erythromycin or CYP3A4 inhibitors (e.g. fluconazole, voriconazole, 
clarithromycin, amiodarone, telithromycin). 
 antibiotics, if taken to treat an active infection. 
 hormone replacement therapy. 
 anti-fungal agents (pentamidine). 
 anti-malarial agents. 
 antihistaminics unless stable dose for 3 months or none for 3 days prior to testing sessions. 
 AIDS/HIV medications. 
 Any QTc prolonging medicinal products. 
 if a participant took antacids or antisecretory agents they were required not to be taken at 
the same time as L-DOPA  
Participants were asked to provide a list of medications and supplements they were taking, 
including alternative medication. A clinician verified each volunteer’s eligibility and that none of 
these medications interfered with co-beneldopa, or domperidone.  
Majority of the exclusion criteria were set to reduce risk of unwanted side effects from taking 
either levodopa or domperidone. The exclusion criteria were set based on the summaries of 
product characteristics for the medications uses in this thesis, expert advice from the study PI 
(Liz Coulthard, consultant neurologist) and from neurologists Dr Claire Rice and Dr Catherine 
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Pennington, as well as members of the NHS ethics board and upon regulatory authority 
recommendation.  
Additional exclusion criteria for DOPAMIND 
For the DOPAMIND study, I excluded volunteers with clinically significant sleep problems in the 
past year. I consider a sleep disorder to be clinically significant when it results in fewer than 6 
hours' sleep per night regularly, in the estimation of the volunteer, and when they self-reported 
impaired sleep. Sleep disorders that required intervention (including equipment or medication) 
likely to interfere with our protocol or people with diagnosed sleep disorders who require 
intervention but who are unable to or have decided not to have the intervention (e.g. people with 
sleep apnoea for which a mask was recommended but who could not tolerate the mask) were also 
excluded. One volunteer was excluded for being a wheelchair user, as it was not possible not 
accommodate for a carer to stay with the volunteer.  
Magnetic resonance 
Participants could take part in other aspects of the DOPAMIND trial even if they were not eligible 
to be scanned in the MRI. For the MRI, participants’ suitability was assessed case-by-case if they 
had any metal in their body, such as: 
 a pacemaker 
 an implantable cardioverter-defibrillator (ICD) 
 a nerve stimulator or a drug pump implant 
 a cochlear implant 
 brain aneurysm clips 
 metallic fragments in or near eyes or blood vessels (common in people who do or have done 
welding or metalwork for a living). 
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 prosthetic (artificial) metal heart valves 
 penile implants 
 eye implants 
 an intrauterine device (IUD), i.e. contraceptive coil 
 artificial joints 
 dental fillings or bridges 
 tubal ligation clips  
 surgical clips or staples used to close wounds after an operation 
Decisions about eligibility to scan were made by the first operator of the MRI scan (typically Hanna 
Isotalus) referring to established guidelines (e.g. MRIsafety.com). Where there was uncertainty, an 
expert radiographer was consulted.  
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Randomisation and blinding 
Treatment order was randomised in blocks of 6 using an Excel randomisation program written 
in Excel. A block randomisation approach was used to allow for interim analyses and safety 
monitoring. Six blocks were randomised in one go (n = 36) and no repeat blocks were allowed.  
Different preparation, randomising and blinding procedures were used for the two studies as 
DOPAMIND drug provision, randomisation and blinding was performed by the pharmacy while 
in DARet these were performed by members of the ReMemBr group.  
DOPAMIND 
The UBH Pharmaceuticals, Bristol Royal Infirmary, performed the randomisation and issued 
drugs and placebos in opaque pre-labelled bottles together with sealed unblinding envelopes. 
The bottles were labelled by participant and visit number. The capsules were not perfectly 
matched as due to copyright – a small imprint (‘Roche’) on the co-beneldopa capsule could not 
be printed on the placebos. The drugs were administered by a study doctor, who was blind to 
treatment allocation, with no investigators in the room. The doctor did not administer any of the 
experimental tasks. Participants were encouraged to pop the capsules directly from the bottle 
into their mouth without inspecting them. 
Unblinding envelopes were sealed and stored on site at CRICBristol in St Michael’s Hospital, 
and copies were stored in the ReMemBr group office in Southmead hospital. Unblinding was 
performed by two researchers after the 1st and 5th blocks of participants, and at the end of the 
study. The first unblinding was done due to adverse events (Appendix A), and the second (after 
5th block) to allow data to be used for MSc and PhD student projects and conference 
presentations. 
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Initially, the DOPAMIND study also had a ropinirole (D2-agonist) arm. However, this was 
given to participants in a dose that induced nausea despite the use of anti-emetic. For this reason, 
this arm of the study was pulled out after first 6 participants had been tested. Further details are 
available in the appendices.  
DARet 
The randomisation was performed by a member of the ReMemBr group (Miss Brogan Knight), 
who had no other role in this study. She prepared two envelopes for each participant – one for 
both (placebo and treatment) sessions – and a master unblinding envelope for the entire study 
and for each block separately. A member of the ReMemBr group, who had no other role in this 
trial, unsealed the envelope and mixed either the placebo or the medication in accordance to 
detailed instructions (Appendix B). The unblinding envelopes were sealed and stored on site. At 
each visit, the person who mixed the cordial held onto the unblinding information until the 
participant was sent home. The master envelopes were opened after 3 blocks – for MSc 
dissertations – and again at the end of the study by two researchers. 
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Treatment 
In the DOPAMIND trial, participants received encapsulated co-beneldopa controlled release 
containing 200mg of L-DOPA. This form of L-DOPA is active in the system for up to ~12h.  
In the DARet trial, participants received a 150mg L-DOPA dispersible. This type of L-DOPA 
reaches tMax in ~1.5h.  
Drug doses were selected based on previous research (Chowdhury et al., 2012). Both studies 
used co-beneldopa and placebo together with the anti-emetic Domperidone. Co-beneldopa 
contains both L-DOPA and benserazide. L-DOPA is a dopamine precursor that is absorbed into 
the blood stream and that passes the blood-brain barrier. It is converted to dopamine by DOPA 
decarboxylase centrally and in the periphery. Benserazide is a DOPA decarboxylase enzyme 
inhibitor. As benserazide does not cross the blood-brain barrier, its coadministration reduces 
peripheral L-DOPA conversion into dopamine increasing dopamine availability centrally.  
Nausea caused by peripheral dopamine binding is a common side effect of dopaminergic 
medications. The antiemetic domperidone, a peripheral dopamine-inhibitor, was used to reduce 
nausea.  
DOPAMIND 
On each testing session, domperidone (10mg) was administered in tablet form. 30 minutes later, 
the volunteers were given a single oral dose of either co-beneldopa controlled-release (CR; 
200mg/50mg administered as 2x capsules of 100mg/25mg), or inert powder (2x microcrystalline 
cellulose in capsule form Figure 45 A. The time to reach maximum plasma concentration (tMax) 
is approximately 3h and the peak serum concentration (cMax) is approximately 58% for co-
beneldopa CR. Figure 45 B provides basic pharmacokinetic information based on the Summary 
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of Product Characteristics and does not present measurements made by mass spectroscopy. 
Instead, a linear rise of tMax was assumed. 
The drugs and the placebo were issued by United Bristol Healthcare Pharmaceuticals.  The 





Figure 45: Co-beneldopa capsules and half-life curve 
 
Figure 45: Co-beneldopa capsules and half-life curve  
Visual guide to blinded capsules and half-life curve for co-beneldopa controlled release 
A) The co-beneldopa capsules had an imprint while the placebo capsules did not. This is a guide to 
demonstrate blinding only and does not correspond exactly to the medicinal products. (B) The area under 
the curve demonstrates an estimate of the total exposure to L-DOPA over time, i.e. the drug concentration 
in plasma as a factor of time. 
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DARet 
In the L-DOPA condition, volunteers were given 10ml of Domperidone suspension (liquid 
form), and 37.5/150mg co-beneldopa dispersible. The half-life of this form of co-beneldopa is ~ 
112 minutes in the elderly population according to the Summary of Product Characteristics. The 
Domperidone was measured using an oral syringe and diluted into 40ml of blackcurrant cordial 
to mask its taste and colour. Co-beneldopa was diluted into 40ml of orange cordial. In the 
placebo condition 40ml blackcurrant and orange cordials with Vitamin C (250mg) mixed into the 
latter were given. Residue from the vitamin mimicked that from co-beneldopa. All mixtures were 
then diluted into a small amount of water. The blackcurrant and orange drinks were used as their 
distinct colours prevented the investigators from accidentally dosing the volunteer with co-
beneldopa first.  
The domperidone and co-beneldopa were purchased from the North Bristol Trust pharmacy, 
Brunel Building, Southmead Hospital, Bristol, and the Vitamin C from a supermarket.  
 
Monitoring 
Participants were carefully monitored throughout the study visits (Appendix C), and study drugs 
(/placebo) were only administered where physiological monitoring was within safe limits. Where 
there was uncertainty the Consultant Neurologist (EJC) was consulted. If a volunteer showed 
signs of nausea following the administration of the L-DOPA, another dose of Domperidone was 
given immediately.  
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Study visit schedule 
An example of a sleep visit evening schedule for the DOPAMIND study for two volunteers tested on the 
same night.  
 
Note that the times are not to scale and that the t(0) in this schedule refers to domperidone and not 
L-DOPA. The first and last column denote target times for events. The 2nd and 3rd columns denote the 
schedule for each participant. Columns 4-6 denote responsibilities allocated to the three researchers carrying 
out the study visit (HKI (me), OR (Oliver Radtke) and RW (Rachel Williams). Column 7 denotes the arrival 
time and responsibilities for the research assistant who stayed up to monitor the night. Column 8 contains 
the timetable for the study doctor. Up to two participants could be tested once. 
Abbreviations are explained in table 4. 
